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ABSTRACT
Soluble enzymes have the unique ability to assist the conversion of complex
substrates in fewer steps compared to conventional chemical synthesis; however, when
immobilized to a surface, the insoluble enzyme's activity and stability can suffer in its new
environment. To improve upon future immobilized enzyme efficacy, a fundamental
understanding of the interactions across the enzyme, linker, and surface during covalent,
site-specific immobilization that can be detrimental to its activity is required. More
specifically, using a well-characterized and model enzyme, T4 lysozyme (T4L), 28 different
cysteine attachment points' effects on site-specifically immobilized activity are examined.
Different combinations of heterobifunctional amine-to-sulfhydryl crosslinkers and
hydrophobic and hydrophilic aminated polymer surfaces are used to immobilize T4L sitespecifically via amine-to-sulfhydryl conjugation. The cysteine mutations availability and
accessibility result in heuristics that minimize nonspecific adsorption while maximizing
site-specific conjugation. Based on the findings, an improved method for site-specifically
immobilizing biotinylated T4L on streptavidin-coated polymer beads is developed. Innate
structural characteristics such as cysteine accessibility, amino acid consensus, and
enzyme surface concentration enhance immobilized enzyme’s specific catalytic efficiency
regardless of the attachment site and orientation.

ii

DEDICATION
Special thanks to my parents.

iii

ACKNOWLEDGMENTS
I want to acknowledge the dissertation committee for their dedication and guidance
along my doctoral path. The committee includes Dr. Mark A. Blenner, Dr. Marc R.
Birtwistle, Dr. Scott M. Husson, and Dr. Alexey A. Vertegel.
I want to acknowledge the very informative conversations between Dr. Rakesh
Sachdeva and Dr. O. Thompson Mefford, regarding the principles and fundamentals of
MALDI-TOF for protein analysis and the limiting factors when dealing with polymercoated particles for immobilization, respectively.
I want to acknowledge the professors and faculty that provided training and
instructions to use their analytical equipment. This includes Dr. Jessica M. Larsen and Dr.
O. Thompson Mefford for the Zetasizer Nano MS (Malvern Instruments), Dr. Marc R.
Birtwistle for the Licor Imager, Russell Hubbard for Bruker's MALDI-TOF, and the
Clemson Light Imaging Facility (CLIF) for flow cytometry.
I want to acknowledge Dr. Sapna Sarupria and Dr. Siva Dasetty for their contribution
to the molecular dynamic simulations of T4 lysozyme.
I want to acknowledge Adam Beitz, Calvin Martin, and Lane Norris for their efforts
and contribution towards reaching the project's goals.
I want to acknowledge that the funding for this dissertation work was provided by
the Defense Threat Reduction Agency, DTRA (HDTRA-1-16-1-0023), Clemson University,
and the Earl C. Ray Fellowship.

iv

TABLE OF CONTENTS

Page
TITLE PAGE ........................................................................................................................ i
ABSTRACT ......................................................................................................................... ii
DEDICATION .................................................................................................................... iii
ACKNOWLEDGMENTS ..................................................................................................... iv
LIST OF TABLES ................................................................................................................. x
LIST OF FIGURES .............................................................................................................. xi
CHAPTER
I.

INTRODUCTION ............................................................................................ 15
Benefits of Enzyme as a Catalyst ..................................................... 15
Industrial Applications of Immobilized Enzyme............................... 16
History of Enzyme Immobilization ................................................... 17
Immobilization Type Influences of Enzyme Structure-Function...... 20
Enzyme-Crosslinker-Surface Complex ............................................. 21
Site-Specific Immobilization............................................................. 24
Dissertation Outline ......................................................................... 26

II.

PROTEIN MODIFICATION ............................................................................. 30
Introduction .......................................................................................... 30
Methods ................................................................................................. 31
Acetylation of T4L ........................................................................... 31
MALDI-TOF Acetylation Detection .................................................. 35
Blocking T4L Carboxylic Acids with EDC ........................................... 36
NHS-(spacer arm)-Maleimide Crosslinker Conjugation to HRP ....... 37
Results and Discussion ........................................................................... 38
Multiple Lysine Acetylation Effects on T4L Solubility ...................... 38

v

Table of Contents (Continued)
Effects of Carbodiimide Conjugation on Enzyme Activity................ 45
Natural Site-Specific NHS-ester Conjugation to HRP ....................... 47
Conclusion .............................................................................................. 48
III.

T4L CREATION, EXPRESSION, PURIFICATION, AND ACTIVITY ...................... 50
Introduction ........................................................................................... 50
Methods ................................................................................................. 54
Primer Design for QuikChange Mutagenesis ................................... 54
Mutagenesis PCR Reaction and Thermal Cycler Conditions ........... 54
Plasmid Verification and Glycerol Stock Creation ........................... 55
T4L Expression Test Using Dot Blot Analysis .................................... 56
Overexpression and Cell Harvest of T4L .......................................... 57
Cell Lysis of T4L................................................................................. 58
Purification of T4L via Ion Exchange Chromatography .................... 58
Lysozyme Activity Assay .................................................................. 60
Determining Initial Rates for Activity Quantitation ......................... 61
Freeze-Thaw Cycles for Storage Stability ......................................... 61
Results and Discussion ........................................................................... 61
Comparable WT and WT* Activity ................................................... 61
Distribution of Cysteine Substitutions in
T4L’s Amino Acid Sequence ....................................................... 63
Variance across T4L Mutant Expression .......................................... 64
Impact of Single Cysteine Mutations on Purification ....................... 66
Buffer Effects on Activity Assays ...................................................... 68
Stability of Storage Conditions ........................................................ 71
Conclusion .............................................................................................. 73

IV.

HETEROBIFUNCTIONAL CROSSLINKER CHARACTERISTICS........................... 74
Introduction ........................................................................................... 74
Methods ................................................................................................. 78
Detecting Maleimide Content for Different Crosslinker Types ....... 78

vi

Table of Contents (Continued)
Hydrolysis Rates of NHS-Ester for Each Crosslinker ........................ 78
Maleimide Activation of Aminated Dynabeads ............................... 79
Results and Discussion ........................................................................... 79
Comparison of Each Heterobifunctional Crosslinker Inherent
Properties................................................................................... 79
Conclusion .............................................................................................. 84
V.

IMMOBILIZATION OF T4L VIA AMINE-TO-SULFHYDRYL CROSSLINKER ....... 86
Introduction ........................................................................................... 86
Methods ................................................................................................. 88
Immobilization of T4L WT*, M1_N2insC, S44C, V57C, A93C, and
Q123C on Aminated Polystyrene via GMBS Crosslinker ........... 88
Immobilization of T4L WT*, M1_N2insC, S44C, and K60C on
Aminated Polystyrene via SM(PEG)2, LC-SMCC, GMBS, and
MBS Crosslinker ......................................................................... 89
Immobilization of T4L WT*and M1_N2insC on Aminated Dynabeads
via GMBS Crosslinker ................................................................. 89
Immobilization of T4L WT*and M1_N2insC on Aminated Dynabeads
via MBS Crosslinker .................................................................... 90
Immobilization of T4L WT*and M1_N2insC on Aminated Dynabeads
via SM(PEG)2 Crosslinker............................................................ 92
Immobilization of T4L WT*and V57C on Aminated Dynabeads via ...
SM(PEG)2 Crosslinker ................................................................. 92
Results and Discussion ........................................................................... 93
Immobilization of T4L WT*, M1_N2insC, S44C, V57C, A93C, and
Q123C on Aminated Polystyrene via GMBS Crosslinker ........... 93
Immobilization of T4L WT*, M1_N2insC, S44C, and K60C on
Aminated Polystyrene via SM(PEG)2, LC-SMCC, GMBS, and
MBS Crosslinker ......................................................................... 99
Immobilization of T4L WT*and M1_N2insC on Aminated Dynabeads
via GMBS Crosslinker ............................................................... 101
Immobilization of T4L WT*and M1_N2insC on Aminated Dynabeads
via MBS Crosslinker .................................................................. 104

vii

Table of Contents (Continued)
Immobilization of T4L WT*and M1_N2insC on Aminated Dynabeads
via SM(PEG)2 Crosslinker.......................................................... 105
Immobilization of T4L WT*and V57C on Aminated Dynabeads via ...
SM(PEG)2 Crosslinker ............................................................... 106
Conclusion ............................................................................................ 108
VI.

NONSPECIFIC ADSORPTION AND CYSTEINE INACCESSIBILITY REMEDIATION
FOR IMPROVED IMMOBILIZATION STRATEGY ..................................... 110
Introduction ......................................................................................... 110
Methods ............................................................................................... 110
Washing beads with various surfactants to reduce nonspecific
binding ..................................................................................... 110
Nonspecific immobilization of T4L WT* and M1_N2insC on
Aminated Polystyrene Beads ................................................... 111
Immobilization of T4L WT* and M1_N2insC on aminated
via MBS crosslinker with nonfat milk blocking ........................ 111
SDS-PAGE for monomer and dimer protein detection .................. 113
Labeling cysteine with Maleimide-C5-AF488 ................................. 113
Results and Discussion ......................................................................... 114
Washing maleimide activated beads with various surfactants to ......
reduce nonspecific binding ...................................................... 114
Nonspecific immobilization of T4L WT* and M1_N2insC on
Aminated Polystyrene Beads with nonfat milk blocking ......... 117
Immobilization of T4L WT* and M1_N2insC on Aminated DynaBeads
via MBS Crosslinker with Nonfat Milk blocking ....................... 119
Cysteine availability (monomer/dimer) ......................................... 121
Cysteine accessibility (maleimide fluorescent probe) ................... 127
Conclusion ............................................................................................ 133

VII.

IMMOBILIZATION OF T4L TO STREPTAVIDIN COATED BEADS VIA BIOTINMALEIMIDE CROSSLINKER ................................................................... 134
Introduction ......................................................................................... 134

viii

Table of Contents (Continued)
Methods ............................................................................................... 139
Conjugation of maleimide-PEG11-biotin crosslinker to T4L ........... 139
Immobilization of biotinylated T4L ............................................... 139
T4L activity assay............................................................................ 141
Results and Discussion ......................................................................... 142
Load and immobilization composition and quantitation ............... 142
Immobilization efficiencies ........................................................... 151
Soluble enzyme concentration effects on activity ......................... 154
Comparison of enzyme activity at different states ........................ 160
Conclusion ............................................................................................ 165
VIII.

CONCLUSION AND FUTURE WORK ............................................................ 168

APPENDICES .............................................................................................................. 175
A:
B:
C:
D:
E:
F:

Number of acetyl group modifications on T4L WT* .................................. 175
T4L mutation creation, expression, and activity........................................ 177
Theoretical model of cysteine substitutions and corresponding structural
elements .............................................................................................. 183
Programmable coding for T4L activity (Opentrons python code) ............. 192
The enzyme cytochrome P450 (CYP201A2) ............................................... 197
Materials .................................................................................................... 206

REFERENCES .............................................................................................................. 213

ix

LIST OF TABLES

Table

Page

2-1

Outline of experimental procedures for acetylation of T4L with acetic
anhydride that highlights key conjugation parameters. ....................... 39

7-1

T4L mutant catalytic efficiency normalized to soluble WT* ..................... 161

B-1

Primers for site-directed mutagenesis of T4L WT* ................................... 178

x

LIST OF FIGURES
Figure

Page

1-1

Examples of immobilized enzymes in industry ............................................ 16

1-2

Each component of enzyme-crosslinker-surface complex forms the basis of
all enzyme immobilization types. .......................................................... 22

2-2

T4L acetylation fraction resulting from different molar ratios of acetic
anhydride to enzyme. ............................................................................ 41

2-3

The relationship of the amount of protein recovered post-desalting
operations to the degree of acetylation from different reaction pHs .. 42

2-1

The reduction in signal intensity of T4L WT* at various levels of acetic
anhydride treatment using MALDI-TOF................................................. 43

2-5

Change in T4L WT* isoelectric point based on acetylation of lysine........... 44

2-6

Detecting blocked carboxylic acids from EDC derived modification using SDSPAGE. ...................................................................................................... 45

2-7

Comparing the activity of T4L WT* when modified by EDC ........................ 46

2-8

(Left) Image of linker characteristics and the site of primary NHS-ester
attachment (K232) of HRP enzyme. (Right) Comparing the activity of HRP
after different modified with four different crosslinker. ....................... 48

3-1

(A) Comparison of T4L WT and cysteine-free WT* and (B) the stability of T4L
WT* throughout five freeze-thaw cycles............................................... 62

3-2

164 amino acid sequence of T4L WT* including selected cysteine
substitutions .......................................................................................... 64

3-3

Comparing the expression levels of T4L mutants on a cell culture turbidity
basis ....................................................................................................... 65

3-4

Shifts in conductivity at time elution for each T4L mutant ......................... 66

3-5

Effects of buffered salt and sodium azide on T4L activity ........................... 68

xi

List of Figures (Continued)
Figure

Page

3-6

Effects of buffered salt on a per normalized T4L mutant basis ................... 70

3-7

Effects of Tween-20 on T4L activity ............................................................. 71

3-8

Stability of T4L mutants after three separate freeze-thaw cycles .............. 71

3-9

Stability of T4L WT* and S44C stored at 4 °C in 50 mM sodium phosphate and
50 mM sodium chloride, pH 7.5. ........................................................... 73

4-1

Four different heterobifunctional crosslinkers for amine-to-sulfhydryl
conjugation ............................................................................................ 76

4-2

NHS-ester and maleimide reaction with amine and sulfhydryl ................... 76

4-3

Difference in maleimide content of NEM (control), GMBS, MBS, LC-SMCC,
and SM(PEG)2 ......................................................................................... 81

4-4

Hydrolysis rates of NHS-ester of different heterobifunctional crosslinkers.82

4-5

Maleimide activation of aminated polymer surface with four different
crosslinkers ............................................................................................ 83

5-1

Order of operations for the enzyme immobilization using amine-to-sulfhydryl
heterobifunctional crosslinker to site-specifically adhere single cysteine
mutants to the bead surface. ................................................................ 87

5-2

(A) Zeta potential of immobilized T4L mutants on aminated polystyrene (PSNH2) via GMBS crosslinker (B) Relative amine amount based on
fluorescamine (RFU) of immobilized T4L mutants on aminated
polystyrene (PS-NH2) via GMBS crosslinker .......................................... 95

5-3

Activity based on initial rates (RFU/s) of immobilized T4L mutants on
aminated polystyrene (PS-NH2) via GMBS crosslinker .......................... 97

5-4

Comparing immobilization of T4L mutants on aminated polystyrene beads
when using different crosslinkers ........................................................ 100

xii

List of Figures (Continued)
Figure

Page

5-5

Immobilization of T4L WT* and M1_N2insC on Dynabeads. .................... 102

5-6

Immobilization of T4L WT* and M1_N2insC on Dynabeads via MBS
crosslinker ............................................................................................ 105

5-7

Immobilization of T4L WT* and M1_N2insC on aminated Dynabeads via
SM(PEG)2 crosslinker. .......................................................................... 106

5-8

Immobilization of T4L WT* and V57C on aminated Dynabeads via SM(PEG)2
crosslinker ............................................................................................ 108

6-1

New technique for quantitating nonspecific binding all while measuring the
effectiveness of different wash conditions in Figure 6-2 .................... 114

6-2

Testing the effectiveness of different surfactants to remove nonspecific
binding. ................................................................................................ 116

6-3

Non-specific immobilization of T4L WT* on animated polystyrene (PS) beads
with nonfat milk. .................................................................................. 118

6-4

Comparing activity of with and without nonfat milk blocking for
immobilization of T4L WT* and M1_N2insC on Dynabeads via MBS
crosslinker ............................................................................................ 120

6-5

T4L with a single cysteine (yellow circle) can exist as monomers (top), dimers
(middle), or both (bottom) .................................................................. 122

6-6

28 single site cysteine mutations exhibit different propensities for monomer
and dimer state. ................................................................................... 123

6-7

Correlation between mutant monomer fraction and its corresponding
cysteine's solvent exposure ................................................................. 126

6-8

Schematic of the possible outcomes of fluorescently tagged protein in the
optional presence of a reducing agent, 5 mM TCEP............................ 128

6-9

The effects of cysteine accessibility have on maleimide labeling ............. 130

xiii

List of Figures (Continued)
Figure
6-10

Page
The effects of cysteine accessibility have on maleimide labeling. ...... 132

7-1

Simplified enzymatic reaction of T4L with Micrococcus lysodeiktus cell wall
(or DQTM Substrate) and corresponding fluorescent emission ........... 138

7-2

SDS-PAGE gels of the resulting biotinylated T4L mutants after maleimidePEG11-biotin conjugation. ................................................................... 142

7-3

Band quantitation standard curve ............................................................. 145

7-4

The distribution of modified T4L mutants (varying degrees of biotinylation)
that are immobilized to streptavidin coated Dynabeads .................... 148

7-5

Composition of biotinylated T4L enzyme mutants before (load) and after
immobilization (immobilized) .............................................................. 149

7-6

Immobilization yield................................................................................... 151

7-7

Immobilization efficiency dependence on individual load amount (left) and
total immobilized amount (right) ........................................................ 152

7-8

Immobilization efficiency based on immobilization type .......................... 154

7-9

The influence T4L WT* enzyme concentration has on normalized reaction
velocity ................................................................................................. 156

7-10

Determining the conversion between substrate concentration and product in
relative fluorescent units ..................................................................... 158

7-11

Catalytic efficiency (kcat/KM) dependence on T4L WT* enzyme concentration.
.............................................................................................................. 159

7-12

The relationship between monomer and dimer catalytic efficiency ........ 162

7-13

Correlation between immobilized T4L mutant catalytic efficiency and
experimental characteristics................................................................ 163

xiv

CHAPTER ONE
INTRODUCTION

Benefits of Enzyme as a Catalyst

Under the right physiological conditions, these enzymes catalyze complex
biological reactions, essential to all life forms, in seconds or hours that would typically
take thousands, millions, or billions of years to spontaneously occur without the enzyme
(Snider & Wolfenden, 2000). Evolution has selected enzymes' specific functions in their
native environment by optimizing the amino acid composition and corresponding
structure. Any change in pH, temperature, or salinity that deviates from the evolved
enzyme's native environment can impact soluble enzyme activity and stability. Similarly,
enzyme structure and function can change when immobilized due to the insoluble foreign
microenvironment. Despite their limitations, immobilized enzymes and proteins are still
prevalent in everyday life.
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Industrial Applications of Immobilized Enzyme

Biopharmaceutical

Biofuel

Food and Beverage

Immobilized PGA for
large-scale
production of
semisynthetic βlactam antibiotics

Immobilized lipase
assists the
transesterification of
oils with alcohol for
large-scale biodiesel
production

Immobilized lysozyme
reduces bacteria
spoilage during wine
production

Figure 1-1. Examples of immobilized enzymes in industry (Cappannella et al., 2016; Maresova, Plackova,
Grulich, & Kyslik, 2014; Sankaran, Show, & Chang, 2016).

Immobilized enzymes are used in industry when they assist the conversion of
complex substrates in fewer steps than conventional chemical synthesis, provide
additional thermal or chemical catalytic stability for processing under harsh conditions,
and require easy recovery of catalytic entity for reprocessing. Three examples of
immobilized enzymes used in industry can be seen in Figure 1-1 and described hereafter.
Immobilized Penicillin G Acylase (PGA), lipase, and hen egg white (HEWL) lysozyme are
examples of immobilized enzymes that aid pharmaceutical, biofuel, and wine production,
respectively. Conversion of these soluble enzymes to immobilized enzymes that retain
structure-function proves helpful for their specific industrial application. In
1990, Guisan et al. increased enzyme stability and retained enzymatic activity by
immobilizing Penicillin G Acylase (PGA) onto glyoxal-agarose gels. As a result, immobilized
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PGA technology enhanced the large-scale production of β-lactam antibiotics currently
used today in the pharmaceutical industry (Maresova et al., 2014). In the biofuel industry,
immobilized lipase plays a prominent role in transesterifying oils with alcohol in biodiesel
synthesis (Sankaran et al., 2016). For example, Novozymes has successfully developed a
commercially available Novozym 435 (N435) with enriched functionality and stability by
immobilizing lipase B from Candida antarctica on a macroporous, hydrophobic resin via
nonspecific, multipoint covalent attachment (Johnson & Bis, 1992; Ortiz et al., 2019). In
the wine industry, hen egg-white lysozyme (HEWL) is immobilized covalently onto
chitosan beads. The immobilized HEWL assists malolactic fermentation by decreasing
sulfur dioxide usage and limiting bacteria spoilage (Cappannella et al., 2016). Despite
the various immobilized enzyme uses in industry, harnessing the function of a soluble
enzyme to be active when immobilized can take decades to develop. Immobilization
techniques are often cycled through trial and error until one method provides an
industrial application's required activity and stability.
History of Enzyme Immobilization

Over the past hundred years, non-covalent adsorption, physical entrapment,
covalent attachment, and alternative bioconjugate techniques to immobilize enzymes
have been explored to increase enzymes' stability and retain enzymatic function (Homaei,
Sariri, Vianello, & Stevanato, 2013). Invertase, the first reported immobilized
enzyme, which converts sucrose to fructose and glucose, underwent multiple
transformations over a hundred years to become effective when immobilized. First,
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invertase was physically adsorbed onto charcoal and aluminum hydroxide by Michaelis
and Ehrenreich in 1908 (Linko, Linko, & Kennedy, 1983; Michaelis & Ehrenreich, 1908).
By 1916, Nelson and Griffin confirmed that invertase retained its specific activity when
adsorbed on charcoal (Nelson & Griffin, 1916). More bioconjugate techniques for
immobilization

of

invertase

1962, Manecke increased immobilized invertase activity

and

emerged. In
stability

by covalently

attaching to crosslinked copolymers. This covalent entrapment prevented enzyme
leaching

and became

known

1970, Filippusson and Hornby

as "enzyme
used covalent,

resin" (Manecke,
multipoint

1962). Then

in

attachment to

immobilize invertase on the surface of polystyrene beads and tubes. The invertase
activity, however, decreased when immobilized to the polymer. Filippusson and Hornby
speculated that the hydrophobic microenvironment at the surface and the lack of enzyme
orientation inhibited substrate diffusion and potentially blocked its active site,
respectively (Filippusson & Hornby, 1970). Alternative enzyme attachment sites are
targeted for invertase immobilization and compared accordingly. In 1978, Wiseman and
Woodward compared immobilized invertase's function when covalently attached to
microcrystalline cellulose via hydroxyl groups, ionically adsorbed to DEAE-Sephadex
and CM-Sephadex, and reversibly adhered to insolubilized concanavalin A on agarose via
carbohydrate moieties. Invertase immobilized on concanavalin A and CM-Sephadex
surfaces, retained the most activity; however, invertase immobilized on concanavalin A
and microcrystalline cellulose surfaces, held the highest thermal stability (Woodward &
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Wiseman, 1978). In 2006, A.E. David et al. used glutaraldehyde to covalently attach
invertase to aminated silica gel (Yang, 2006). To summarize what took over a century for
developmental work, immobilization techniques cycled through physically adsorbed
(Michaelis & Ehrenreich, 1908; Nelson & Griffin, 1916), covalent entrapment (Manecke,
1962), covalent attachment (Filippusson & Hornby, 1970), physical entrapment (Marconi,
Gulinelli, & Morisi, 1974), semi-specific reversible attachment in 1978 (Woodward &
Wiseman, 1978), and a combination of specific covalent surface attachment and
entrapment, eventually led to immobilized invertase in 2006 that exhibited no significant
activity loss, high stability, increased substrate affinity, and highest enzyme loading
capacity to date (David, Wang, Yang, & Yang, 2006). Each immobilization method and
their respective crosslinker-surface components are interchanged until the highest
immobilized activity and stability are achieved.
Throughout the evolution of enzyme immobilization, there has been a constant
shuffle in how enzymes are immobilized. The protein moiety site for attachment, the
crosslinker that adheres the enzyme to the surface, and the insoluble surface form the
basis of each immobilization technique. The enzyme-crosslinker-surface complex and its
inherent chemical properties dictate whether the immobilized enzyme retains its function
and stability. Since there is a lack of universal predictive parameters for immobilizing any
enzyme, trial and error methods combined with years of experience are needed to
immobilize enzymes that retain high activity levels and structural stability for a given
application.
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Immobilization Type Influences of Enzyme Structure-Function Relationships

Each immobilization method provides inherent differences that make one
technique more attractive for a particular application than another. Non-specific covalent
or multipoint attachment allows for reusability without the need for surface
regeneration, thus extending the enzyme's productive lifetime. Multipoint covalent
attachment may increase structural stability and is the preferred method under harsh
environmental conditions. Adsorbed enzyme immobilization is a passive immobilization
technique that requires no bioconjugation. However, adsorbed enzymes exhibit different
orientations that could potentially block active sites. Entrapment (porous) immobilization
methods effectively sequester specific substrates through channeling (Li et al., 2016).
However, the insoluble porous structure hinders substrate diffusion to the enzyme's
reactive site from the bulk solution, and the pores themselves can clog after repeated
use. Despite these inherent immobilization technique differences, the common goal for
immobilizing any enzyme is activity and stability maximization.
A fundamental understanding of the inherent differences among each
immobilization strategy can help determine how to immobilize an enzyme for a given
application. Kienle et al. compared the structure-function relationship among three
different immobilization methods: physically adsorbed, nonspecifically tethered, and sitespecifically tethered nitroreductase (NfsB). Site-specific immobilization showed the
highest ratio of substrate binding per correctly folded enzyme, while nonspecifically
tethered had a higher correctly folded percentage. Physically adsorbed NfsB had retained
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higher structural stability than nonspecifically tethered enzyme but lowered specific
substrate binding (Kienle, Falatach, Kaar, & Schwartz, 2018). Using an alternative enzyme,
lipase, the same lab demonstrates that as the number of attachment sites increased,
stability increased, the activity decreased during multipoint covalent attachment on a
polymer brush surface (Weltz, Kienle, Schwartz, & Kaar, 2020). The direct comparison of
different immobilization types and the effects of attachment portray the delicate balance
between immobilized activity and stability.
Enzyme-Crosslinker-Surface Complex

Immobilized enzymes generally consist of three (or two) components, as seen in
Figure 1-2: the enzyme, the crosslinker (optional), and the surface. For instance, sitespecific immobilization requires one surface and one crosslinker per enzyme, nonspecific
immobilization requires one surface and multiple crosslinkers per enzyme, and physical
adsorption requires one surface and no crosslinker per enzyme.
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Figure 1-2. Each component of enzyme-crosslinker-surface complex forms the basis of all enzyme
immobilization types.

Understanding how each component influences the overall immobilized activity
and stability may provide insight into what makes one immobilization technique more
effective than the next. For example, the surface and its chemistry can create a synergistic
microenvironment for physically adsorbed and covalently attached enzymes to retain
immobilized enzymatic activity (Abouhmad, Dishisha, Amin, & Hatti-Kaul, 2017;
Thyparambil, Wei, & Latour, 2015). The size and corresponding curvature of the surface
affects the structure-function and immobilization efficiency of the adsorbed enzyme
(Shrivastava, Nuffer, Siegel, & Dordick, 2012; Vertegel, Siegel, & Dordick, 2004). In
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addition, the surface smoothness allows for better orientation control during sitespecifically immobilization (L. Shen et al., 2016). The crosslinker's chemical structure and
length may change the activity and stability of an immobilized enzyme. For instance, when
immobilizing glucose-6-phosphate dehydrogenase (G6PDH) via multipoint attachment
using glutaraldehyde (GA), terephtalaldehyde (TE), 1,4-phenylene diisocyanate (DIC), 1,4phenylene diisothiocynate (PDC), and 1,3-phenylene diisothiocynate (MDC) showed
differences across the crosslinkers of equivalent length but varying chemistry and
structure. MDC, GA, and TE crosslinked G6PDH to silanized surfaces outperformed DIC
and PDC crosslinkers in terms of immobilized enzyme activity. However, despite its low
activity, the DIC crosslinker exhibited the highest stability after repeated use (Aissaoui,
Landoulsi, Bergaoui, Boujday, & Lambert, 2013). Subtle changes in crosslinker chemical
structure can affect activity and stability. When the lengths of the crosslinker vary, and
chemistry remains constant, immobilized enzyme activity may also be affected. Choline
oxidase and glucose oxidase both showed seven-fold and four-fold, respectively, higher
activity when immobilized with the longer N-succinimidyl 6-maleimidocaproate (EMCS)
crosslinker than its shorter analog N-succinimidyl 4-maleimidobutyrate (GMBS) (Rusin,
Fare, & Stemple, 1992). Simple changes to the crosslinker length and chemistry may
significantly affect its activity and stability. Finally, where and how the enzyme crosslinks
to its surface can dictate the effective substrate binding. Site-specific immobilization can
remediate substrate diffusion limitations because it controls orientation to expose the
enzyme active site to the bulk solution (L. Shen et al., 2014). The balance among the three
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components of the enzyme-crosslinker-surface influences immobilization efficacy. To
better understand the isolated effects of the enzymes’ attachment site, crosslinker
chemistry, and surface properties has on immobilized activity and stability, site-specific
immobilization is studied herein.
Site-Specific Immobilization

Site-specific immobilization provides greater enzyme orientation control (L. Shen
et al., 2016; L. Shen et al., 2014) and potentially retained activity (Liu et al., 2013) at the
cost of stability compared to other conventional immobilization techniques. Furthermore,
limiting one attachment site per enzyme during site-specific immobilization provides a
more controllable and systematic approach to immobilization to study the homogeneous
orientation. In turn, it allows for the study of how the site of attachment affects
immobilized activity.
Site-specific immobilization requires innate or mutated amino acid that introduces
a chemically reactive site for single point attachment. Conventional techniques of enzyme
attachment utilize reactive residues available in the protein's amino acid sequences, such
as lysine, carboxylic acids, or cysteine (Lim & Kwon, 2016). Unfortunately, when targeting
a specific amino acid residue for linker attachment, other amino acids with the same
chemistry in an enzyme's amino acid sequence could interfere with site-directed linker
attachment. As a result, the intended position of the linker attachment will not necessarily
be achieved and could ultimately affect the enzyme's specific activity by blocking the
active site with the linker attachment (Raliski, Howard, & Young, 2014). Since most
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enzymes do not contain unique chemistry, creating a unique residue moiety is required
for site-specific immobilization. Bachas et al. achieved site-specific immobilization,
inserting a unique cysteine in naturally cysteine-free subtilisin (Huang, Wang,
Bhattacharyya, & Bachas, 1997). They discovered how different attachment sites,
although far away from the active site, can affect immobilized specific activity by looking
at two different sites for immobilization (Huang et al., 1997). Bundy et al. studied sitedirected attachment of T4 lysozyme by introducing single noncanonical amino acids that
contain a unique chemical moiety apart from the 20 amino acids as an attachment site.
For three different attachment sites for immobilization orientation control can improve
activity and stability when choosing the appropriate attachment site (J. C. Wu, Hutchings,
Lindsay, Werner, & Bundy, 2015). Mutations to the soluble enzyme for site-specific
attachment may decrease soluble enzymatic activity but when immobilized that same
enzyme mutant may increase activity and stability (J. C. Wu et al., 2015). Other studies
examined different cysteine mutations to control the immobilized protein orientation of
horseradish peroxidase (Ferapontova, Schmengler, Börchers, Ruzgas, & Gorton, 2002)
and glucose-galactose receptor (GGR) (Wang, Luck, & Suni, 2007) and improve electron
transfer signal for biosensor development. In all the above examples, site-specific
immobilization studies explore no more than 1 to 3 different attachment sites.
Conclusions on the effectiveness of site-specific immobilization are limited to those select
sites of attachment. Expanding the site-specific study by immobilizing an enzyme at 20-
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30 different single point locations will provide general insight into how the point of
attachment influences immobilized activity.
Dissertation Outline

As the need for immobilized enzymes increases in scale and diversity, a more
thorough systematic structure-function approach is necessary to improve current
immobilization techniques. Herein, systematic site-direct mutagenesis, designed to
immobilize enzymes in a homogenous orientation, is discussed to determine how the
attachment site influences enzyme activity. Whether the attachment site is spatially
distant from the active site or in a position known to tolerate mutations, the ability to
predict where to attach enzymes for efficient immobilization site-specifically is necessary.
There is a lack of knowledge on how exactly different attachment site influences activity
during site-specific immobilization. It will expand the fundamental understanding of
where to immobilize an enzyme by examining the correlation between 28 different sitespecific attachment sites.
Each of the following chapters is designed to mimic the process that occurs when
designing a means for effective immobilization. The methods and results for this
dissertation are described under each chapter, whereas the materials and equipment
used in those methods are listed in detail in Appendix F. All together, each component in
the enzyme-crosslinker-surface complex is examined, and heuristics are developed to
improve immobilization efficiency and efficacy for site-specific immobilization.
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Generally, for multiple and single site-specific immobilization, the enzyme must
undergo some protein modification. In chapter two, the adverse effects on protein
solubility and activity after modifying different amino acids with three different
conjugation chemistries exemplify the need for minimal alterations to the enzyme for
immobilization. Therefore, site-specific immobilization, which only requires the
modification and conjugation to a single amino acid, is minimally intrusive and preferred
to avoid these issues. In chapter three, the system for studying site-specific
immobilization begins to develop, starting with the model enzyme T4L variant, WT*, that
contains no cysteine amino acids. Single cysteine substitutions into the amino acid
sequence will result in a protein displaying a unique sulfhydryl moiety for site-specific
immobilization. Creating, expressing, and purifying these T4L cysteine mutants
demonstrates the effects a single cysteine has on the overall production and surface
charge. This chapter continues to probe the initial activity and stability of storage
conditions necessary to maintain the enzyme's integrity through future immobilization.
The next chapter introduces the second component of the enzyme-crosslinker-surface
complex, the amine-to-sulfhydryl crosslinker. These crosslinkers conjugate the enzyme's
cysteine residue to an amine-covered surface for immobilization. The NHS-ester
hydrolysis rates, and the NHS-ester and maleimide reactivity that differentiate the four
heterobifunctional crosslinkers, are examined in this chapter. Chapter five incorporates
all three components, enzyme-crosslinker-surface, during the site-specific immobilization
attempts. Different T4L cysteine mutants, crosslinkers, and polymeric surfaces are
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interchanged to find the most efficient combination for site-specific immobilization.
However, the process exemplifies that nonspecific immobilization is unavoidable with the
current enzyme-crosslinker-surface system. When studying the effects of attachment site
has on immobilized activity, the uncontrollable and heterogeneity of included
nonspecifically bound enzymes generates a noise problem. Reducing nonspecific
interference becomes a priority. Chapter five identifies the problems associated with
studying site-specific immobilization, and chapter six looks at different methods to fix the
problem by reducing nonspecific binding while maximizing site-specific immobilization
efficacy. The potential solutions to reduce nonspecific adsorption include the wash
conditions, blocking agents, and the availability and accessibility of each cysteine on T4L
mutants. The significant change involves switching from amine-to-sulfhydryl to a
streptavidin-to-sulfhydryl scheme for a multitude of reasons. Hydrophilic, streptavidincoated surfaces act as a natural blocking agent. Knowing which cysteine mutants are
accessible, biotin-maleimide crosslinker conjugation to the enzyme can occur prior to
surface immobilization, improving its immobilization specificity. Finally, although nearly
covalent, the streptavidin-biotin complex can be reversed, resulting in direct quantitation
of immobilization efficiency. The results presented in chapter seven demonstrate the
specificity, and nonspecific binding reduction of the new streptavidin-to-sulfhydryl,
enzyme-crosslinker surface system. In turn, it allows for the study of site-specific
immobilization void of any significant noise from nonspecific binding. The findings in this
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chapter indicate that enzyme surface concentration is the defining factor that correlates
to high site-specific immobilization activity retention.
Heuristics for creating an enzyme-crosslinker-surface system can avoid timeconsuming optimization of immobilization protocols by understanding parameters that
may predict efficient immobilization. This dissertation aims to develop a universal
understanding of the characteristics required for better immobilization. More specifically,
the benefits of controlled orientation to study how a single point of attachment influences
the specific activity of an immobilized enzyme.
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CHAPTER TWO
PROTEIN MODIFICATION
Introduction
Multipoint attachment and site-specific immobilization involving a crosslinker to
attach the protein to a surface undergo amino acid modification during conjugation.
Essentially, these amino acids blocked during crosslinker conjugation could influence the
solubility and functionality of the protein when immobilized. To demonstrate the effects
of amino acid modification, the primary amines and carboxylic acids of T4 lysozyme (T4L)
are blocked with a small molecule in solution. Acetylation of T4L involves blocking lysine
with an acetyl group. Each different acetylation method described in this chapter aims to
find the conditions necessary to prevent protein precipitation. As more positively charged
residues (lysines) are converted to a more neutral charge during acetylation, the solubility
of T4L decreases at neutral pH. Seeing that acetylation of lysine amino acids decreases
solubility, and in turn, immobilization efficiency, different amino acids, glutamic and
aspartic acid, are targeted. Conjugation of carboxylic acids in T4L, however, results in
diminishing activity. Choosing which amino acid type and the degree to which those
amino acids are blocked or modified can harm potential immobilization efficiency via
multipoint attachment. A more minimalistic approach to amino acid conjugation may be
preferable. To test this, the semi-site-specific attachment of four different crosslinkers via
NHS-ester does not affect the activity or solubility of Horseradish Peroxidase (HRP). This
chapter builds the reasoning behind choosing site-specific immobilization over multipoint
attachment through anecdotal trials.
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Methods
Acetylation of T4L

The following methods are adapted from Bioconjugate Techniques (Hermanson,
2008) unless specified otherwise.
Method A:

The acetylation of T4L WT* requires three reaction steps. First, 6.2 nmol of T4L
WT* in 50 mM sodium phosphate buffer, 50 mM sodium chloride (NaCl) at pH 7.5, was
mixed with 74 µmol of acetic anhydride and 73 µmol sodium hydroxide (NaOH). The
acetylation reaction was incubated for 20 minutes at 4 °C while on the VWR® Tube
Rotator Unit. Next, 53 µmol of acetic anhydride and 80 µmol NaOH were added to the
above reaction, followed by another incubation step. Finally, 42 µmol of acetic anhydride
and 73 µmol NaOH was added, and incubation was repeated for the third time. Samples
treated without acetic anhydride were the control group to test the acetylation efficiency.
Excess acetic anhydride and byproducts were removed by running each sample through
a ZebaTM Spin Desalting Columns per the manufacturer's protocol.
Acetic anhydride treated T4L WT* (10 µL) was mixed with 50 µL of 3 mg/mL
fluorescamine working solution from AmpliteTM Fluorimetric Fluorescamine Protein
Quantitation Kit and 50 µL of phosphate buffered saline (PBS) in a 96-well black plate. The
reaction between the fluorescamine and the amine-containing protein was incubated for
30 minutes at room temperature. After that, each sample's fluorescence was read at an
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excitation and emission of 380 nm and 470 nm (Ex/Em 380/470), respectively, using the
Synergy MX BioTek microplate reader. Since there was a possible sample lost during the
desalting procedure, the relative fluorescent units (RFU) measurements were normalized
to the protein concentration of each sample.
Method B:

Initially, each of the three samples contained 10.2 nmol T4L WT* in 50 mM sodium
phosphate, 50 mM NaCl (pH 7.5). Potassium phosphate dibasic (5.9 µmol) was added to
each sample followed by 1.36 µmol acetic acid or 1.36 µmol acetic anhydride or 1.29 µmol
acetic anhydride-D6. The reaction was incubated with constant tilt and rotation on the
VWR® Tube Rotator Unit for 1 hour at room temperature (25 °C). The reaction pH was
checked every 20 minutes with Whatman® Panpeha™ pH indicator strips. The reaction
sample pH stayed constant at pH 7.5. Excess acetic anhydride and byproducts were
removed by running each sample through a ZebaTM Spin Desalting Columns per the
manufacturer's protocol.
Each sample of 7.5 pmol of treated T4L WT* was combined with 25 µL of 2.5
mg/mL fluorescamine working solution and 67.5 µL of PBS in a single well of a 96-well
black plate. RFU at Ex/Em 380/470 nm was measured every minute for 30 minutes with
constant (fast) shaking.
Method C:

The acetylation of T4L A93C requires three reaction steps. First, to 9.16 nmol of
T4L WT* in 50 mM sodium phosphate and 50 mM NaCl (pH 7.5), 10.6 µmol of acetic
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anhydride and 16.3 µmol NaOH were added together. The reaction was incubated for 5
minutes at room temperature with constant mixing on the VWR® Tube Rotator Unit. To
the reaction, 10.6 µmol of acetic anhydride and 25.0 µmol NaOH were added followed by
incubation for 10 minutes at room temperature with constant mixing. Finally, 10.6 µmol
of acetic anhydride and 19.9 µmol NaOH were added to the reaction and incubated for 1
minute at room temperature with constant mixing. Samples treated without acetic
anhydride were the control group to test the acetylation efficiency. Excess acetic
anhydride and byproducts were removed by running each sample through a ZebaTM Spin
Desalting Columns per the manufacturer's protocol. The RFU of each sample treated with
fluorescamine was measured and normalized to sample protein concentration,
Method D:

Initially, each sample contained 10.2 nmol T4L WT* in 50 mM sodium phosphate,
50 mM NaCl (pH 7.5). Each sample was treated with 15.9 µmol of acetic anhydride or
acetic acid, followed by the addition of 68.5 µmol of potassium phosphate dibasic or 43.5
µmol of NaOH. The resulting four samples were incubated for 30 minutes at room
temperature with constant tilt and rotation on the VWR® Tube Rotator Unit. The process
was repeated an additional three times before undergoing desalting operations. The total
molar ratio of acetic anhydride to T4L WT* is about 6200:1. The final pH prior to buffer
exchange for samples with potassium phosphate dibasic added was 7.5, while the pH of
NaOH treated samples was >9.0.
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Fifteen micro-liters of treated T4L WT* were mixed with 10 µL of 2.5 mg/mL
fluorescamine working solution and 60 µL of PBS in a 96-well black plate. RFU at Ex/Em
380/470 nm on plate reader every minute for 5 minutes with continuous shaking (fast).
Method E:

The acetylation of T4L WT* requires three reaction steps. First, to 6.2 nmol of T4L
WT* in 50 mM sodium phosphate and 50 mM NaCl (pH 7.5), 10 µl of 1:3 volumetric ratio
of acetic anhydride (neat) and 7.25 M NaOH was added. Samples were vortexed briefly
then incubated for 20 minutes at 12 °C with horizontal rotation. The addition of acetic
anhydride/NaOH mixture and incubation was repeated two more times. Excess acetic
anhydride and byproducts were removed by running each sample through a ZebaTM Spin
Desalting Columns per the manufacturer's protocol.
672 pmol of treated T4L WT* (25 µL) was mixed with 20 µL of 10 mg/mL
fluorescamine working solution and 50 µL of PBS in a 96-well black plate. The reaction
proceeded for 10 minutes at room temperature, followed by RFU readings every 10
minutes at Ex/Em 380/470 nm on Synergy MX BioTek microplate reader.
Method F:

Initially, each sample contained 8.6 nmol T4L A93C in 50 mM sodium phosphate,
50 mM NaCl (pH 7.5), 0.005 % Tween-20, 5 mM dithiothreitol (DTT). Samples were
incubated for 30 minutes at 50 °C. Fifty microliters of 1 M sodium carbonate (pH 9.5) and
31.7 µmol of acetic anhydride are added to the reaction, followed by another 5-minute
incubation at room temperature. Finally, 50 µL of 1 M Tris (pH 8.0) was added to the
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reaction. Excess acetic anhydride and byproducts were removed by running each sample
through a ZebaTM Spin Desalting Columns per the manufacturer's protocol. RFU at Ex/Em
380/470 nm on plate reader every minute for 5 minutes with continuous shaking (fast).
MALDI-TOF Acetylation Detection

Cleaning MALDI Target Plate

In a fume hood, 200 µL of neat trifluoroacetic acid (TFA) was spotted evenly on
the SP 96 target plate from Bruker Daltonik GmbH and allowed to completely dry (~10
minutes). A Kimwipe was wetted with isopropyl alcohol (IPA) and gently wiped the
surface/matrix spots on the MALDI target plate. The wiping process was repeated with
another Kimwipe wet with water instead of IPA. The plate was submerged in IPA and
sonicated for 10 minutes in the Bransonic™ Ultrasonic Cleaning Bath without heat. The
sonication process was repeated with the plate submerged in 30:70 [v/v] acetonitrile:TFA
0.1% in water (TA30) instead of IPA. Finally, the plate was allowed to dry in a biosafety
cabinet with constant airflow for 20 minutes.
Protein Acetylation for MALDI-TOF analysis

Acetic anhydride was mixed with T4L WT* at a molar ratio of 6, 20, 58, 176, 527,
and 1578 for Figure 2-1 and 6542 for Appendix A, Figure A-1. The reaction was neutralized
with 1 M potassium phosphate dibasic to maintain pH of 7-8. The samples were reacted
for 2 hours at room temperature at constant rotation. Excess acetic anhydride and
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byproducts were removed by running each sample through a ZebaTM Spin Desalting
Columns per the manufacturer's protocol.
Sample MALDI Spotting

10 mg sinapinic acid (Appendix A, Figure A-1) or alpha-Cyano-4-hydroxycinnamic
acid (CHCA) (Figure 2-1) matrix solution (in 50:50 [v/v] acetonitrile: water, TFA 0.15%) was
added to each desalted sample at a 1:1 ratio. One microliter of the mixture was then
spotted onto the plate and allowed to dry for at least 20 minutes.

MALDI-TOF Detection

The desalted sample was loaded onto the plate at a concentration of ~100 ng/µL
of T4L. The MALDI-TOF machine was placed in linear mode (105 cm effective flight path)
and 2000 shots at a laser level 20-70% was used to ablate the sample. The detector gain
was set to 2827V, laser level to 60 Hz. The analysis was determined based on the positive
ion spectrum.
Blocking T4L’s Carboxylic Acids with EDC

1.3 mg of N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) was
added to 130 μL of T4L WT* (1300 ng/μL) in 0.1 M MES buffer and 0.1 M ethanolamine
(pH 4.7) solution. At room temperature, the reaction was incubated for two hours with
constant tilt and rotation on the VWR® Tube Rotator Unit. Using ZebaTM Spin Desalting
Columns per the manufacturer's protocol, excess ethanolamine was removed, and the
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protein was resuspended in 50 mM sodium phosphate buffer, 50 mM NaCl, 0.01 %
Tween-20 (pH 7.5). Each sample was processed for SDS-PAGE analysis per the
manufacturer’s protocol. This protocol involved: (1) protein linearization in 2x Laemmli
sample buffer followed by heating samples for 10 minutes at 95 °C, (2) fixation of the
Mini-PROTEAN® TGX™ Precast Gels in Mini-PROTEAN Tetra Vertical Electrophoresis Cell
and filling with SDS-PAGE running buffer (Biorad), (3) loading a total of ~500 ng of protein
sample per gel well, (3) applying 180 V for 40 minutes with the PowerPac™ HC HighCurrent Power Supply for protein migration, and (4) removing the gel from cast and
staining using Bio-Safe™ Coomassie Stain and corresponding manufacturer's protocol.
The SDS-PAGE gels were imaged using LICOR Imager at 700 nm. The resulting band signals
were processed and measured using Image Studio Lite for quantitation.
NHS-(spacer arm)-Maleimide Crosslinker Conjugation to HRP

NHS-spacer-Maleimide Crosslinker was conjugated to HRP in the following
method. HRP was dissolved in 100 mM sodium phosphate buffer (pH 8.0), 100 mM
carbonate buffer (pH 8.5), or 100 mM borate buffer (pH 9.0) to a final concentration of
4.41 g/L. One microliter of crosslinker stock was added to 250 µL of HRP solution and
allowed to react for 30 minutes. Samples were buffer exchanged into potassium
phosphate buffer using ZebaTM Spin Desalting Columns per the manufacturer's protocol.
The activity of HRP was determined using a colorimetric assay. In each well on a
96-well plate, 50 µL of HRP sample in potassium phosphate buffer was mixed with 25 µL
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of Azino-bis-[3-ethylbenzthiazoline-6-sulphonate] (ABTS) and 25 µL of 0.35 % (w/w)
hydrogen peroxide solution in water. Absorbance at 405 nm was recorded every 20
seconds for 10 minutes using the absorbance microplate reader, Epoch 2, from BioTek.
The absorbance (405 nm) at time zero was used to calculate the HRP concentration from
HRP’s heme group. Initial rates were determined by finding the maximum slope from a
set of ten consecutive time points. Subsequently, the initial rates were normalized to
absorbance at time zero and subsequently to the initial rate of unconjugated HRP.
Results and Discussion
Multiple lysine acetylation effects on T4L solubility

Capping primary amines with acetyl groups is an example of protein modification
that can have unintended consequences. If changed, lysine residues that participate in
substrate binding could alter substrate specificity or hinder enzymes' kinetics. Lysine
residue modification may also change the surface charge, isoelectric point, and protein
solubility leading to unwanted precipitation. The below sub-section explores the
unintended precipitation of multipoint protein modification when using acetic anhydride
to cap the lysine residues of T4L.
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Table 2-1. Outline of experimental procedures for acetylation of T4L with acetic anhydride that highlights key conjugation parameters. Refer to the
Methods section for details of A-F. The molar ratio of acetic anhydride to T4L is labeled as "Ratio Acid/Protein.” "Protein Retention" refers to the fraction
of protein yielded post desalting/buffer exchange. Finally, "Acetylated Fraction" is the ratio of acetic anhydride treated (RFU/protein) to untreated
control (RFU/protein) when exposed to fluorescamine with the uncertainties represented by sample standard deviation. Direct correlation between the
amount of acetic anhydride added and acetylation efficiency.
Method

Mutant

Acid
Treatment
Acetic
Anhydrided6

Ratio
Acid/Protein
1.26E+02

Base Treatment
Potassium
Phosphate
Diabasic
Potassium
Phosphate
Diabasic

pH

B

WT*

B

WT*

Acetic
Anhydride

1.33E+02

F

A93C

Acetic
Anhydride

6.15E+02

Sodium
Carbonate

7 to 9

C

A93C

Acetic
Anhydride

3.46E+03

Sodium
Hydroxide

7 to 9

D

WT*

Acetic
Anhydride

6.23E+03

Potassium
Phosphate
Diabasic

7 to 9

A

WT*

Acetic
Anhydride

2.73E+04

Sodium
Hydroxide

7 to 9

D

WT*

Acetic
Anhydride

6.23E+03

Sodium
Hydroxide

>9

E

WT*

Acetic
Anhydride

1.28E+04

Sodium
Hydroxide

>9
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7 to 9

7 to 9

Reaction Scheme
1 hour at room
temperature with
constant mixing
1 hour at room
temperature with
constant mixing
5 minutes at room
temperature with
constant mixing
5+10+1 minutes at
room temperature
with constant mixing
4 x 30 minutes at
room temperature
with constant mixing
3 x 20 minutes at 4
°C with constant
mixing
4 x 30 minutes at
room temperature
with constant mixing
3 x 20 minutes at 12
°C with constant
mixing

Protein
Retention

Acetylated
Fraction

0.84

0.10 ± 0.02

0.84

0.08 ± 0.02

0.53

0.4 ± 0.1

0.12

0.9 ± 0.1

0.12

0.97 ± 0.01

0.07

0.992 ±
0.007

0.53

0.94 ± 0.02

0.59

0.996 ±
0.003

Acetylation of T4L is predictable and tolerant of a variety of reaction conditions.
Varying the reaction buffer, pH, time, and temperature (see methods A-F and summary
in Table 2-1) has minimal influence on the acetylation efficiency. Instead, the molar ratio
of acetic anhydride to T4L primarily determines the degree of acetylation, as shown in
Figure 2-2. At a low acetic anhydride to protein ratio of 1000:1, 50 % of the available
amines have acetyl caps. When that ratio increases to 6000:1, acetylation efficiency
increases to 95 %. Although not linear, increasing acetic anhydride increases protein
acetylation. The nonlinear response may stem from higher-order reaction kinetics or a
byproduct of detecting acetylation fraction with a fluorescence signal. The acetylation
efficiency is low considering the N-terminus, and 14 lysines of T4L make a possible 15
locations for acetyl capping. That is, of course, if all possible primary amines are accessible
by acetic anhydride within the protein's three-dimensional structure. A dose-dependent
response shows that the acetylation is predictable under various conditions based on
acetic anhydride to T4L molar ratio despite low reaction efficiency.
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Acetylated Fraction

pH > 9
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0
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Acetic Anhydride to T4L molar ratio
Figure 2-2. T4L acetylation fraction resulting from different molar ratios of acetic anhydride to enzyme. The
black circles and pink squares represent acetylation reaction at pH 7-9 and pH > 9, respectively. Error bars
represent sample standard deviation.

pH does not affect the acetylation fraction but instead influences acetylated
protein solubility. When the acetylation reaction occurs at a pH of 7-9, acetylation causes
the protein to precipitate out of the solution. During the subsequent desalting/buffer
exchange step, the precipitated protein cannot pass through the column resin. At pH
greater than 9, precipitation and thus protein loss during desalting/buffer exchange is
minimal, as shown in Figure 2-3.
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1.0

pH 7-9

Acetylated Fraction

pH > 9

0.5

0.0
0.0

0.2

0.4

0.6

0.8

1.0

Protein Retention
Figure 2-3. The relationship of the amount of protein recovered post-desalting operations to the degree of
acetylation from different reaction pHs. Amine quantitation is based on fluorescamine reaction and
subsequent RFU readings with error bars representing sample standard deviations. Protein retention refers
to the amount of protein recovered post desalting with a spin column. The pink squares are samples that
underwent acetylation at pH > 9, whereas the black circles are the reactions that maintained pH 7-9. A
linear correlation designated above has an R2 value of 0.996.

Protein solubility may be a function of its overall net charge. As acetylation lowers
the protein's total charge, repulsive forces diminish between proteins, and the protein
tends to aggregate, precipitating out of solution. In Figure 2-1, the signal intensity of the
whole T4L dissipates as acetylation increases. The same is true when comparing BSA
and acetylated BSA: there is no m/z peak associated with the acetylated BSA while BSA
exhibits a peak at ~66.5 m/z (data not shown). The possible explanation for decreased
detection in acetylated protein is that proteins with neutral charge prevent ionization
necessary during MALDI operations and detection. Although roundabout in execution,
the combination of protein retention and ionization detection demonstrates that protein
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modification can negatively impact protein recovery because of its change to the natural
surface charge of proteins.

Normalized Peak Intensity

e5

e4

e3

e2
e1

e2

e3

e4

e5

e6

e7

e8

Acetic Anhydride to T4L Molar Ratio

Figure 2-1. The reduction in signal intensity of T4L WT* at various levels of acetic anhydride treatment using
MALDI-TOF. (Inset, upper left) Numerical data of the peak intensities per enzyme sample concentration.
The upper right inset quantitates the peak intensities from MALDI-TOF as a function of acetic anhydride
treatment.

To see if another protein with a different isoelectric point also decreases in
solubility when amine groups are neutralized through acetylation, bovine serum albumin
(BSA), and acetylated BSA (Ac-BSA) are treated with acetic anhydride. Although Ac-BSA is
already acetylated, both BSA and Ac-BSA are exposed to acetic anhydride to rule out the
possibility that the developed in-house process of acetylation itself does not cause
protein precipitation. In comparison T4L and contrast to Figure 2-3, treating BSA and AcBSA with acetic anhydride did not decrease protein's solubility at neutral pH (data not
shown). This begs the question, is the acetylated protein's solubility protein specific?
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Figure 2-5, the theoretical isoelectric point of T4L, calculated based on the amino acid
sequence by Prot pi calculator <protpi.ch>, shifts from 9.5 to 5 as the number of lysines
modified with acetyl groups increases from 0 to 14. Such a significant shift in protein
isoelectric point could expose it to conditions during which the acetylated T4L isoelectric
point equals its surrounding pH, in other words when the acetylated protein's solubility is
minimal. For instance, in Figure 2-5, T4L with six to nine modified lysine will struggle to
stay in solution with a pH at 5.5-8.5. This might explain why specific pH-controlled
acetylation reactions promote protein solubility.

Isoelectric Point (pI)

10

8

6

4
0

2

4

6

8 10 12 14

Number of Lysine Modified
Figure 2-5. Change in T4L WT* isoelectric point based on acetylation of lysine. Theoretical data generated
using Prot pi calculator <protpi.ch> with varying acetyl group modifications to lysine.
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Effects of Carbodiimide Conjugation on Enzyme Activity

STD

STD

STD

37 kDa
25 kDa
20 kDa
15 kDa
10 kDa

Control

EDC treated

Figure 2-6. Detecting blocked carboxylic acids from EDC derived modification using SDS-PAGE. Molecular
weight standards in lanes 1, 7, and 13. Third dilutions of control (untreated) and EDC treated samples from
lanes 2-6 and 8-12, respectively.

Gel electrophoresis can sometimes detect protein modifications with slight shifts
to the band migration patterns. Figure 2-6 shows a slight upward shift in T4L bands when
treated with EDC compared to its control. The upward shift is not a result of additional
molecular weight from EDC conjugates but rather an effect caused by the hindrance or
rutter-like effect the linearized peptides experience when traveling down the gel. The
same effect could explain how EDC treated bands are wider than its control. EDC-modified
peptides could vary in the number of carboxylic modifications creating a broader
apparent band distribution. There are two other faint bands present in EDC-treated T4L.
The lower band (18.6 kDa) indicates unmodified T4L, and the upper band (37 kDa)
indicates EDC inter-protein crosslinking; T4L connected between one carboxylic amino
acid to another primary amine amino acid. The migration patterns of SDS-PAGE can
provide insight into the state of proteins after amino acid modification.
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Figure 2-7. Comparing the activity of T4L WT* when modified by EDC. IC50 represents the enzyme
concentration that a half-maximal initial rate occurs: IC50 = 1.603 x 10-9 M (control) and 6.845 x 10-7 M (EDC
treated).

Protein modification is required for immobilization, but doing so may harm activity
in non-obvious ways. The combination of EDAC and ethanolamine converts carboxylic
acids to ethanolamide and in turn decreases T4L enzymatic activity. In T4L, two of three
residues that make up the catalytic triad (Hong, Park, & Yoo, 2014) (Anand, Stephen, &
Narang, 1988) are carboxylic acids, E11 and D20. When these residues are modified there
is a 420-fold shift in half-maximal activity as seen in Figure 2-7. Previous literature
confirms that mutation E11D retains 16.2 %, D20E retains 1.2 %, and the combination
E11D and D20E retains 5.6 % specific wildtype activity (Anand et al., 1988). Any
modifications to the enzyme should generally avoid alterations around the active site.
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Natural Site-Specific NHS-ester Conjugation to HRP

So far, high acetylation leads to insolubility, and modifying active site amino acids
diminishes enzymatic activity for T4L. Reducing the number of sites modified and keeping
the site's location far away from the enzyme's active residues will avoid protein
modification-induced insolubility and enzymatic inactivity. To test semi-site-specific lysine
modification, T4L cannot be used. Acetylation of T4L modifies approximately 2-4 lysine
residues as shown in Figure A-1 in Appendix A. on the other hand, HRP is unique for it has
a natural residue for semi-site-specific modification. A previous study shows six lysines
present in HRP – three of which are accessible to EGNHS [ethylene-glycol bis(N-hydroxy
succinimidyl succinate)] acylation. Of those three, K174 and K241 undergo partial
modification, while K232 undergoes complete modification. (Mogharrab, Ghourchian, &
Amininasab, 2007). When conjugating four different NHS-ester crosslinkers to HRP, the
activity of the modified enzyme retains as shown in Figure 2-8. However, slight differences
in each crosslinker's chemistries may explain slight variations in the enzyme-crosslinker
complex activity. Whether the activity changes because of allosteric effects on the
catalytic site, the free end of the linker interacting with the enzyme surface, or van der
Waals forces between the linker spacer-arm and the substrate, are unknown.
Furthermore, no precipitation was observed when adding the reacted linker to the
protein mixture to a final concentration of less than one millimolar. The benefits of site-
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specific protein modification prove valuable to retain the activity and solubility of the
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Figure 2-8. (Left) Image of linker characteristics and the site of primary NHS-ester attachment (K232) of HRP
enzyme. (Right) Comparing the activity of HRP after different modified with four different crosslinkers.
Conjugated HRP activity is normalized to unconjugated HRP activity. Error bars represent the sample
standard deviations.

Conclusion
Proteins are long polymer chains that, when folded for function, display multiple
chemical moieties on their surface. Since only twenty amino acids make up a protein,
some of which show bias to the protein surface, the diversity of moiety is limited yet
repeated. Immobilizing proteins requires the modification of these exposed residues for
surface attachment. Targeting a specific amino acid for modification often leads to
multipoint attachment when immobilizing. Multisite modification of primary amines
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(lysine) and carboxylic acid (aspartic and glutamic acid) can cause a decrease in protein
solubility and enzymatic activity, respectively. For instance, blocking the lysine amino
acids on T4L WT* with acetic anhydride causes the acetylated T4L WT* to precipitate out
of the solution. If carboxylic acids are blocked instead of lysine residues, the active site
residues that convert substrate to a product are inactivated. Carboxylic acid modification
of T4L leads to substantial activity decline. Choosing which amino acid may prevent
activity loss and the degree of modification. For example, the lysine modification on a
different enzyme, HRP, retained activity by reducing the degree of modification. Since
protein modification is necessary for immobilization, avoiding multipoint attachment and
relying more on site-specific attachment to reduce the degree of modification may be
best for retaining enzyme solubility and function.
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CHAPTER THREE
T4L CREATION, EXPRESSION, PURIFICATION, AND ACTIVITY
Introduction
Site-specific attachment is a controlled method of immobilization that limits the
number of amino acid modifications during tethering. Using a unique moiety on the
protein’s surface, the corresponding amino acid can be tethered to the surface by a
crosslinker. Lysine and cysteine are the two most common amino acids used for covalent
attachment due to their primary amine and thiol chemistries, respectively, that exhibit
high nucleophilicity (Brinkley, 1992) (Bischoff & Schlüter, 2012) (Hermanson, 2008).
However, utilizing one of the available lysine and cysteine present for linker attachment
could potentially alter the structure and desired function of the enzyme. Furthermore,
site-specific immobilization requires a unique amino acid for tethering that is different
from the other amino acids that make up the enzyme. There may be multiple lysine or
cysteine present per enzyme that would require protein engineering methods, like-sitedirected mutagenesis, to create a particular attachment site.
First, modification or crosslinker attachment to residues critical to the enzyme's
specific activity should be avoided. Although some amino acids' importance to enzyme
function is known (e.g., catalytic residues), others are more cryptic. A common approach
to immobilizing an enzyme is identifying which reactive amino acids are available for
crosslinker attachment without inhibiting the enzyme's activity. An alanine scan (the
replacement of individual amino acids with alanine, a non-reactive amino acid) is one
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method of predicting which amino acids are essential to the enzyme's structure-function
(Heinz, Baase, & Matthews, 1992). Avoiding these functionally critical amino acids for
crosslinker attachment can prevent loss of activity when immobilized.
When choosing between lysine and cysteine for the attachment site-specific
immobilization, it is essential to consider how many lysine or cysteine are present per
enzyme. Like the primary amines of lysine, the chemistry targeted for crosslinker
conjugation could require significant protein modification to narrow down the single
point for attachment. Generally, cysteines are in lower abundance per enzyme than lysine
(Nakashima, Nishikawa, & Ooi, 1986; Nishikawa, Kubota, & Ooi, 1983a, 1983b; Nishikawa
& Ooi, 1982). Removing all cysteine from an enzyme, then inserting a cysteine back into
a chosen location where it is accessible for linker attachment and does not affect native
enzymatic activity would be an ideal moiety for site-specific immobilization. In addition,
removing all native cysteine would prevent the introduction of improper disulfide bonds
or disruption of native disulfide bonds when incorporating a cysteine mutation. Some
enzymes naturally do not contain cysteine, like subtilisin, while others are engineered to
be cysteine-free. For example, pseudo-wild-type T4L (WT*) does not contain any
cysteines (C54T and C97A) yet retains a similar structure and activity to WT T4L (Pjura,
Matsumura, Wozniak, & Matthews, 1990). T4L WT* is a well-characterized model enzyme
that retains native activity yet has no cysteines (Gassner et al., 2002), making it an ideal
model enzyme for site-specific immobilization. A single cysteine mutation in T4L WT* will
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create a unique location for the linker tethering site to study its effects on immobilized
activity.
Choosing the locations to compare the effects of tethering sites must be
considered to avoid any significant activity loss from the mutation itself. If the cysteine
substitution itself is detrimental to the soluble activity, the chances of regaining activity
when immobilized is unlikely. Previous literature has mapped out which cysteine
mutations would lower enzyme activity of T4L WT. Rennell et al. inserted single amber
mutations at each of the 163 codons in T4L. Those amber mutations were used to
substitute in 13 different amino acids, one of which happened to be cysteine. They looked
at the resulting function of each cysteine mutant to develop a pattern to which residues
can be altered and why. Overall, T4L tolerates single amino acid substitutions in 90 out of
the 164 amino acid positions (Rennell, Bouvier, Hardy, & Poteete, 1991). The relative
insensitivity of T4L to mutations allows for the introduction of single cysteine mutations
that presumably do not significantly affect its activity. Herein, cysteine point mutations
to T4L WT* are utilized for studying the effects of different attachment sites has on sitespecifically immobilized activity.
The creation of the single cysteine mutants through site-directed mutagenesis
begins the process to creating the enzyme-crosslinker-surface complex required for sitespecific immobilization. The site of each cysteine mutation across the 164 amino acid T4L
WT* sequence generally follows a few guidelines: the mutations must be relatively
spaced across the entire sequence, must be surface exposed for linker attachment, and
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the cysteine mutation cannot be detrimental to soluble enzymatic activity. There are a
few exceptions to be noted for the selection of these 32 mutations. First, T4L mutant T21C
directly next to one of the active site amino acids, D20. Although D20 is less important to
the overall activity than E11 (Anand et al., 1988), a cysteine substitution around these
amino acids may negatively impact activity. Prior literature shows substituting the
noncanonical amino acid, p-propargyloxyphenylalanine, for threonine at position 21 in
T4L WT*, (T21pPa) 92 % activity loss when soluble and 95.5 % activity when sitespecifically immobilized (J. C. Wu et al., 2015). Mutant T21C mutant is chosen as the
negative control for site-specific immobilization. In comparison, L91C is expected to act
as a positive control because previous literature shows that site-specifically immobilizing
T4L at position 91 results in two-thirds activity retention (J. C. Wu et al., 2015). Also,
alanine mutations to the solvent-exposed N40 and S44 increase thermostability (Heinz et
al., 1992). Although not a direct comparison, the hope is that cysteine mutations may
have similar stabilizing effects, significant to immobilized activity. Lastly, mutants A98C,
V149C, and T152C are selected to demonstrate a buried amino acid's effect on efficient
conjugation to a crosslinker. The following chapter describes the creation of these T4L
cysteine mutants through expression, purification, activity, and stability analysis.
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Methods
Primer design for QuikChange Mutagenesis

Primers were designed initially using Agilent's online QuickChange II SDM
software

<https://www.genomics.agilent.com/primerDesignProgram.jsp>.

The

overlapping primer pairs for site-directed mutagenesis (SDM) (Novoradovsky et al., 2005)
designed by Agilent's software that did initially generate mutations were modified by
adding or removing base pairs from the 5' and/or 3' to shift the primer's melting
temperature. For the list of primers used to create single cysteine mutations, see Table
B-1 in Appendix B.
Mutagenesis PCR Reaction and Thermal Cycler Conditions

Plasmid DNA, which contains the T4L WT* gene (addgene # 18111), was extracted
from an overnight cell culture and purified using ZppyTM plasmid purification kit per the
manufacturer's instruction manual (Zymo Research Corp. Ver. 1.2.6.)
Methods for T4L mutant creation are based on Agilent's QuikChange Site-Directed
Mutagenesis Kit—Instruction Manual Cat #200518. Rev. A.01. Significant modification to
the method is as follows. For a 50 μL reaction, 50 ng of dsDNA template (T4L WT*) was
mixed with 0.01 nmol of each primer (forward and reverse), 10 nmol of each nucleotide
(dNTPs), and 0-8 % dimethyl sulfoxide (DMSO) in water. Two different sets of polymerase
and corresponding buffers were used: (1) 1 unit of Q5 HF DNA polymerase and 5x Q5
Reaction buffer (with an optional addition of 5x Q5 GC Enhancer) and (2) 1 unit of Phusion
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DNA polymerase and 5x Phusion GC Buffer. The reaction was created on ice, and the order
in which each component was mixed in the PCR reaction tube is as follows: water,
reaction buffer, DNA template, DMSO, primers, nucleotides, and polymerase.
Each PCR reaction was inserted into the thermal cycler with a lid temperature of
103 °C with an initial incubation time of 2-3 minutes. Samples then underwent 16-25
cycles consisting of a 10-second denaturation step (98 °C), 30-second annealing step (55
or 67.2 °C), and 2 ½ - 4 minutes elongation step (72 °C). After the cycles finished, samples
were put on ice.

Plasmid Verification and Glycerol Stock Creation

The PCR product was cleaned and concentrated using DNA Clean &
ConcentratorTM Kit from Zymo Research. Plasmids were digested with DpnI restriction
enzyme from New England Biolabs (NEB) per the manufacturer's protocol. The digested
parental DNA and PCR products were cleaned and concentrated once again. Eurofins
Scientific sequenced the plasmid DNA. Figure B-2 in Appendix B shows the location of the
sequencing primers that reside upstream and downstream of the T4L WT* gene. Once
the correct cysteine mutation was sequence confirmed, the plasmid was transformed into
Escherichia coli BL21(DE3) bacterial cell line. These transformed colonies underwent
overnight expanse before storing the T4L mutant in 20 % glycerol at -80 °C.
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T4L Expression Test Using Dot Blot Analysis

From each T4L mutant glycerol stock, cells were streaked onto Lennox Broth (LB)
media and 100 µg/mL ampicillin containing Petri dishes (FisherBrand) . Cell colonies
developed overnight at 37 °C. Single colonies were used to inoculate 250 μL of
autoinduction media ZYM-5052 (Studier, 2005) and 100 μg/mL of ampicillin in Nuclon
Delta MultiDish 48 Well Plates. Samples deemed "uninduced" were grown in
autoinduction media that did not contain any lactose. Each well-plate culture was
incubated for 48 hours at room temperature with constant shaking (250 RPM) on the
Corning® LSE™ Digital Microplate Shaker. Each culture's absorption readings at 600 nm
(turbidity) were taken using the Epoch 2 microplate reader from BioTek to record the
culture cell density at harvest time.
The microplate cultures underwent five freeze-thaw cycles to lyse the cells. Each
cycle consisted of 25 minutes at -80 °C followed by 25 minutes at 37 °C. After the cells
lysis, cultures were centrifuged at 4000 x g for 20 minutes using Sorvall Legend XFR
Centrifuge (Thermo Fisher Scientific) with swing buckets and the Sorvall 75006449
Microplate Buckets. The cell debris congregated at the bottom of each well while soluble
protein remained in the supernatant.
Two microliters of each sample's supernatant were spotted on a nitrocellulose
membrane (GE Healthcare) and allowed to dry for 45 minutes at 37 °C. The blots were
incubated for 1 hour in 20 mM Tris, 150 mM NaCl, 0.1 % Tween-20, and 1% (w/v) nonfat
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milk (pH 7.5) at room temperature. Excess blocking agent, nonfat milk, was washed away
with 3 x 5-minute washes in TBST (20 mM Tris, 150 mM NaCl, 0.1 % Tween-20 at pH 7.5).
Next, the blots were incubated with 1 μg/mL of mouse Anti-T4 Lysozyme (T4L) Antibody
(Millipore Sigma) primary antibody in 10 % TBST and 0.1 % nonfat milk for 12 hours at 4
°C. Membrane unbound primary antibodies were washed away with 3 x 5-minute washes
in TBST. Finally, the blots were incubated in 1 μg/mL goat anti-mouse IgG (H+L)
SuperclonalTM, Secondary Antibody, Alexa Fluor 647 from Thermo Fisher Scientific in 10
% TBST and 0.1 % nonfat milk for 1 hour at room temperature. Membrane unbound
secondary antibodies were removed with 3 x 5-minute washes in TBST and 1 x 5-minute
wash in 20 mM Tris, 150 mM NaCl (pH 7.5). Blots images were captured using LICOR
Imager at 700 nm with 337 μm resolution. Signal quantitation of each sample blot was
quantified using Image Studio Lite software.

Overexpression and Cell Harvest of T4L

A preculture, consisting of 10-50 mL of LB or Yeast Extract Trypton (2xYT) and 100200 μg/mL of ampicillin, was inoculated from glycerol stock stab and allowed to grow
overnight in a 25-250 mL baffled Erlenmeyer flask at 37 °C and 200-250 rpm.
Subsequently, the whole preculture was introduced to 0.5-1.5 L of 2xYT media with 100200 μg/mL of ampicillin and allowed to grow at 37 °C and 200-250 rpm. At a culture
absorbance reading of 0.8-1.5 (adjusted to pathlength) using the NanoDrop 2000C
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pedestal, isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final
concentration of 0.5 mM and the incubator temperature was reduced to 18 °C for 16
hours. Cells were harvested via centrifugation in 250 mL conical tubes at 3000-4816 x g
for 20 minutes in a swing bucket, prior to removing spent media supernatant each time
until culture was depleted. Wet cell pellets were stored at -20 °C.

Cell Lysis for T4L Extraction

Frozen cell pellets were thawed and resuspended via vortex in 20-40 mL in water
or 50 mM sodium phosphate buffer, pH 7.5. The cell suspension underwent cell lysis using
the Sonic Dismembrator: Ultrasonic Processor, FB-120 model from Thermo Fisher
Scientific with a 1/4” probe (FB4435). Cells were sonicated for 40 minutes, cycling
between 15/5 seconds (on/off) at 40 % amplitude in an ice bath in a cold room (4 °C).
Lysed cells were transferred to a 50 mL conical tube and spun down at 20,000 x g for over
an hour at 4 °C using Thermo Fisher Sovell's centrifuge with a fixed angle rotor. The
supernatant was filtered using Whatman 0.45 µm syringe filter and stored at 4 °C until
purification processing.

Purification of T4L via Ion Exchange Chromatography

Purification of T4L mutant requires a two-buffer system (start and elution buffer),
a HiTrap SP HP, 5 x 5 ml for cation exchange (Cytiva Life Sciences), and a two-pump
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chromatography skid (NGC Chromatography System from Bio-Rad Laboratories). Start
Buffer is 50 mM sodium phosphate buffer (pH 7.5) and is directly connected to pump A
on the NGC Chromatography System. Elution Buffer is 50 mM sodium phosphate buffer,
0.5-1.0 M NaCl (pH 7.5), is directly connected to pump B on the NGC Chromatography
System. The Start and Elution Buffers are filtered and degassed using Nalgene™ RapidFlow™ Sterile Single Use Bottle Top Filters (PES membrane, pore size=0.2 µm) attached
to Welch™ Compact Aspiration/Filtration Vacuum Station (2515 series). Soluble protein
samples containing about 30-50 mL of cell lysate are connected to inlet lines. These inlet
lines feed into pump A alongside the Start Buffer. This setup allows the chromatography
skid to switch from a column equilibration step to a load step seamlessly. All lines are
primed before each chromatography run with their respective buffer, except the sample
inlets are primed with Start Buffer. A controller determines the flow rate throughout the
chromatography run. The pump adjusts its speed not to exceed the column cartridge's
pressure limit (380 kPa). Typically, this results in a 1-2.5 mL/min flow rate throughout the
entire run. Each chromatography run follows the general scheme as provided by the
manufacturer (Cytiva Life Sciences). The first two steps to purification are the
conditioning step followed by the equilibration step. Five column volumes (CVs) of elution
buffer followed by 5 CVs of Start Buffer are passed through the column. The next step is
the load step, where 95 % of the sample is loaded onto the column. The column is washed
with Start buffer following the load step until the ultraviolet (UV) reading is less than 1025 A.U. Immediately following the wash step, the UV is zeroed, and the gradient elution
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begins. Over the following 10 CVs, the Start Buffer running through the column is slowly
replaced by Elution Buffer. In other words, the Elution Buffer percentage that passes
through the column increases from 0 to 100 as the Start Buffer percentage that passes
through the column decreases from 100 to 0. The gradient elution process occurs over
the 10 CVs resulting in a gradual increase in conductivity passing over the column. Protein
is slowly eluted from the cation column resin. The resulting UV peak from eluted protein
is collected into fractions for future purity analysis. Finally, the column is stripped with 5
CVs of 100% Elution Buffer and regenerated with 5 CVs of Start Buffer before the process
repeats for the following sample.
Lysozyme Activity Assay

Per the manufacturer's protocol, 1 mg of Micrococcus lysodeikticus, labeled with
fluorescein (DQTM lysozyme substrate, fluorescein conjugate) was resuspended in 1 mL of
water. Forty micro-liter aliquots of resuspended substrate were frozen and stored at -20
°C. Each aliquot was thawed for at least 30 minutes and diluted 20-fold in 50 mM sodium
phosphate buffer, 50 mM NaCl, pH 7.5, unless specified otherwise. Fifty micro-liters of
working substrate were added to 50 µL of sample in each well immediately prior to the
kinetic assay. The final substrate and enzyme concentration per well were 25 and 2.5 ng/
µL (unless specified otherwise), respectively.
The Synergy MX BioTek microplate reader was preheated to 37 °C. Fluorescence
(RFUs) at Ex/Em = 494/518 nm was monitored every 20-30 seconds for 5-10 minutes
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with a 5 second fast shake prior to each read. The gain was set to 125 with a slit width of
9 nm.
Determining Initial Rates for Activity Quantitation

The initial rate was determined by sampling 10 consecutive time points and fitting
a second order polynomial set of 10. For instance, if there are 20 time points, a total of
11 different polynomial fits are generated. The initial slope of each second order
polynomial is determined and compared to one another. The initial slope with the
maximum value is assigned as the initial rate for that sample. This method of calculation
prevents any influence of poor mixing early on in the sample reads when determining its
maximum velocity.
Freeze-Thaw Cycles for Storage Stability

Each aliquot of T4L in 50 mM sodium phosphate buffer, 50 mM NaCl, pH 7.5, was
flash frozen using liquid nitrogen and placed in -80 °C for 25 minutes. Samples were then
thawed at room temperature for 25 minutes. The process of freeze and thaw is deemed
as one cycle.
Results and Discussion
Comparable WT and WT* Activity

Before introducing site-directed cysteine, native cysteines of T4L are removed.
This ensures that any new cysteine residues introduced to the cysteine-free T4L (WT*)

61

will not disrupt any existing disulfide bonds essential to enzymes' stability and/or function
and the cysteine’s sulfhydryl side chain is unique to all other amino acid chemistries in
T4L WT*. Not all proteins/enzymes will retain their structure and function when their
cysteines are removed. Therefore, it is necessary to see whether T4L is both stable and
functional without its native cysteines (C54 and C97) as seen in the below figure.

A

B 1.5
Relative Activity

Relative Activity

1.5

1.0

0.5

0.0

1.0

0.5

0.0
WT*

WT

0

T4 Lysozyme

1

2

3

4

5

Freeze-Thaw Cycle of T4L WT*

Figure 3-1. (A) Comparison of T4L WT and cysteine-free WT* and (B) the stability of T4L WT* throughout
five freeze-thaw cycles. The relative activity is normalized to WT* and based on initial rates (RFU/s).

Previous literature demonstrates how mutating the only two cysteines (C54T and
C97A) of T4L WT creates a pseudo-WT T4L (WT*) with a similar structure and equivalent
activity to its parent (Matsumura & Matthews, 1989). Using fluorescently labeled
Micrococcus lysodeikticus as a substrate and a reaction temperature of 37 °C, T4L WT has
70 % relative activity to T4L WT*. In comparison, Matsumura et al. show T4L WT has an
equivalent activity to WT with E.coli cell wall as a substrate at a reaction temperature of
23 °C. As shown in Figure 3-1 (right), T4L WT* is stable until up until 3-4 freeze-thaw
cycles. Reintroducing cysteine to the cysteine-free T4L (WT*) may increase or decrease
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activity; however, knowing that T4L WT* has stability when stored and an adequate
activity baseline reassures any variations in mutant activity can be detected and
discernable.
Distribution of Cysteine Substitutions in T4L’s Amino Acid Sequence

Site-directed cysteine mutations are distributed throughout the T4L WT* amino
acid sequence. The mutations consist of 3 to 4 stacked at both the N- and C-terminus, 23
within alpha-helixes, two within beta-sheet, seven within coils/turns, one directly next to
an active residue, and three pairs of adjacent amino acids. There are 7-11 hydrophobic,
polar uncharged, positively charged amino acids each that are mutated to cysteine. The
mutation distribution provides a sampling of T4L WT* and the effects of cysteine
mutations of structure and activity.
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Figure 3-2. The 164 amino acid sequence of T4L WT* including selected cysteine substitutions. Secondary
structures highlighted with different colors: yellow for turns/coils, blue for beta-sheets, and green for alphahelixes. E11, D20, and T26 in bold black lettering indicates active site. Number labeling identifies single
cysteine mutation sites. Mutants signified by parentheses are created but because of expression or
purification complications, these mutants are not pursued.

Variance across T4L Mutant Expression

Cysteine point mutations can influence expression levels depending on sequence
location. If a mutation inhibits the overexpression of said enzyme, then purification and
following collection can become more complex. All mutants underwent an expression test
via dot blot and subsequent quantification in Figure B-3 and Figure B-4 of Appendix B,
respectively. When examining the summarized expression levels of each cysteine
mutation, in Figure 3-3, mutants between 21-57 collectively have higher expression than
all other mutants. Individually mutant S44C and T21C have the highest level of
overexpression. All mutants, except for K65C, had higher expression levels than WT*. Due
to the low expression levels, K65C could not be efficiently purified to the standards set by
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the chromatography method designed for the expression levels of WT*. Thus, K65C has
been left out of future studies from here on out.
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Figure 3-3. Comparing the expression levels of T4L mutants on a cell culture turbidity basis. The secondary
antibody produces a signal for each dot at 700 nm wavelength. That signal signifies the expression amount
of T4L, while absorbance at 600 nm, measurement of cell culture turbidity at the time of harvest. (p-value
< 0.0001, one-way ANOVA)
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Impact of Single Cysteine Mutations on Purification
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Figure 3-4. Shifts in conductivity at time elution for each T4L mutant. Grouping based on amino acid
characteristics. ROUT method (Q = 1 %) removes outliers in each grouping (Motulsky & Brown, 2006).

Types of protein purification include but are not limited to hydrophobic
interaction chromatography (HIC), ion exchange (IEX), size exclusion (SEC), and affinity
chromatography. Fortunately, T4L WT* has a very high isoelectric point of 9.6, as seen in
Figure 2-5. Separation of overexpressed T4L from native BL21 proteins based on pI is the
logical choice. Previous literature has purified T4L by cation exchange, Amberlite IRC-50,
column (Tsugita, Inouye, Terzaghi, & Streisinger, 1968). T4L and its corresponding
mutants are purified in-house with a similar method using a cation exchange column and
high buffered salt gradient elution. The conductivity at the elution peak was recorded for
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each mutant as seen in Appendix B, Figure B-5, and summarized in Figure 3-4. The
mutants behaved as expected when interacting with the IEX column. For example, the
overall surface charge increases when positively charged amino acids are mutated to
more neutral charge cysteine. Therefore, T4L mutants that are less positive are not as
firmly held to the cation column and require less salt for protein-column dissociation. The
opposite is true for negatively charged mutations; a higher conductivity solution is
required for elution. Each mutant is purified using a gradient elution to compensate for
the shifts in eluent conductivity. However, such a shift for the negatively charged amino
acid group, D159C and E5C, introduced new contaminant proteins in the elution that
could not be separated. Fractions of each elution peak are collected and analyzed for
purity, as seen in Appendix B, Figure B-6. For consistency and to avoid discrepancy in
purity, D159, E5C, and N68C mutants did not undergo any polishing step and were left
out of future studies because of poor purity. K65C could not be purified because of
deficient expression levels.

67

Buffer Effects on Activity Assays
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Figure 3-5. Effects of buffered salt and sodium azide on T4L activity.

After purifying each mutant, it is crucial to make sure the protein integrity and
structure are retained. One way to check for significant protein unfolding is by measuring
the enzyme’s activity: enzymes are unlikely to retain activity if unfolded. Furthermore,
understanding how different buffer environments promote enzyme activity is imperative
since each enzyme undergoes various environmental conditions during crosslinker
conjugation, immobilization, and long-term storage. Low concentrations of sodium azide
(NaN3) are added to biological samples to prevent bacterial growth from contaminating
and degrading protein samples. As seen above, two mM NaN3 does not significantly affect
T4L activity. However, when comparing the mutant activity in low (50 mM sodium
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phosphate buffer, 50 mM NaCl, pH 7.5) and high (100 mM sodium phosphate buffer, 100
mM NaCl, pH 7.5) buffered salt solution in Figure 3-5, low buffered salt promotes T4L
activity. T4L requires water to complete its forward reaction, which might explain why all
mutants, collectively, have higher activity in lower buffered salt.
On the other hand, Figure 3-6 shows that each mutant behaves differently
towards lower salt conditions. Relative to WT*, S44C, K60C, T109C, and T21C increase
activity in higher buffered salt conditions than lower buffered salt conditions, whereas
R137C is not affected. This may indicate that some mutants are more stable in higher salt
than T4L WT* and damp effects that higher salt can disrupt protein internal hydrogen
bonds. Explaining the subtle activity differences can be challenging without further
experimentation or molecular simulations but knowing that these differences exist can
elucidate the sensitivity of enzymes to different environmental changes.
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Figure 3-6. Effects of buffered salt on a per normalized T4L mutant basis. Sample average determined with
and without 2 mM sodium azide with **** = <0.0001, * = 0.0141, ** = 0.0031 (p-values). Error bars
represent sample standard deviation.

Finally, the activity of T4L WT* was tested under the presence of 0-3 % (v/v)
Tween-20. Tween-20 is a non-ionic surfactant with a critical micelle concentration (CMC)
of 0.06-0.07 % in water at room temperature. The surfactant is considered to minimize
protein adsorption to surface interfaces (non-specific binding) and particles from
coaggregation. As shown in Figure 3-7, activity is not affected by the presence of Tween20 above and below the CMC. Continual exploration of environmental conditions involved
in immobilization requirements only helps confirm that the activity of T4L is preserved
when modifying all 28 mutants in a high throughput manner.
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Figure 3-7. Effects of Tween-20 on T4L activity. Error bars represent sample standard deviation.
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Figure 3-8. Stability of T4L mutants after three separate freeze-thaw cycles. Error bars represent sample
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For long-term storage of T4L, aliquots of each mutant are frozen at -80 °C in 50
mM sodium phosphate buffer, 50 mM NaCl, pH 7.5. To show that freezing T4L mutants
does not result in significant activity loss from cold denaturation, the stability of select
mutants undergoes three freeze-thaw cycles. Figure 3-8 shows an increase in activity after
the initial freeze-thaw cycle and a slow decline to normal as the cycles ensue. A possible
explanation for the initial spike in activity after initial freeze-thaw is that protein, when
frozen, undergoes a final refolding mechanism after potential cold denaturation. Through
molecular simulations, previous literature has observed the refolding of Trp-cage at a
temperature 55 K below solvent freezing point (Kozuch, Stillinger, & Debenedetti, 2019).
If T4L follows a similar subcooled induced refolding mechanism as Trp-cage, it could
explain the initial increase in T4L activity after its freeze-thaw cycle. Once folded correctly
through freezing, the enzyme may be less susceptible to unfolding during its thaw cycle.
All T4L mutants are stored effectively at -80 °C without activity loss. Once a frozen aliquot
of T4L thaws for use, it is stored at 4 °C from then on out. At 4 °C, T4L does not lose its
activity for up to about 100 days, as shown in Figure 3-9. The combination of frozen longterm and subsequent cold short-term storage ensures the T4L mutant activity is not lost.
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Figure 3-9. Stability of T4L WT* and S44C stored at 4 °C in 50 mM sodium phosphate and 50 mM NaCl, pH
7.5. Error bars represent sample standard deviation.

Conclusion
Creating an enzyme-crosslinker-surface system to study the characteristics of sitespecific enzyme immobilization begins with protein development. This encompasses
inserting a unique amino acid chemistry into the preexisting enzyme and showing that
these modifications are not detrimental to enzyme expression, purification, activity, and
stability. First, removing the two native cysteines in T4L WT results in a more active
cysteine-free T4L WT*. Insertion of any cysteine back into T4L WT* creates unique
chemistry apart from all other 19 amino acid side chains. In turn, the sulfhydryl moiety
can be targeted for site-specific immobilization. Thirty-two single cysteine substitutions
are made to T4L WT* that span across the 164 amino acids. Each mutation does not stifle
over expression in bacteria except for K65C. Hundreds of milligrams are produced by liter
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of cell culture subsequently undergo purification by chromatography. T4L cysteine
mutants behave as expected during purification when a positive or negative charged
amino acid is substituted for a more neutral cysteine amino acid. Gradient elution
consistently accounts for these elution peak shifts caused by the mutant’s increased or
decreased affinity to the ion exchange column. Future adjustments to single cysteine T4L
mutant purification involve including a reducing agent like tris (2-carboxyethyl)phosphine
hydrochloride (TCEP) or DTT in each buffer to ensure T4L remains monomeric.
Nevertheless, all mutants except for E5C, N68C, and D159C, result in high purity. Finally,
the activity and stability retention are sampled for some of the mutants. If a point
mutation is detrimental to enzyme activity, its chances of regaining activity when
immobilized are low. The 50 mM sodium phosphate and 50 mM NaCl, pH 7.5, low salt
buffer conditions show the high activity even for the expected nonactive T21C mutant. If
future applications like preventing polymer bead aggregation during immobilization
require a surfactant, there is minimal, if any, effect increasing Tween-20 surfactant on T4L
activity. Long-term storage at -80 °C and short-term storage 4 °C of T4L has little to no
effect on activity and stability. Knowing that the T4L mutants are isolated, retain activity,
and can be stored appropriately alleviates the doubt that outside influences may affect
immobilization operations and performance. The characteristics of the second
component in the enzyme-crosslinker-surface complex are explored in the next chapter.
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CHAPTER FOUR
HETEROBIFUNCTIONAL CROSSLINKER CHARACTERISTICS
Introduction
The second component, the crosslinker, of the enzyme-crosslinker-surface
complex is studied to understand the characteristics and limitations of different spacer
arm chemistries on reactivity, stability, and conjugation efficiency. The chosen
heterobifunctional crosslinkers conjugate amine-to-sulfhydryl. Therefore, a support
surface presenting primary amines and the single cysteine T4L mutants can crosslink for
immobilization. Not knowing what specific spacer arm chemistries of the crosslinker will
enhance, retain, or impede activity when the enzyme is immobilized suggests a variety of
crosslinkers should be tested. Four heterobifunctional crosslinkers MBS, GMBS, LC-SMCC,
and SM(PEG)2, as depicted in Figure 4-1, are selected for site-specific immobilization
because of their different spacer arm lengths and hydrophobicity.
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Figure 4-1. Four different heterobifunctional crosslinkers for amine-to-sulfhydryl conjugation.

The crosslinker MBS contains a short, hydrophobic spacer arm, while the
crosslinker GMBS, of the same length as MBS, has an aliphatic spacer arm. The crosslinker
LC-SMCC contains a long, hydrophobic spacer arm while the crosslinker SM(PEG)2, of the
same approximate length as LC-SMCC, has a hydrophilic spacer arm. All crosslinkers
selected have NHS-ester and maleimide functional groups that form covalent bonds with
primary amines and sulfhydryls. The conjugation scheme of NHS-ester to amines and
maleimide to sulfhydryls can be seen in Figure 4-2.

Figure 4-2. NHS-ester and maleimide reaction with amine and sulfhydryl, respectively.
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At slightly alkaline pH, primary amines are positively charged and nucleophilic by
nature. N-hydroxysuccinimide esters (NHS esters) can attach the nucleophilic amine to
form a covalent amide bond (Brinkley, 1992). The stability of these heterobifunctional
crosslinkers refers to their ability to retain amine and sulfhydryl reactivity. An aqueous
solution can hydrolyze NHS-ester preventing the conjugation to primary amines. The
maleimide functional group is more resistant to hydrolysis and stable in an aqueous
solution compared to the NHS-ester. Furthermore, the chemical structure of the spacer
arms influences the stability of the maleimide group. The maleimide group of the
crosslinker SMCC is more stable than GMBS, and GMBS is more stable than MBS
(Hermanson, 2008).
Another factor that may influence reactive group stability is the spacer arm
hydrophobicity. If the hydrophobic spacer arm results in water-insolubility, the
sequestered reactive NHS-ester and maleimide may not hydrolyze. Furthermore,
depending on the degree of conjugation, the crosslinker can alter the solubility of the
protein in solution. For instance, attaching a crosslinker with a hydrophilic, water-soluble
spacer arm like PEG can increase the conjugated protein’s solubility (Hermanson, 2008).
Hydrophilic linkers are often preferred over hydrophobic or aliphatic linkers because it
prevents aggregation of proteins in solution.
When conjugated to the surface, the crosslinker may inhibit enzyme-surface
interactions or alter the surface properties enough to promote substrate diffusion.
Although not testing a variety of surface chemistries, it is safer to use a longer crosslinker
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to avoid unintended surface interaction between the enzyme and the surface. A longer
linker could extend the enzyme towards the bulk solution and reduce the influence of
polymeric surface charge. The linker can promote or inhibit the formation of substrateenzyme complex depending on the linker and substrate electrostatic interactions. For the
case of T4L immobilization, the negatively charged linker may repel lysozyme substrate,
the cell wall of Micrococcus lysodeikticus, because it exhibits an overall negative charge
as well.
Herein, the characteristics of each crosslinker are examined by looking at the
maleimide reactivity, hydrolysis rate or stability of NHS-ester in aqueous solution, and the
ability to maleimide activate the aminated polymer surface. Appreciating these inherent
differences among crosslinkers will help interpret their influence on enzyme conjugation
and T4L activity when immobilized.
Methods
Detecting Maleimide Content for Different Crosslinker Types

Using the Amplite Fluorimetric Maleimide Quantitation Kit, the maleimide content
of each crosslinker in 10 % DMSO was measured per the manufacturer’s protocol.
Hydrolysis Rates of NHS-Ester for Each Linker

Two micro-liters per sample were placed on the “TAKE 3” plate reader insert. The
absorbance at 260 nm was monitored for each crosslinker in PBS, 10 % DMSO, pH 7.2
without mixing. Time points from 30 to 65 minutes were collected.
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Maleimide Activation of Aminated Dynabeads

Aminated Dynabeads (1.95 mg) were washed three times with 0.111 M sodium
phosphate buffer, 0.167M NaCl (pH 8.0). The crosslinker stock in DMSO (25 µL) was
added to the 225 µL bead suspension. The conjugation reaction was incubated for 30
minutes at room temperature with constant mixing on the Tube Rotator Unit. The
maleimide activated Dynabeads were washed twice in 0.1 M sodium phosphate buffer
with 5 mM ethylenediaminetetraacetic acid (EDTA) and once with Amplite maleimide
green assay kit buffer. The maleimide content of the bead-activated surface was
quantitated using Amplite maleimide green assay kit and the manufacturer’s
corresponding protocol.

Results and Discussion
Comparison of Each Heterobifunctional Crosslinker inherent Properties

Amine-to-sulfhydryl heterobifunctional crosslinkers are designed for a variety of
applications such as protein-protein crosslinking and protein-surface immobilization.
Each crosslinker chemistry varies slightly and could influence conjugation, protein
stability and/or protein function. For instance, hydrophobic crosslinkers inhibit the
diffusion of the aqueous protein solution to the surface required for conjugation. Other
times, the reactive enzyme of NHS-ester and maleimide could be susceptible to hydrolysis
preventing crosslinking. Therefore, it is vital to know the subtle differences among
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crosslinkers, such as the reactive end integrity and conjugation efficiency, to ensure their
efficacy during T4L immobilization.
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Figure 4-4. Hydrolysis rates of NHS-ester of different heterobifunctional crosslinkers. Error bars represent
sample standard deviation.

Examining the NHS-ester functional group of the amine reactive end, Figure 4-4
shows the hydrolysis rate varies, not based on the linker length but, spacer arm chemistry.
The aliphatic spacer arms of GMBS and LC-SMCC could have sequestered itself away from
water, lowering NHS-ester hydrolysis rates to essentially zero. The NHS-ester on MBS is
more unstable in terms of retaining its reactivity than SM(PEG)2. It is possible that the
aromatic, hydrophobic spacer arm of MBS when solubilized in 10 % DMSO aqueous
solution is more unstable than the water-soluble SM(PEG)2. However, introducing an
insoluble polymer surface for NHS-ester crosslinker conjugation could favor those
crosslinkers that are resistant to hydrolysis and sequester themselves to the aminated
surface.
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Figure 4-5. Maleimide activation of aminated polymer surface with four different crosslinkers. Error bars
represent sample standard deviation.

The uncertainty of why both ends, maleimide and NHS-ester, behave differently
across all linker chemistries hint at the need for its effectiveness to maleimide activate
amine coated beads. Figure 4-5 shows MBS and LC-SMCC as far more efficient than
SM(PEG)2 and GMBS in activating the beads with maleimide. If taking into consideration
that maleimide RFU signal gets quenched by long linkers, LC-SMCC is highly effective at
activating the beads surface. The second most effective crosslinker is another
hydrophobic linker, MBS, despite its high NHS-ester instability. Nevertheless, all
crosslinkers activate the surface to some degree despite the difference in chemical
makeup.
Conclusion
Amine-to-sulfhydryl crosslinkers with varying spacer arm chemistries behave
differently. Some croslinkers are more water-soluble or contain longer spacer arms, which
may contribute to crosslinker stability. Special attention is needed when dealing with
NHS-easter and maleimide reactive ends that lose reactivity from hydrolysis. NHS-ester is
less stable than maleimide in an aqueous solution. As a result, using NHS-ester and
maleimide containing heterobifunctional crosslinkers NHS-ester reaction with amines
takes priority, followed by maleimide-to-sulfhydryl conjugation. Initially, the crosslinker
reacts with amine-coated polymer to activate the surface with maleimides for the
following immobilization to single cysteine mutants. At a crosslinker to available surface
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amines molar ration of greater than ten, most crosslinkers saturate the surface resulting
in complete maleimide activation. These molar requirements for maleimide surface
activation are the first step to immobilizing single cysteine mutants, site-specifically. The
outcomes that linker chemistries have on surface charge and immobilization efficiency
and activity are to follow.
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CHAPTER FIVE
IMMOBILIZATION OF T4L VIA AMINE-TO-SULFHYDRYL CROSSLINKER
Introduction
There are two common themes for better enzyme immobilization techniques: (1)
how to adhere enzymes to a surface efficiently and (2), once immobilized, how to
maximize an enzyme’s functional efficacy. Developing rational design rules for universal
enzyme immobilization necessitates knowledge and understanding of the contributions
from enzymes, linkers, and surfaces in the immobilization complex. This chapter aims to
define the enzyme-crosslinker-surface complex that results in high site-specific
conjugation of T4L. If T4L mutants can be site-specifically immobilized, then the effects of
different attachment sites for immobilization can be compared on an activity basis.
However, through trial and error, it is soon realized that nonspecific adsorption is
prevalent in tandem with site-specific immobilization. Any residual activity from
nonspecifically adsorbed enzymes may interfere with site-specific activity measurements
and should be avoided. Therefore, two polymeric surfaces, four heterobifunctional
linkers, and up to seven T4L mutants were studied to find the conditions that maximize
site-specific immobilization while minimizing nonspecific adsorption.
Each surface utilized for site-specific immobilization has amines for covalent
conjugation with the amine-to-sulfhydryl crosslinker, NHS-ester-[spacer]-maleimide.
Each linker covalently conjugates polymeric nanoparticles (-NH2) with enzymes containing
site-directed cysteine mutations (-SH). The heterobifunctional linkers are tethered to the
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surface prior to adding the enzyme. Maleimide activating the surface first prevents the
NHS-ester end from attaching to the primary amines of the enzyme. The cysteine mutants
are then added to the maleimide activated polymer beads for site-specific attachment. A
rudimentary depiction of the process is seen in Figure 5-1.

Figure 5-1. Order of operations for the enzyme immobilization using amine-to-sulfhydryl heterobifunctional
crosslinker to adhere single cysteine mutants to the bead surface site-specifically. The schematic begins
with conjugating the linker to the aminated beads exposing a reactive maleimide end on the surface,
followed by thioether bond formation between maleimide and the single cysteine substitution of T4L
mutant.

Different measurements ranging from surface amine quantitation to zeta
potential of the immobilized T4L mutants, for example, are utilized to determine the
effects of each component of the enzyme-crosslinker-surface has on immobilization
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efficiency. As a result, general guidelines are developed to reduce nonspecific adsorption
and activity when site-specifically immobilizing T4L.

Methods
Immobilization of T4L WT*, M1_N2insC, S44C, V57C, A93C, and Q123C on Aminated
Polystyrene via GMBS Crosslinker

In the conjugation buffer (PBS, 0.1 % Tween-20, 10 % DMSO, pH 7.2), aminated
polystyrene beads were mixed with the crosslinker GMBS at a ratio of 0.88 μmol GMBS
per mg of beads. Maleimide activation of the polymer beads was allowed to incubate at
room temperature with constant mixing for 1 h. Maleimide activated beads were then
washed five times with conjugation buffer. T4L mutant was added to the maleimide
activated polymer beads at a ratio of 1.11 nmol T4L to mg of beads. Enzyme
immobilization was incubated for 2 hours at room temperature with constant mixing.
Beads were washed once with PBS, 0.1 % Tween-20, 0.4 M NaCl, 10 % DMSO, once with
conjugation buffer at three times with 50 mM sodium phosphate buffer, 50 mM NaCl, 0.1
% Tween-20 (pH 7.5) for a total of five washes.
Samples were diluted in conjugation buffer and loaded into clear disposable zeta
cells. The zeta potential in mV was measured using the Zetasizer Nano MS (Malvern
Instruments) for each sample. Amplite Fluorescamine kit per the manufacturer's protocol
was used to determine primary amine content. Finally, the activity assay for each
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immobilized enzyme was performed per the manufacturer's protocol using the EnzChek
Lysozyme Assay kit. The initial rates (RFU/s) were calculated and compared across each
sample.
Immobilization of T4L WT*, M1_N2insC, S44C, V57C, and K60C on Aminated Polystyrene
via SM(PEG)2, LC-SMCC, GMBS, and MBS Crosslinker

In the 10 mM sodium phosphate buffer, 0.1 % Tween-20 (pH 7.2), aminated
polystyrene beads were mixed with the crosslinker at a ratio of 9.26 μmol of crosslinker
per mg of beads. Maleimide activation of polymer beads was allowed to incubate for 30
min at room temperature with constant mixing. T4L mutant was added to the maleimide
activated polymer beads at a ratio of 0.159 μmol T4L (treated with 5 mM TCEP) per mg of
beads. Enzyme immobilization reaction was incubated for 2 hours at room temperature
with constant mixing. Beads were washed once with PBS, 0.1 % Tween-20, 0.4 M NaCl, 10
% DMSO, once with 10 mM sodium phosphate buffer, 0.1 % Tween-20 (pH 7.2), and three
times with 50 mM sodium phosphate, 50 mM NaCl, 0.1 % Tween-20 (pH 7.5) for a total
of five washes.
Immobilization of T4L WT* and M1_N2insC on Aminated Dynabeads via GMBS
Crosslinker

One hundred microliters of Dynabeads stock (2 x 108 beads) were washed twice in
crosslinking buffer (0.1 M sodium phosphate buffer with 0.15 M NaCl, pH 8.0). To the
beads, 1.77 μmol of GMBS were added and allowed to react for 30 minutes at room
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temperature with constant mixing. Note that the reaction has 15 % DMSO in solution and
a pH of 8.0. Maleimide activated beads were washed twice with crosslinking buffer + 10
% DMSO and once with 0.1 M sodium phosphate buffer (pH 6.5). Twenty-five microliters
of T4L enzyme (1280 mg/L) in 50 mM sodium phosphate buffer + 50 mM of NaCl, pH 7.5
were added to the maleimide activated beads and incubated for 2 hours at room
temperature with constant mixing. Beads were washed four times with PBS and then
resuspended in 50 mM sodium phosphate + 50 mM of NaCl (pH 7.5).
Beads containing immobilized enzyme were washed three times in PBS + 0.05 %
Tween 20, pH 7.4 (antibody buffer). Then the beads were incubated with mouse IgG1,
anti-T4L, primary antibody (0.01 mg/mL) for 30 minutes at 37 °C with slow tilt and
rotation. Excess primary antibody was washed away twice in antibody buffer. Next, the
beads were incubated with goat, anti-Mouse IgG (H_L) Superclonal Secondary Antibody,
Alexa Fluor 647 (0.01 mg/mL) for 30 minutes at 37 °C with slow tilt and rotation. Beads
were then washed four times in antibody buffer.
Immobilization of T4L WT* and M1_N2insC on Aminated Dynabeads via MBS Crosslinker

Dynabead stock (598 µL or 12 x 108 beads) was washed in 0.111 M sodium
phosphate buffer with 0.167 M NaCl (pH 8.0) twice. MBS crosslinker (230 µL of 119 mM
stock solution or 27.4 µmol) was added to beads and incubated for 30 minutes at room
temperature with constant mixing. Maleimide activated beads were washed once with
0.111 M sodium phosphate buffer, 0.167 M NaCl, 10% DMSO (pH 8.0) and once with 0.1
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M sodium phosphate buffer, 5 mM EDTA (pH 6.5) before resuspending in 9 x 202.5 µL.
Twenty-five microliters of T4L (1282 ng/µL for WT* and 1270 ng/µL for M1_N2insC in 50
mM sodium phosphate + 50 mM of NaCl, pH 7.5) were added to each sample and allowed
to react for 2 hours at room temperature with constant mixing. After that, 1.35 µL of βmercaptoethanol (βME) was added to quench the reaction. Samples were incubated for
15 minutes at room temperature. Beads were washed four times with PBS, two times
with PBS, 1 % (v/v) Tween-20 (pH 7.4), and once more in PBS. Finally, beads were
resuspend in 50 mM sodium phosphate + 50 mM of NaCl, 0.01 % (v/v) Tween-20, pH 7.5.
Beads containing immobilized enzymes were resuspended in antibody buffer.
Then the beads were incubated with mouse IgG1, anti-T4L , clone 6A6 (0.01 mg/mL) for
30 minutes at 37 °C with slow tilt and rotation. Excess primary antibody was washed away
once in antibody buffer. Next, the beads were incubated with rat, anti-Mouse IgG1
Secondary Antibody, FITC (0.5 mg/mL) for 30 minutes at 37 °C with slow tilt and rotation.
Beads were then washed three times in antibody buffer.

Flow cytometry analysis:

Using CytExpert Software, 104 to 105 beads were passed through the flow
cytometer and collected for analysis. The forward (FSC-A) and side scatted area (SSC-A)
signal was analyzed and gated for singlets. The singlet counts covered 70-90% of total
counts. The the PE and FITC channel fluorescent signal per beads count were exported to
an .fcs files and reopened using fcsread.m (code provided by Robert Henson) in MATLAB
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for data analysis. Data was plotted on a frequency distribution in Graphpad Prism 9 for
visualization.
Immobilization of T4L WT* and M1_N2insC on Aminated Dynabeads via SM(PEG)2
Crosslinker

First, 1663 μL of Dynabead stock (or 32 x 108 beads) were washed in coating buffer
(0.111 M sodium phosphate buffer with 0.167 M NaCl, pH 7.2) thrice. To the washed
beads, 50 μmol of SM(PEG)2 crosslinker was added and allowed to react for 5 minutes at
room temperature with constant mixing. To the bead solution, 0.05 M Tris-HCl buffer (pH
7.25) at 1:1 (v/v) ratio was added to quench the NHS-ester reaction. Beads were washed
thrice in 0.1 M MES buffer (pH 4.5). An equal volume of 51.3 nmol of M1_N2insC or 52.6
nmol of WT* in 50 mM sodium phosphate, 50 mM of NaCl (pH 7.5) was added to the
maleimide activated beads and allowed to react for 30 minutes at room temperature with
constant mixing. One hundred and fify microliters of βME (neat) was added to quench the
reaction for 10 minutes, followed by four washes with 50 mM sodium phosphate, 50 mM
of NaCl, 0.01 % (v/v) Tween-20 (pH 7.5).
Immobilization of T4L WT* and V57C on Aminated DynaBeads via SM(PEG)2 Crosslinker

Dynabeads (420 μL of stock or 8.4 x 108 beads) were washed with coating buffer
thrice. Next, 9.4 μmol of SM(PEG)2 crosslinker was added to washed beads and allowed
to react for 5 minutes at room temperature with constant mixing. Note that the reaction
has about 11.3 % DMSO. Half a milliliter of 0.05 M Tris-HCl buffer (pH 7.25) was added to
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the 0.5 mL crosslinker conjugation reaction to quench the NHS-ester reaction. The beads
were washed thrice in 0.1 M MES buffer (pH 4.5). V57C or WT* (400 µL of 1304 or 1272
ng/µL) in 50 mM sodium phosphate, 50 mM of NaCl (pH 7.5) were added to the beads
and allowed to react for 30 minutes at room temperature with constant mixing. Next,
0.25 µL of βME (neat) was added to quench the reaction for 10 minutes. Beads were
washed four times with 50 mM sodium phosphate, 50 mM of NaCl, 0.01 % (v/v) Tween
20 (pH 7.5).
Each sample (5 µL) was mixed with 1 µL of Alexa Fluor™ 488 C5 Maleimide
(Thermo Fisher Scientific) stock solution and 25 µL of 50 mM sodium phosphate buffer,
50 mM NaCl (pH 7.5), and 25 µL of 0.1 MES (pH 4.55). The reaction took place for 2 hours
at room temperature. Afterward, beads were washed four times with 50 mM sodium
phosphate buffer, 50 mM NaCl (pH 7.5). Each sample was loaded onto a black 96-well
microplate, and the Synergy MX BioTek microplate reader measured the RFU at Ex/Em
493/516 nm.

Results and Discussion
Immobilization of T4L WT*, M1_N2insC, S44C, V57C, A93C, and Q123C on Aminated
Polystyrene via GMBS Crosslinker

To understand the surface-linker-enzyme complex system, five T4L mutants, and WT*
as the control were crosslinked to aminated polystyrene beads with the
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heterobifunctional linker GMBS. Multiple measurements, such as the electric potential
between the diffuse layer and bulk solution (zeta potential), amine content
representative of enzyme detection and aminated surface (fluorescamine), and
immobilized activity (initial rate), are examined to cross-validate the local surface
environment and function of immobilized enzymes. First, GMBS is covalently bound to
the polystyrene beads via the NHS-ester functional group. Next, the single cysteine
mutants are added and immobilized to the maleimide activated surface. Enzymes that do
not contain cysteine are not expected to bind covalently to the maleimide activated
surface. In other words, T4L WT* should only experience nonspecific binding, if any.
Furthermore, the linker must attach to the aminated surface first for two reasons.
First, the NHS-ester hydrolyzes faster than maleimide in an aqueous solution.
Immobilization takes numerous washes over hours of lab work. The risk of deactivating
the NHS-ester functionality can be avoided if amine to NHS-ester occurs before the
maleimide reaction. Secondly, the reactivity of NHS-ester and maleimide towards amine
and sulfhydryl groups, respectively, are controlled by overlapping pH regimes. NHS-ester
reacts with amino groups at pH 7-9, while maleimide reacts with sulfhydryl groups at pH
6.5-7.5. Maleimide is also reactive towards amine groups in alkaline buffers. Controlling
the specificity of amine and sulfhydryl functional groups on heterobifunctional
crosslinkers is difficult on the sliding scale of pH.
Furthermore, there are 13 lysine and 1 N-terminus in T4L compared to the single
cysteine substitution. Considering the odds and promiscuity of crosslinkers' reactive
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groups towards nucleophiles, attaching the crosslinker to the aminated bead surface is
best to avoid the above problems. Despite taking these precautions, there is evidence
that nonspecific binding occurs when looking at the zeta potential, amine content, and
activity of immobilized T4L on polystyrene beads.
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Figure 5-2. (A) Zeta potential of immobilized T4L mutants on aminated polystyrene (PS-NH2) via GMBS
crosslinker. Welch’s t test was performed between PS-NH2 and PS-NH2+GMBS with a two-tailed p-value of
0.0034. (B) Relative amine amount based on fluorescamine (RFU) of immobilized T4L mutants on aminated
polystyrene (PS-NH2) via GMBS crosslinker. Error bars represent sample standard deviation.

In Figure 5-2 (A), there is an significant increase in zeta potential from -20 to -17
mV when aminated polystyrene conjugates with GMBS. A shift in zeta potential above
that of the surface when linker is added indicates the extent of contributions from certain
linkers and enzymes. The surface is coated with GMBS and expected to be maleimide
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activated. By contrast, there is no significant difference between polystyrene and GMBS
coated polystyrene beads when quantifying amine content using fluorescamine in Figure
5-2 (B). The lack of differentiation may indicate that the blocking of bead surface amines
is insufficient with GMBS or below the assay’s sensitivity. GMBS nonspecifically coats the
bead surface without covalently attaching to the surface amines if the former is true.
Further analysis of the zeta potential also shows that, when coated with T4L, all mutants
and WT* on the surface decrease the zeta potential equally to roughly -26 mV. The
negative shift in zeta potential is unusual but consistent, considering T4L carries a positive
charge at pH 7.5. The slipping plane of hydrophobic beads may extend away from its
surface and not represent the expected electric potential near the surface. Measuring the
zeta potential may help determine the surface coverage of an enzyme when coupled to
the beads (Sofińska, Adamczyk, Kujda, & Nattich-Rak, 2014) (Schultz, Metreveli, Franzreb,
Frimmel, & Syldatk, 2008). Initially, the uniform change in zeta potential across all
mutants indicates complete surface saturation and efficient immobilization. However,
WT*, containing no cysteine, has an equivalent zeta potential as the cysteine mutants.
Assuming WT* immobilization is adsorbed nonspecifically, are the mutants covalently
immobilized or adsorbed nonspecifically? The amine quantification, Figure 5-2 (B), also
shows similar amounts of T4L WT* on the bead surface as the T4L mutants. Fluorescamine
assay appears more sensitive to the difference in immobilized enzyme quantities. For
example, there is a more significant amount of T4L Q123C immobilized than T4L WT*
based on the fluorescamine assay when the zeta potential indicates equal amounts of T4L
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WT* and Q123C immobilized. Maybe more Q123C enzymes can fit onto the surface when
site-specifically immobilized via the maleimide group, in addition, to nonspecifically
adsorbed to the surface. There are also differences in amine detection between mutants.
Maybe some cysteine locations are more accessible for conjugation than others. Another
possible reason is that different attachment sites lead to different enzyme orientations
when the mutant is immobilized. Thus, the location of lysine in one enzyme orientation is
harder to access because of surface-enzyme or enzyme-enzyme crowding than other
orientations.

5

Initial Rate, RFU/s

4

3

2

1

0

T*

C
ns

C
7C
3C
4C
23
S4
V5
A9
Q1
+
+
+
S
+
S
S
B
B
B
BS
+
GM
M
GM
GM
+
S
G
+
+
+
B
2
+
2
H2
H2
H2
NH
NH
GM
-N
-N
SS+
-N
PS
PS
P
P
S
2
P
H
-N
PS
+
BS
M
G

W

N
1_
M

2i

Figure 5-3. Activity based on initial rates (RFU/s) of immobilized T4L mutants on aminated polystyrene (PSNH2) via GMBS crosslinker. Error bars represent sample standard deviation.

Analyzing the T4L immobilization from a third dimension by looking at each
mutant’s activity further elucidates the functionality of the immobilized environment.
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Figure 5-3 shows similar activity for every mutant including WT*. Although if the specific
activity is approximated based on fluorescamine signal, T4L M1_N2insC has the greater
specific activity than that of Q123C. If this hold true, Q123C is prone to unfold on the bead
surface, exposing more lysine, and producing high fluorescamine signal with low specific
activity. Measuring the enzyme-linker-surface complex using different techniques reveals
what the enzymes are experiencing on the surface of the bead. One thing is for certain,
nonspecific binding is prevalent in the polystyrene-GMBS-T4L system.
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Immobilization of T4L WT*, M1_N2insC, S44C, V57C, and K60C on Aminated Polystyrene
via SM(PEG)2, LC-SMCC, GMBS, and MBS Crosslinker

To reduce nonspecific binding, different linkers with different spacerarm
chemistries are explored to activate the polystyrene surface with maleimide. The thinking
behind changing the crosslinker is that some cross linkers may make the hydrophobic
polystyrene surface more hydrophilic; thus, reducing the likelihood for water soluble
enzyme to nonspecifically adsorb to the surface. Four T4L mutants and WT* are
immobilized to polystyrene beads with or without a crosslinker. The activity ratio of
immobilized enzymes via crosslinker to immobilized enzyme activity without a linker is
measured as relative activity. For instance, the initial rate of PS+SM(PEG)2+S44C is divided
by the initial rate of PS+S44C. Theoretically, this ratio represents the specifically to
nonspecifically bound enzymatic activity. Relative activity values less than one indicate
that nonspecifically bound enzyme has a higher activity than specifically bound enzyme
or the linker negatively impacts enzyme activity.
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Figure 5-4. Comparing immobilization of T4L mutants on aminated polystyrene beads when using different
crosslinkers. Relative activity is the initial rate (RFU/s) ratio of immobilized T4L via crosslinker to
immobilized T4L without crosslinker. Error bars represent sample standard deviation.

Figure 5-4 shows that environments surrounding different linkers are consistent
with hydrophilicity of linker on surface. For instance, SM(PEG)2 and GMBS crosslinked
enzymes have similar activity profile. They both are more hydrophilic than LC-SMCC and
MBS, and mutant’s activity is retained under hydrophilic surface. It also becomes more
apparent that nonspecific binding is uncontrollable with hydrophobic polystyrene beads.
The hydrophobic interactions of enzyme-polystyrene complex could exacerbate
nonspecific binding and mask the electrostatic forces required for nonspecific binding
reduction (Breite, Went, Prager, & Schulze, 2015; Wadu-Mesthrige, Amro, & Liu, 2000).
With high WT* activity when adsorbed, it must be assumed that there is always some
nonspecific protein-bead association. Mutants differ in effective binding but nonspecific
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to specific binding ratio is unknown. One thing is certain hydrophobic linkers negatively
affect T4L activity. Moving forward hydrophilic surface may prove beneficial in specific
activity retention.

Immobilization of T4L WT* and M1_N2insC on Aminated Dynabeads via GMBS
Crosslinker

Compared to the polystyrene beads, Dynabeads are composed of a highly
crosslinked polystyrene shell coated with a hydrophilic, glycidyl ether outer layer. The
hope is that switching to a hydrophilic surface and using a GMBS crosslinker for
attachment will reduce nonspecific adsorption and retain site-specifically immobilized
enzyme activity. The T4L mutant for conjugation analysis is M1_N2insC. T4L M1_N2insC
exhibits high specific activity when immobilized to polystyrene beads. Also, its cysteine
insert is most likely accessible because of its proximity to the unstructured N-terminus
tail.
Like previous experimental analysis, immobilized activity (initial rate), amine
quantitation (fluorescamine), and zeta potential measurements in Figure 5-5 (A-C)
compare the T4L M1_N2insC and WT* on Dynabeads via GMBS immobilization
characteristics. The immobilized activity and amine content exhibit a similar behavior on
hydrophilic Dynabeads as hydrophobic polystyrene beads. For instance, immobilized T4L
M1_N2insC has slightly higher activity and fewer surface amines than nonspecifically
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adsorbed WT*. The difference lies in the zeta potential (Figure 5-5, C). On a hydrophilic
surface, the zeta potential of M1_N2insC shifts significantly upward in the positive
direction from the surface-linker negative control, where the positive control (WT*) has
no significant difference. Unlike the zeta potential of protein-covered hydrophobic
polystyrene beads, the zeta potential became more positive as the positively charged T4L
covered the hydrophilic bead surface. A positive shift indicates there are possibly more
M1_N2insC immobilized than WT* adsorbed.
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Figure 5-5. Immobilization of T4L WT* and M1_N2insC on Dynabeads (DB). (A) The activity in terms of initial
rate. (B) Immobilized enzyme concentration amine quantitation. (C) Zeta Potential of enzyme-crosslinkersurface complex. (D) Immobilized enzyme concentration based on indirect BCA assay: back calculated by
running a BCA assay on the 5 washes and subtracted from the total added originally. (E) Immobilized
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444 ± 18, 379 ± 21, 411 ± 37, and 470 ± 26 for DB, DB+GMBS, DB+GMBS+WT*, and DB+GMBS+M1_N2insC,
respectively. Error bars represent sample standard deviation.
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To confirm the difference between immobilized M_N2insC and WT* exist, two
other methods of immobilization quantitation are observed in Figure 5-5, (D) and (E).
First, plot D determines the amount of T4L immobilized by subtracting the amount of T4L
washed away from the initial amount added to the beads for immobilization through a
BCA assay. The second method, plot E, uses a direct measurement instead of the previous
indirect method for detecting immobilized enzymes. Primary, anti-T4L, designed for both
immune precipitation and western blots, and a secondary, signal-producing antibody
adhere in tandem to any T4L immobilized on the surface. The signal generated from each
T4L, GMBS, and Dynabead complex is monitored through flow cytometry in plot E. It is
important to note that raw Dynabeads alone have high autofluorescence from their iron
core. When covered with GMBS, the linker suppresses the innate autofluorescence signal.
In both indirect and direct quantitation analysis, M1_N2insC is more abundant on the
surface than WT*. Also, the fact that the fluorescamine signal for WT* is higher than
M1_N2insC could, yet again, be a function of T4L unfolding and exposing more lysine
residue than when folded correctly. However, if WT* unfolding is prevalent, plot A would
indicate that the remaining, correctly folded WT* has higher specific activity than
immobilized M1_N2insC. Taken all together, the signal to noise of specific to nonspecific
has an incremental improvement of Dynabeads compared to polystyrene. However, the
nonspecific binding still dominates the activity profile. Switching beads seems beneficial,
but more investigation is needed.
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Immobilization of T4L WT* and M1_N2insC on Aminated Dynabeads via MBS Crosslinker

In concordance with the hypothesis that hydrophilic surfaces, not the linker,
primarily represses nonspecific binding, the aliphatic GMBS crosslinker is substituted with
its aromatic analog, MBS, for immobilization M1_N2insC and WT* on Dynabeads. From
the flow cytometry derived frequency distribution analysis in Figure 5-6 (A), more
M1_N2insC binds to the Dynabeads via MBS than WT*. Again, the Dynabeads reduce
nonspecifically bound WT* whether crosslinked with MBS or GMBS. The slight amount of
WT* nonspecifically adsorbed has higher activity than immobilized M1_N2insC, as seen
in Figure 5-6 (B). The activity results hint at the fact that MBS promotes nonspecifically
immobilized activity (WT*) while demoting specifically immobilized activity (M1_N2insC).
Similar results are seen in Figure 5-4. Again, the nonspecific amount of adsorbed enzyme
is reduced with a hydrophilic surface, and total activity of nonspecifically bound is
enhanced with MBS. Transitioning from GMBS to MBS crosslinker for T4L immobilization
on Dynabeads, shows that both linkers provide an environment where nonspecifically
adsorbed WT* retains activity.
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Figure 5-6. Immobilization of T4L WT* and M1_N2insC on Dynabeads via MBS crosslinker. (A) Immobilized
enzyme relative amount based on antibody detection and subsequent flow cytometry: MFI equivalent to
470 ± 12, 492 ± 26, and 530 ± 28 for DB+MBS, DB+MBS+WT*, and DB+MBS+M1_N2insC, respectively. (B)
Activity assay (blanked by DB+MBS).

Immobilization of T4L WT* and M1_N2insC on Aminated Dynabeads via SM(PEG)2
Crosslinker

A different, more hydrophilic, and longer spacerarm than GMBS and MBS, crosslinker
is used for site-specific immobilization, hereafter, to see the linkers effects on nonspecific
binding and its activity. Comparing the immobilization quantitation of WT* and
M1_N2insC on Dynabeads using SM(PEG)2 crosslinker in Figure 5-7 (A), it shows WT*
absorbs to the surface twice as much as M1_N2insC immobilized. In contrast, an aliphatic
crosslinker, GMBS, on Dynabeads has the opposite trend in Figure 5-5 (D): twice the
amount of M1_N2insC immobilized compared to adsorbed WT*. Further investigation of
the zeta potential in Figure 5-7 (B) possibly contradicts immobilized concentration
findings. There is no significant positive shift in zeta potential between the control and
WT* sample but a more significant shift between WT* and M1_N2insC. This shift suggests
more T4L M1_N2insC than WT* is immobilized. Examining the specific activity of both
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samples in Figure 5-7 (C) shows M1_N2insC has 2.5-fold greater catalytic efficiency than
nonspecifically adsorbed WT*. If nonspecific binding is unavoidable, then perhaps having
surface conditions of Dynabeads with SM(PEG)2 that promote site-specific and suppress
nonspecific activity could allow for comparison of all 28 mutants activity when sitespecifically bound. In addition, the adaptation of Michaelis Menten kinetics is a more
sensitive means for activity and provides binding affinity and turnover rates, rather than
simply initial rates.
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Figure 5-7. Immobilization of T4L WT* and M1_N2insC on aminated Dynabeads via SM(PEG)2 crosslinker.
(A) Indirect BCA assay of immobilized enzyme: measured washes for back calculations. Error bars represent
sample standard deviation. (B) Zeta potential of immobilized enzyme system taken in water, indicated pvalue = 0.0157. (C) Michaelis-Menten kinetics of immobilized enzyme -- WT*: kcat = 8.9 x 105 , Km = 0.99 ,
kcat/Km = 9.0 x 105 and M1_N2insC: kcat = 6.4 x 106 , Km = 2.79 , kcat/Km = 2.3 x 106

Immobilization of T4L WT* and V57C on Aminated DynaBeads via SM(PEG)2 Crosslinker

T4L mutant M1_N2insC has been used to test initial immobilization efficiency
because its located at the N-terminus. This cysteine insertion is most likely sterically
unincumbered and accessible to conjugation. To validate if the maleimide activated
Dynabeads with SM(PEG)2 apply sufficiently to another T4L cysteine mutant, a more
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centralized T4L mutant, V57C, is immobilized. T4L V57C and WT* both immobilized
equally, as seen in Figure 5-8 (A), using SM(PEG)2 on Dynabeads. The BCA assay is a direct
measurement of the enzyme concentration on the surface of the beads. In other words,
beads are present in the assay sample and blanked by a negative control. Suppose the
BCA assay is significantly interfered by the polymer beads and their surface chemistry
during the spectroscopy could lead to nearly equal concentration readings. Another
reason for the similar immobilization concentrations between WT* and V57C is that the
V57C cysteine substitution is more accessible than M1_N2insC leading to higher
immobilization efficiency. To check if V57C is site-specific and attached through its single
cysteine residue, a fluorescent maleimide probe is introduced to the immobilized
samples. The Alexa Fluor 488-C5-maleimide probe will attach to any free cysteine that is
present on the surface-bound enzymes. Figure 5-8 (B) shows each sample's resulting
fluorescence (RFU) distribution, indicative of cysteine. The maleimide activated beads and
the nonspecifically adsorbed WT* have an overlapping fluorescent spectrum, whereas
the immobilized V57C sample shifts to the right. This shift from negative and positive
controls means cysteine is present when V57C is supposedly site-specifically attached via
maleimide-to-sulfhydryl, thioether bond. That is to say, V57C is not covalently attached
to the maleimide activated beads through its single cysteine residue. Nonspecific binding
is unavoidable for WT* but could be neglected if the activity is low. An additional problem
arises, T4L single cysteine mutants, like V57C, may also immobilize primarily via
nonspecific

adsorption.

Assessing

the
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entire

enzyme,

sulfhydryl-to-amine

heterobifunctional crosslinker, and animated polymer bead, a change to the current
system for effective site-specific immobilization is imminent.
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Figure 5-8. Immobilization of T4L WT* and V57C on aminated DynaBeads via SM(PEG)2 crosslinker. (A)
Direct BCA to quantify amount of enzyme immobilized. Error bars represent sample standard deviation. (B)
Relative fluorescence units from maleimide-C5-AF488 reaction of immobilized samples.

Conclusion
To study the effects of different cysteine attachment points has on immobilized
activity, site-specifically attachment is maximized while nonspecific adsorption is
minimized. The path to immobilization optimization is developed through trial and error
by varying the three main components: surface, crosslinker, and enzyme. Heuristics are
developed based on the combination of surface-linker-enzyme complexes to improve
site-specific immobilization. The hydrophobic surface of polystyrene beads, however,
shows proclivity towards nonspecific adsorption. Different crosslinkers, SM(PEG)2 and
GMBS, on polystyrene both retain more site-specific activity than their analogs, LC-SMCC
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and MBS. Switching the surface from hydrophobic polystyrene to hydrophilic Dynabeads
results nonspecific binding decrease with hydrophobic linkers, GMBS and MBS, and an
increase in nonspecific binding with the hydrophilic linker, SM(PEG)2. In relationship to
their activity, hydrophilic surfaces with hydrophobic linkers promote nonspecific activity.
In contrast, hydrophilic surface and linker, SM(PEG)2 suppress nonspecific activity. If
nonspecific binding is inevitable, a hydrophilic PEG linker on a hydrophilic polymer surface
will allow for studying the site-specific immobilized activity with little noise from
nonspecifically bound T4L. The final component of the immobilized system to consider is
the enzyme. Each T4L mutant has a different immobilization efficiency and only differs in
cysteine location. For instance, V57C does not site-specifically immobilize as well as
M1_N2insC. The next chapter will explore the cysteine availability and accessibility to
explain the differences between each mutant’s immobilization efficiency.
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CHAPTER SIX
NONSPECIFIC ADSORPTION AND CYSTEINE INACCESSIBILITY REMEDIATION FOR
IMPROVED IMMOBILIZATION STRATEGY
Introduction
Irrespective of each component in the enzyme-crosslinker-surface complex,
nonspecific binding remains prevalent during site-specific immobilization. Alternative
approaches to reducing or removing nonspecifically bound enzymes that do not involve
the enzyme, crosslinker, or surface are explored. These include finding harsher wash
conditions to strip off the nonspecifically bound enzyme and preventing nonspecific
binding with a blocking agent. Furthermore, an investigation into understanding why
some T4L mutants do not bind site-specifically or have lower conjugation efficiency during
immobilization than other mutants is observed in this chapter. The cysteine availability
and accessibility of each T4L mutant may explain these differences and the overall
limitations of using cysteine as the point of attachment.

Methods
Washing beads with various surfactants to reduce nonspecific binding

To a 10 mM PBS, 5 mM EDTA, and 0.01 % Tween-20 (pH 7.2) solution, 1.23 mg of
maleimide activated beads (Ocean NanoTech) were added with and without 1.2 μmol Lcysteine (L-cys). Then 11.37 μg (0.611 nmol) T4L N40C was added to begin the conjugation
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reaction and allowed to incubate overnight with constant mixing at 4 °C. Beads were
washed three times in 10 mM surfactant solution followed by two washes with 10 mM
PBS, 5 mM EDTA, and 0.01 % Tween-20 (pH 7.2). Conjugated bead samples were then run
through an SDS-PAGE gel.
Non-specific Immobilization of T4L WT* and M1_N2insC on Aminated Polystyrene Beads

Aminated polystyrene beads (0.1 µL of stock) were resuspended in 50 mM sodium
phosphate buffer, 50 mM NaCl, 0.1% Tween-20, and 1 % nonfat milk (pH 7.5). For 30
minutes at room temperature, the beads were incubated to promote surface blocking.
Samples treated with milk are considered “blocked” while samples that did not undergo
blocking are the control. The blocked beads were then washed once. For 1.5 hours at
room temperature with constant mixing, 0, 0.428, 1.284, 3.852, or 11.56 ng of T4L WT*
was mixed with the “blocked” and “control” aminated polystyrene beads. The beads were
washed three times to remove any excess T4L WT* that did not nonspecifically adsorb to
the bead surface. Sample activity and zeta potential measurements were conducted in 50
mM sodium phosphate buffer, 50 mM NaCl, 0.1% Tween-20 (pH 7.5).

Immobilization of T4L WT* and M1_N2insC on Aminated DynaBeads via MBS Crosslinker
with NonFat Milk blocking

Aminated Dynabeads (197 μL or stock or 4 x 108 beads) were washed three times
in protein buffer (0.1 M sodium phosphate, 5 mM EDTA, pH 6.5). The beads were mixed
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with 25 μL of 100 g/L (10% w/v) Carnation Nonfat Milk (filtered) with gentle vortexing.
The beads were incubated for 2 hours at room temperature with constant mixing. The
beads were washed three times in protein buffer to remove excess nonfat milk. To the
beads, 7.5 µmol of NEM was added to block any cysteine groups on the surface adsorbed
nonfat milk. The maleimide-thiol reaction proceeded for 30 minutes at room temperature
with constant mixing. To quench the reaction, 5 μL of βME (neat) was added and allowed
to incubate for 15 minutes with mixing. The beads were washed with 0.111 M phosphate
buffer with 0.167 M NaCl (pH 8.0) twice. MBS (8.925 μmol) was added to beads and
allowed to react for 30 minutes at room temperature with constant mixing. After
incubation, wash beads once with 0.111 M sodium phosphate buffer, 0.167 M NaCl, 10 %
DMSO (pH 8.0), and once with protein buffer. Ten micrograms of T4L in 50 mM sodium
phosphate, 50 mM NaCl (pH 7.5) were added and allowed to react with the beads for 2
hours at room temperature under constant mixing. To quench the reaction, 5 μL of βME
(neat) was added and allowed to incubate for 15 minutes with mixing. The beads were
washed three times with PBS, twice with PBS and 1 % (v/v) Tween-20 (pH 7.4), once with
PBS, and finally resuspended in 600 μL of 50 mM sodium phosphate buffer, 50 mM of
NaCl, 0.01 % (v/v) Tween-20, pH 7.5.
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SDS-PAGE for Monomer and Dimer Protein Detection

Stock T4L mutants are mixed with 2x Laemmli sample buffer with and without 2.5 % βME.
Samples with βME in the sample buffer reduce disulfide bonds present in the protein.
Hereafter, the samples are processed for SDS-PAGE electrophoresis per the
manufacturer’s protocol. This protocol briefly involves (1) protein linearization in sample
buffer by heating samples for 10 minutes at 95 °C, (2) fixing the Mini-PROTEAN® TGX™
Precast Gels in Mini-PROTEAN Tetra Vertical Electrophoresis Cell and filling with SDSPAGE running buffer (Biorad), (3) loading roughly 500 ng of protein sample per gel well,
(3) applying 180 V for 40 minutes with the PowerPac™ HC High-Current Power Supply,
and (4) removing the gel from cast and staining using Bio-Safe™ Coomassie Stain. Gels
were imaged using LICOR Imager at 700 nm. The resulting band signals were processed
and measured using Image Studio Lite for quantitation.
Labeling Cysteine with Maleimide-C5-AF488

T4L was pretreated with 5 mM TCEP for 3 hours at room temperature in two-thirds
by volume of 50 mM sodium phosphate buffer, 50mM NaCl, (pH 7.5) and one-third by
volume of 10 mM PBS, 5 mM EDTA, 0.01 % Tween-20 (pH 7.2). Ten molar excess of
maleimide-C5-AF488 (fluorescent probe) was added to reduced T4L solution and
incubated for 2 hours at room temperature. Samples were mixed with Laemmli sample
buffer without any βME and ran on 4-20% gradient, Mini-PROTEAN® TGX™ Precast Gels.
The gels were washed with water and left unstained. Unstained gels were imaged on Bio-
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Rad Molecular Imager (ChemiDoc XRS+) using the XcitaBlue™ Conversion Screen for
AlexaFluor 488 fluorescent signal capture. The gels were subsequently stained with BioSafe™ Coomassie Stain and imaged using a White Conversion Screen for total protein
content detection.
Results and Discussion
Washing maleimide activated beads with various surfactants to reduce nonspecific
binding
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Figure 6-1. A new technique for quantitating nonspecific binding all while measuring the effectiveness of
different wash conditions in Figure 6-2.

New methods are adapted to detect and reduce the nonspecifically bound protein
byproduct of site-specific immobilization. The first attempt at reducing the nonspecifically
bound protein is to improve the wash conditions post-immobilization. Enzyme
immobilized beads are washed three times with five different 10 mM surfactant solutions
to try to remove nonspecifically bound T4L N40C. The site-specifically attached T4L N40C
does not wash away because these enzymes are tethered through the enzyme’s cysteine
and bead’s surface maleimides, forming a covalent thioether bond. To compare sitespecifically and nonspecifically immobilized enzymes, N40C is also forced to nonspecific
adsorption through concurrent L-cys treatment. T4L samples treated with L-cys primarily
undergo nonspecific binding to the bead surface because the L-cys is expected to
outcompete T4L N40C for maleimide conjugation. Furthermore, free L-cys may block sitespecific immobilization through disulfide bond formation with the single cysteine on T4L
mutants. A depiction of the immobilization process and detection are seen in Figure 6-1.
Suspended beads treated with and without L-cys and washed with different surfactants
are loaded into each well for SDS-PAGE. Covalently attached T4L via maleimide-sulfhydryl
attachment will remain on the bead as nonspecifically bound protein is forced off the
bead surface and migrate down through the gel during electrophoresis.
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Figure 6-2. Testing the effectiveness of different surfactants to remove the nonspecific binding. The y-axis
is the fraction of band signal (bottom image) for nonspecifically bound protein after washing with specified
surfactant per the band signal of its initial load. The dark spots, covering some of the bands were treated
as background signal. This average background signal was subtracted from sample band signal using Image
Studio Lite. Furthermore, the intensity profile of each sample band was void of any intensity spikes from
background signal.

The point of the experiment is to see if it is possible to remove the nonspecific
binding. In Figure 6-2 (bottom), each protein band represents the nonspecifically bound
protein that remains after washing each bead suspension with the specified surfactant.
The anionic SDS is most effective at stripping the beads of nonspecifically bound T4L
N40C, as seen in lanes 7 and 14 of the above gel. The negative charge of SDS could be
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attracted to the surface-bound and positively charged T4L and better for nonspecific
removal. Other nonionic detergents that vary in molecular weight and hydrophobichydrophilic tail chemistries are not effective at nonspecific removal. However, the
experiment may have some bias since the electrophoresis gel (SDS-PAGE) contains SDS.
The nonspecifically bound enzyme is forced off the beads by SDS during electrophoresis.
Other nonspecifically bound proteins may remain on the bead surface and only come off
with nonionic surfactants. Despite the uncertainty, high concentration washes of
detergent that stick to T4L may interfere with enzyme activity regardless (Hung, Lin, Chen,
& Wang, 2010). Instead of trying to remediate nonspecific binding, nonspecific binding
prevention may be a better choice.

Non-specific Immobilization of T4L WT* on Aminated Polystyrene Beads with nonfat milk
blocking

Polymer beads have a nonuniform surface riddled with undulations and
imperfection. Proteins will interact with the surface, attaching and detaching, until they
find a spot to adsorb irreversibly (Weltz, Schwartz, & Kaar, 2016). To study site-specific
immobilization, enzymes attachment to the maleimide surface should avoid interaction
with surface “hotspots” that promote nonspecific binding and prevent site-specific
attachment. Inert proteins or protein cocktails like casein, nonfat milk, or BSA are
sometimes used to block these “hotspots” and prevent nonspecific adsorption of the

117

protein of interest. To test the effects of blocking on nonspecific reduction, polystyrene
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beads are blocked with inert nonfat milk before adding T4L WT* in Figure 6-3.
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Figure 6-3. Non-specific immobilization of T4L WT* on animated polystyrene (PS) beads with nonfat milk.
The “blocked” (pink squares) refers to the beads precoated with nonfat milk, and the “control” (black
circles) are not pretreated with nonfat milk. Both samples are subsequently mixed with different amounts
of T4L WT*, and the effects of T4L WT* nonspecifically bound to the surface are examined through the zeta
potential (A) and T4L activity or initial rate (B). No heterobifunctional crosslinkers are used in the above
process. Error bars represent sample standard deviation.

Polystyrene beads coated with nonfat milk reduce the ability for T4L to bind to the
polymer surface nonspecifically. Figure 6-3 (A) shows that the zeta potential decreases as
the nonspecifically adsorbed T4L increases. On the contrary, polystyrene beads, blocked
with nonfat milk did not see such a decline. The diminished difference in zeta potential
suggests that blocking the surface with nonfat milk prevents nonspecific binding. In Figure
6-3 (B), the activity data at high T4L addition says a similar story. Surface blocking helps
prevent nonspecific binding. Applying the same principle to Dynabeads with crosslinker
attachment follows.
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Immobilization of T4L WT* and M1_N2insC on Aminated DynaBeads via MBS Crosslinker
with Nonfat Milk blocking

Integration of nonfat milk blocking to the site-specific immobilization of T4L via a
heterobifunctional crosslinker requires extra precautions for immobilization. The surface
of Dynabeads is covered with nonfat milk proteins, which changes the chemistry of the
polymer surface from aminated to a mixture of reactive residues on the surface. Although
effective at blocking surface spots that promote nonspecific binding, the protein
composition of nonfat milk is likely to contain free cysteine and lysine residues available
for conjugation (Davis et al., 1994). A free sulfhydryl could potentially react with the single
cysteine residue of T4L mutants negating the need for an amine-to-sulfhydryl crosslinker.
The creation of essentially a zero-length covalent disulfide bond for immobilization is
avoided by treating the surface-bound nonfat milk proteins with NEM to block the free
sulfhydryl, resulting in Figure 6-4. Newfound lysine residues from nonfat milk blocking
provide an advantage for the prospective amine-to-sulfhydryl crosslinker system. From
Figure 5-5 (B), attaching protein to the surface of Dynabeads increases its amine content.
In turn, more linkers could maleimide activate a protein blocked surface via lysine
residues than the stock aminated Dynabeads. The results of using nonfat milk for blocking
can be seen below in Figure 6-4.
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Figure 6-4. Nonfat milk blocking effects on activity when immobilizing T4L WT* and M1_N2insC on
Dynabeads via MBS crosslinker. Error bars represent sample standard deviation. The asterisk (*) has a pvalue = 0.0231 between WT* control and blocking samples. No significant (ns) difference between
M1_N2insC control and blocking samples.

In Figure 6-4, blocked Dynabeads are treated with nonfat milk, whereas the
control does not undergo any blocking. T4L enzyme is immobilized via MBS after that.
Compared to its control, WT*, nonspecific binding is significantly reduced when the
surface is pretreated with nonfat milk (blocked). In contrast, M1_N2insC binding is not
significantly reduced when blocked. The trend in the above figure indicates that nonfat
milk reduces nonspecific binding. To what degree nonfat milk reduces nonspecific binding
is unknown since measurements in the above figure are based on activity. Combining the
lessons learned from Figures 6-2, 6-3, and 6-4, rigorous wash conditions and surface
blocking are required to reduce nonspecific binding.
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Cysteine Availability (Monomer/Dimer)

Proteins with a single cysteine residue can exist as monomers, homodimers, or a
mixture of monomers and homodimers, depending on the cysteine location and
corresponding accessibility. A depiction of the interprotein attractions and outcomes
derived from single cysteine mutants can be seen in Figure 6-5. Understanding the
propensity for some T4L single cysteine mutants to form dimers while others do not can
help elucidate why some mutants immobilize more efficiently. For instance, Figure 5-2
shows subtle variations in immobilization efficiency across five different mutants. If T4L
cysteine mutant forms a homodimer, the cysteines involved in the disulfide bond
formation are unavailable for maleimide crosslinker conjugation. In turn, homodimers will
never site-specifically bind. On the other hand, if T4L mutants do not form dimers, it could
mean that the single cysteine residue is inaccessible for disulfide bond formation. If the
cysteine cannot form interprotein disulphide bonds, then that cysteine may not be
accessible for maleimide attachment of the crosslinker. Understanding how each mutant
behaves natively in solution will help improve its potential immobilization.
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Figure 6-5. T4L with a single cysteine (yellow circle) can exist as monomers (top), dimers (middle), or both
(bottom).

Each T4L mutant exhibits a different propensity for monomer and homodimer
formation. As the control, mutants are forced into their monomer states by including a
reducing agent, βME, in the sample buffer to break all disulfide bonds. As linearized T4L
migrates down the gel, it settles at a molecular weight of 18.6 kDa (the molecular weight
of T4L) as seen in the top gel of Figure 6-6. On a side note, it is evident that every mutant
is highly purified from previous chromatography operations with little to no contaminates
in any T4L mutant stock. The middle and bottom gel replicates in Figure 6-6 show the
migration of T4L when no reducing agent (-βME). A dimer band appears at ~37 kDa when
gels are run without a reducing agent. Each mutant has a different propensity for dimer
formation: some mutants primarily exist as monomer or dimer and some mutants exist
as both.
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Figure 6-6. The 28 single site cysteine mutations exhibit different propensities for monomer and dimer state. Top gel ran with a reducing agent, +βME
forcing all protein into monomer state. The middle and bottom gels are replicates of nonreduced gels (+βME) displaying the monomer and dimer states
of each mutant. Note the bottom gel is the same gel as the bottom gel in Figure 6-8 (Coomassie stain). Molecular weight standards are in the central
lane with the corresponding molecular weights on the right. Visualization of band composition are on the far left.
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Mutants T21C, N40C, S44C, Q123C, R137C, K162C, and L164C form dimers in
Figure 6-6. These mutants’ ability to form dimers can result from cysteine solvent
accessibility. Other mutants like L15C, L91C, R96C, A98C, V149C, T151C, and T152C are
primarily monomers. These mutants may have solvent inaccessible cysteine substitutions.
Mutants that exist partially as monomers and partially as dimers are interesting. One
possible explanation for mutants that exist simultaneously as monomers and dimer is that
the cysteine substitution takes on different conformations. For instance, the cysteine
residue at position 80 can take on a conformation where the residue is inaccessible and
half of the time where the cysteine is accessible, leading to the protein existing as both
monomer and dimer. Future transient studies on dimer formation with the use of NEM
to periodically quench dimerization could provide additional clarity to the dynamic nature
of protein.
The migration pattern of the dimer bands shifts slightly above and below
approximately 37 kDa. For example, mutants T21C, N40C, and S44C dimer bands did not
migrate as far as mutants R76C and R80C down the gel. The difference in dimer band
migration is not suspected to be a function of molecular weight change but rather due to
the steric hindrance of two linear protein chains connected with a disulfide bond. Two
peptides connected at position 44 could exhibit a greater apparent molecular weight than
those connected at position 76. Another interesting observation is the third band
associated with A73C. Again, the two dimer bands could have different conformations
when two linear peptides, connected by a disulfide bond, migrate down the gel.
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Alternatively, the third band is a product of protein degradation or another protein
contaminating the sample.
The overarching parameter that dictates homodimer formation is the cysteine’s
solvent accessibility. To compare monomer/dimer propensities observed in Figure 6-6,
structural properties of each cysteine mutation are identified. Single cysteine mutations
are incorporated into the structural model of T4L WT* (PDB: 1LW9) and measured for
solvent accessibility in UCSF Chimera (Pettersen et al., 2004; Sanner, Olson, & Spehner,
1996). Most cysteine mutations do not drastically change the native residue solvent
exposure, as seen in Appendix C, Figure C-1A. However, the calculations of solvent
exposure based on the static crystal structure alone exclude the residue idiosyncrasies in
a dynamic protein that might alter its solvent exposure.
Furthermore, there is an exponential relationship between residue solvent
exposure and its RMSF value shown based on 100 ns time-scale in Appendix C, Figure C1D: the more exposed a residue is, the greater its RMSF. When relating the cysteine
solvent exposure to the monomer fraction of each mutant, there is an expected inverse
correlation shown in Figure 6-7. When the single cysteine residue is less solvent-exposed,
it primarily exists as a monomer and vice versa. In the case of T4L monomer and dimer
propensities, the experimental observations coincide with theoretical structural
characteristics of cysteine mutations.
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Figure 6-7. Correlation between mutant monomer fraction and its corresponding cysteine solvent exposure.
Monomer fraction determined from the band signals in Figure 6-6, middle and bottom gels. Cysteine solvent
exposure theoretical calculation was performed using UCSF’s Chimera (see Appendix C).

Understanding if the cysteine substitution in all 28 T4L mutants is available for
maleimide conjugation proves vital. Not all mutants exist as monomers. Those mutants
that are primarily dimers do not have free cysteines available for conjugation. Maybe a
reducing agent will allow for crosslinker conjugation of dimers. Furthermore, the mutants
that are primarily monomers with little cysteine accessibility can be accessed with a
hydrophobic linker that wiggles into the hydrophobic core of T4L. The exploration of each
mutants’ cysteine accessibility experimentally with and without a reducing agent is to
follow.
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Cysteine Accessibility (Maleimide Fluorescent Probe)

If the cysteine of each T4L mutant is accessible, then there is a high chance that
such a mutant can efficiently be immobilized through maleimide conjugation. Each
mutant mixes with and without the reducing agent TCEP and a maleimide fluorescent
probe to test its cysteine accessibility. This fluorescent probe is comprised of a maleimide
functional group on one end and Alexa Fluor 488 on the other end, connected by a fivecarbon chain. If the probe conjugates to the single cysteine, the enzyme is tagged
fluorescently, indicating the cysteine was accessible for crosslinker attachment via
maleimide conjugation. The reducing agent, TCEP, is used instead of βME or DTT because
TCEP does not contain any sulfhydryl groups that could interfere with maleimide
conjugation. Thus, TCEP can remain in solution during the probe attachment to cysteine.
The schematic in Figure 6-8 shows the possible scenarios during which the
fluorescent probe can attach. Ideally, the maleimide fluorescent probe can only attach to
a monomer T4L depending on whether the cysteine is accessible. Observations in the top
fluorescent gel in Figure 6-9 show the presence of maleimide conjugation. However, the
degree to which the maleimide probe conjugates varies among mutants and whether a
reducing agent is present.
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Figure 6-8. Schematic of the possible outcomes of fluorescently tagged protein in the optional presence of
a reducing agent, 5 mM TCEP.

When 5 mM TCEP is present during the maleimide reaction, T4L mutants N40C,
R76C, K83C, A93C and T109C have high conjugation efficiency as seen by the fluorescent
intensity of the upper left in Figure 6-9. T4L mutants WT*, L91C, R96C, A98C, V149C, and
T152C with a reducing agent have no detectable fluorescence, thus cannot conjugate with
maleimide. Since T4L WT* has no cysteine present and does not conjugate with the
maleimide fluorescent probe, no fluorescent band indicates there is minimal off-target
binding of maleimide to other nucleophile amino acids such as lysine and histidine
(Brewer & Riehm, 1967) (Paulech, Solis, & Cordwell, 2013). In contrast, T4L WT* does
exhibit unwanted conjugation to the maleimide probe when no reducing agent is present
during the conjugation reaction. It is possible that the negatively charged TCEP coats the
protein, blocking primarily the positively charged lysine, and preventing maleimide from
off-target conjugation. Without the negatively charged TCEP, T4L WT* is fluorescently
tagged along with the dimer of the mutants. The mutants L91C, R96C, A98C, V149C, and
T152C that do not conjugate with maleimide in the presence of TCEP but interestingly
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undergo fluorescent labeling do when TCEP is not present. Many of these mutants are
only conjugated without TCEP; their cysteine is not solvent-exposed. The hydrophobic
spacer arm of the fluorescent probe could insert itself into the hydrophobic enzyme core
and attach it to the buried cysteine. Since pH can influence maleimide conjugation
specificity, all stock solutions of TCEP are buffered with 50 mM sodium phosphate buffer,
50 mM NaCl, and adjusted to pH 7.5 with NaOH prior to addition to the reaction.
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Figure 6-9. Fluorescent labeling of cysteine mutations. (Top) The signal was produced by the fluorescently labeled T4L mutants with maleimide-C5-Alexa
Fluor 488 in SDS-PAGE gel. The labeling occurs prior to protein denaturing required for SDS-PAGE operations. (Bottom) Colorimetric detection of
Coomassie-stained T4L bands. Both gels did not have a reducing agent present during the electrophoresis. The 5 mM and 0 mM TCEP labels at the top
of the gels indicate whether TCEP is present during the fluorescent label conjugation.
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When comparing the solvent exposure of the cysteine residue in each of the T4L
mutants to the maleimide, fluorescent labeling efficiency provides a link between the
structural properties and experimental observations. In Figure 6-9, there is no correlation
between the degree of cysteine solvent exposure and its ability to conjugate with the
maleimide probe when no reducing agent is present. The lack of a clear trend could infer
that all mutants, regardless of their cysteine position, are prone to off-target conjugation
or that the enzyme structure is far more dynamic than predicted. In contrast, when 5 mM
TCEP is present during conjugation, off-target conjugation is reduced, and a positive
correlation between cysteine solvent exposure and labeling efficiency emerges, in
congruence to previous findings (Iwakura & Kokubu, 1993). Knowing that all T4L mutants’
cysteine locations are labeled with and without a reducing agent confirms that it is
possible to immobilize all mutants using a maleimide crosslinker. On the other hand,
Nonspecific binding will be determined based on the ratio of unconjugated to conjugated
enzyme immobilized to the surface.
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Figure 6-9. The effects of cysteine accessibility have on maleimide labeling. The y-axis is the ratio of
fluorescent signal of top gels per band area of lower gels in Figure 6-8. The black circles are the monomer
bands when 5 mM TCEP is present during AF488-C5-maleimide conjugation. The blue triangles are the
monomer bands when 0 mM TCEP is present during AF488-C5-maleimide conjugation. The yellow squares
are the dimer bands when 0 mM TCEP is present during AF488-C5-maleimide conjugation. Cysteine solvent
exposure theoretical calculation was performed using UCSF’s Chimera (see Appendix C).
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Conclusion
A three-pronged approach to reducing the nonspecific binding and improving
conjugation efficiency has evolved in this chapter. First, the anionic surfactant in the wash
removes nonspecific binding. Although, such harsh detergent conditions may negatively
influence T4L structure-function, the concept of using SDS and corresponding SDS-PAGE
for nonspecific and immobilization efficiency quantitation seems viable. Second, blocking
the polymer bead surface with inert protein reduces the nonspecific binding. Switching
to streptavidin-coated polymer beads could act as a natural blocking agent and provide
more specificity to T4L site-specific immobilization. Third, examination of each mutant’s
cysteine availability and accessibility highlights the importance cysteine location has on
conjugation efficiency. Solvent accessible cysteine form homodimers through disulfide
bond. In turn, a reducing agent is needed to make the cysteine available for conjugation.
The reducing agent reverts cystine to cysteine and, as an added benefit, minimizes offtarget maleimide conjugation. Even if some buried cysteine conjugate with maleimide,
the other, biotin activated, end may not extend out into the solvent. To avoid this
potential problem, a maleimide-PEG11-biotin crosslinker that is more than three times as
long as SM(PEG)2 and longer than of T4L structure, will be used in the following chapter
to biotinylate T4L.
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CHAPTER SEVEN
IMMOBILIZATION OF T4L TO STREPTAVIDIN COATED BEADS VIA A BIOTIN-MALEIMIDE
CROSSLINKER
Introduction
In the previous immobilization method, the crosslinker was bound to the surface
first. Next, the enzyme, containing a single cysteine, finds and orients itself via a covalent
irreversible thioether bond with the maleimide activated surface, completing the
immobilization process. Crosslinker conjugation in this order could reduce enzyme
conjugation since the surface attached crosslinker is sterically hindered and diffusionlimited during attachment. In comparison, a maleimide fluorescent probe, representing a
crosslinker, can efficiently conjugate to each T4L mutant depending on its single cysteine
availability and accessibility. It is possible that conjugating the crosslinker to the enzyme
first could improve the previous immobilization inefficiency. However, amine-tosulfhydryl heterobifunctional crosslinker does not allow for maleimide to solely interact
with the protein first since the NHS-ester could react with the other lysine on the protein.
Therefore, a new linker that contains a maleimide group and orthogonal chemistry on the
other end is required to allow for conjugation of the enzyme first prior to surface
attachment. Herein, the benefits of substituting the amine-coated beads with
streptavidin-coated beads and NHS ester-spacerarm-maleimide with biotin-PEG11maleimide crosslinker are discussed.
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The streptavidin-coated surface may improve the immobilization efficiency and
prevent enzyme denaturation while reducing nonspecific binding during immobilization.
Blocking agents, like nonfat milk, help reduce the nonspecific binding during site-specific
immobilization by precoating the surface. Similarly, the streptavidin on the surface of the
beads could act as a natural blocking agent. Another added benefit of streptavidin is its
overall negative charge. Surface-coated streptavidin could attract the positively charged
T4L to the surface, thus, inducing biotin-avidin complex formation. As more enzymes
conjugate to the inert protein-coated surface, the higher density composition of enzyme
and streptavidin may prevent enzyme denaturation due to protein crowding.
Improvements to immobilized enzyme stability and activity have been seen when using
BSA as a spacer for enzyme immobilization (Nouaimi, Möschel, & Bisswanger, 2001).
The long, hydrophilic spacer arm of biotin-PEG11-maleimide could also be
beneficial for enzyme-surface conjugation, lowering nonspecifically adsorbed enzyme
activity, and reducing the detrimental surface interaction between the surface and
enzyme. PEG11 is about the same length as the long axis of the folded T4L itself. When
conjugated to the single cysteine-containing enzyme, it will extend out away from the
enzyme. Semi-accessible cysteine residues, if biotinylated, will become more accessible
for biotin-streptavidin immobilization. After immobilization, the enzyme will extend out
away from the surface, hopefully reducing enzyme-surface interactions detrimental to
immobilized enzyme activity. In addition, increasing spacer arm length seemed to
increase activity because a higher density of lysozyme immobilized to the surface (Y. Wu
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& Daeschel, 2007). Lastly, in Chapter Five, SM(PEG)2 lowered nonspecifically bound T4L
WT* activity compared to hydrophobic crosslinkers on the same hydrophilic surface. The
long PEG11 spacer arm is expected to minimize activity associated with nonspecific
binding.
Biotin-avidin complex is known to withstand extreme environments such as high
concentrations of urea or hydrochloride and can maintain a high affinity for each other
even under extreme pH, buffer salt, and elevated temperatures (Hermanson, 2008).
However, in 1 % SDS at 95 °C for 10 minutes, this harsh environment has been shown to
disrupt the biotin-avidin complex (Bayer, Ben-Hur, Gitlin, & Wilchek, 1986; Cheah &
Yamada, 2017). Unlike immobilization with NHS-ester and maleimide crosslinkers, biotinavidin immobilization is reversible when exposed to these high anionic surfactant
concentrations and heat conditions. Identifying the immobilized enzymes type,
unbiotinylated or biotinylated, and corresponding concentrations can be achieved by
stripping the enzyme-streptavidin-coated beads and SDS-PAGE analysis. As discussed in
Chapter Six, this gel electrophoresis removes noncovalently attached proteins from the
bead surfaces. Unbiotinylated and biotinylated enzymes removed from the bead surface
exhibit different migration shifts in the gel, as seen in Chapter Two with the acetylated
enzyme. Identification of immobilized enzyme type and quantity is only possible with a
reversible crosslinker.
Each immobilization classification has inherent assumptions. Adsorption assumes
that only non-biotinylated enzymes adhere to the surface via enzyme-streptavidin or
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enzyme-surface interactions because it lacks the activated biotin for specific attachment.
Site-specific immobilization takes on two assumptions. First, the maleimide-PEG11-biotin
crosslinker covalently binds with the single cysteine mutation (mono-biotinylation).
Second, mono-biotinylated enzymes undergo site-specific attachment to streptavidin
while avoiding any significant nonspecific adsorption. Occasionally, multiple crosslinkers
can attach nonspecifically to a single enzyme. As seen in the following chapter, cysteine
residues that are not accessible by the linker and undergo maleimide conjugation without
TCEP present can exhibit poly-biotinylation. In these conditions, maleimide can react to
other nucleophiles such as primary amines for crosslinker conjugation. Like site-specific
immobilization, non-specific or multipoint immobilization also forms streptavidin-biotin
complexes with poly-biotinylated T4L. However, one poly-biotinylated enzyme can create
complexes with multiple streptavidin at the same time. If the new streptavidin-biotin
immobilization strategy favors specific immobilization, the efficiencies will increase in the
following classification order: adsorption < site-specific < non-specific.
Once the specificity of immobilization via biotin-maleimide cross-linkage is
established, the immobilized activity can be assessed using Michaelis-Menten kinetics.
Obstacles such as enzyme concentration influence soluble activity are accounted for by
normalization of all activity to soluble T4L WT* activity. The reaction scheme used to
monitor T4L initial rates is seen in Figure 7-1. Catalytic efficiency is reported for 28
mutants in their natural, monomer, and immobilized states. Characteristics that correlate
to high immobilized activity are associated with increasing immobilized enzyme
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concertation per surface area. Using the biotin-streptavidin complex formation for sitespecifically immobilizing T4L mutants, nonspecific binding decreased, specific binding
increased, and heuristics for predicting where to attach an enzyme site-specifically to
retain activity emerged.

Figure 7-1. Simplified enzymatic reaction of T4L with Micrococcus lysodeiktus cell wall (or DQTM Substrate)
and corresponding fluorescent emission. The substrate of unknown lengths is comprised of alternating nacetylmuramic acid (NAM) and n-acetylglucosamine (NAG) with quenched fluorescently tag. Upon T4L
hydrolysis of β-(1-4)-glucosidic linkages, NAG and NAM are separated, and fluorescent probes are
unquenched. The resulting signal is proportional to T4L activity.
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Methods
Conjugation of maleimide-PEG11-biotin crosslinker to T4L

Maleimide-PEG11-biotin crosslinker (300 nmol) was introduced to 1.2 nmol of T4L
(crosslinker to protein molar ratio of 250:1) in 126.55 µL of 50 mM sodium phosphate, 50
mM NaCl, 4.88 mM TCEP (pH 7.5). The conjugation reaction was incubated overnight at 4
°C. Unlike the other T4L mutants, L91C, R96C, A98C, V149C, and T152C did not have TCEP
present during their conjugation reaction. T4L WT* was reacted in both the presence and
absence of TCEP. The excess crosslinker was removed using PierceTM Dye and Biotin
Removal Spin per the manufacturer’s protocol with minor adjustments. The spin columns
were equilibrated with 400 µL of 50 mM sodium phosphate, 50 mM NaCl, 0.01 % Tween20 (pH 7.5), and a 120 µL of the sample was loaded onto each column. The flow-through
was then loaded onto a second, new column. The above buffer exchange process was
repeated. Sample flow-through was collected, and 9 µL was set aside for SDS-PAGE.
Immobilization of Biotinylated T4L

The unreacted maleimide-PEG11-biotin crosslinker may still be present in each
biotinylated T4L sample even after two buffer exchanges with the PierceTM Dye and Biotin
Removal Spin columns. The excess crosslinker not conjugated to T4L can outcompete the
biotinylated T4L for streptavidin binding sites. For precaution, streptavidin-coated beads
(DynabeadsTM M-280 Streptavidin from Thermo Fisher Scientific) were initially introduced
to clear the sample of any free maleimide-PEG11-biotin crosslinkers. Subsequent added
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streptavidin-coated beads were more likely to favor the immobilization of biotinylated
T4L with free, excess crosslinker numbers diminishing. Thus, 100 µL of each biotinylated
T4L sample was reacted with 0.25 mg of streptavidin beads for 15 minutes at room
temperature. Then 0.25 mg of streptavidin beads was added and allowed to react for 15
minutes. Then 0.5 mg of streptavidin beads was added and allowed to react for 15
minutes. Then 1 mg of streptavidin beads was added and allowed to react for 15 minutes.
Finally, 2 mg of streptavidin beads were added (final total volume of 0.5 mL) and allowed
to react for 48 hours at 4 °C, rotating. The reaction was placed on a magnetic separator
for 2 minutes which allowed the magnetic beads to separate. Half a milliliter of liquid
without any beads was removed, followed by the addition of 1 mL of PBS, 0.1 % (w/v)
BSA, 0.1 % (v/v) Tween-20 (pH 7.4). The mixture was placed on a rotator at 4 °C for 24
hours. The reaction was placed on a magnetic separator for 2 minutes, allowing the beads
to be pulled to the side of the tube. One milliliter of liquid was removed followed by the
addition of 1 mL of PBS, 0.1 % (w/v) BSA, 0.1 % (v/v) Tween-20 (pH 7.4). The mixture was
placed on a rotator at 4 °C for 24 hours. The reaction was placed on a magnetic separator
for 2 minutes, allowing the beads to be pulled to the side of the tube. One milliliter of
liquid was removed, followed by the addition of 1 mL of deionized water. The mixture
was placed on a rotator at room temperature for 1 hour. The reaction was placed on a
magnetic separator for 2 minutes, allowing the beads to be pulled to the side of the tube.
One milliliter of liquid was removed followed by the addition of 1 mL of 50 mM sodium
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phosphate, 50 NaCl, 0.01 % (v/v) Tween-20 (pH 7.5). The mixture was placed on a rotator
at 4 °C for 24 hours.

T4L Activity Assay

For preparing the black 96-well plate for T4L activity kinetic assay, 50 µL of DQTM
substrate in water was added to 50 µL of T4L sample in 50 mM sodium phosphate buffer,
50 mM NaCl, 0.01 % Tween-20 (pH 7.5) using Opentrons’ programmable pipetting
automation (see the general python code for method details in Appendix D). T4L enzyme
that was converted to monomers underwent a 3-hour incubation with 5 mM TCEP. Each
well's final enzyme and substrate concentrations ranged from 10-12 to 10-5 M and 10-3 to
103 ng/µL, respectively. The working plate was loaded directly into the Synergy MX
fluorescent plate reader for the kinetic assay. The plate temperature was set to 25 ᵒC with
continuous (fast) shaking. Each well was monitored every 2 minutes at Ex/Em = 494/518
with (slit width = 9 and gain 88) for 20-60 minutes. The initial rate of the results was
calculated using the previously described “Determining Initial Rates” method in Chapter
3. Subsequently, initial rates in units of RFU/s, enzyme concentration in molarity, and
substrate concentration converted to RFU for each mutant tested were compiled and
imported into GraphPad. Michaelis-Menten Nonlinear regression was performed using
GraphPad Prism version 9.2.0 for Windows, GraphPad Software, San Diego, California
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USA, www.graphpad.com. The resulting catalytic efficiency is normalized to that of
soluble T4L WT* at the given enzyme concentration.
Results and Discussion
Load and Immobilization Composition and Quantitation

A

D
B
C

Figure 7-2. SDS-PAGE gels of the resulting biotinylated T4L mutants after maleimide-PEG11-biotin
conjugation. T4L Mutants that underwent conjugation reaction with TCEP present are labeled in blue. T4L
mutants that underwent conjugation reaction without TCEP present are labeled in purple. T4L standards
(A) are labeled in black with their corresponding band quantities in picomoles. Bands (B) are mono
biotinylated, bands (C) are not biotinylated, and bands (D) are assumed to be poly-biotinylated T4L.

Understanding that some T4L mutants prefer conjugation to maleimide without
the presence of a reducing agent, L91C, R96C, A98C, V149C, and T152C are biotinylated
using maleimide-PEG11-biotin without any TCEP. All other mutants are biotinylated with
5 mM TCEP. Figure 7-2, shows the resulting biotinylation of each mutant with and without
a reducing agent, TCEP. As previously shown in Figure 2-6, protein modification with EDC
leads to a slight upward shift in band migration. Similarly, conjugation of maleimidePEG11-biotin to single cysteine mutants also exhibits an upward shift due to the attached
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crosslinker’s steric hindrance during electrophoretic migration. In Figure 7-2, the lower
doublet, and sometimes triplet, bands in the lower half of the above gel represent the
ratio of the unmodified to the biotinylated enzyme. For instance, in the first lane, WT*
does not have any cysteine and does not conjugate to the maleimide crosslinker
producing a single band. No biotinylation occurs for WT* with 5 mM TCEP. In the second
lane, M1_N2insC with one cysteine has two bands. The upper band (B) is the biotinylated
protein, and the lower band (C) is the un-biotinylated enzyme. Since the WT* control does
not undergo any biotinylation, it is safe to assume that any biotinylation that occurs across
the single cysteine mutants is a single crosslinker attachment or mono-biotinylated. In 5
mM TCEP, all mutants are biotinylated to some degree. It is important to note that the
unbiotinylated to biotinylated ratio does not indicate cysteine solvent exposure due to
the 250-molar excess of crosslinker used. T4L mutants L91C, R96C, A98C, V149C, and
T152C, do not conjugate with AF488-C5-maleimide fluorescent probe in the presence of
TCEP (as seen in Figure 6-8), undergo crosslinker reaction with no TCEP. Again, some offtarget maleimide conjugation emerges in the WT* sample without TCEP (sixth lane from
the right) as indicated by the faint upper band of the doublet. T4L mutants L91C and R96C
also show a solid mono-biotinylated band. A third upper band (D) appears above L91C
and R96C consistent with WT* off-target binding. It is assumed that the band above the
mono-biotinylated band is poly-biotinylated. In T4L A98C, V149C, and T152C, all bands
are considered poly-biotinylated due to their faintness and general residue inaccessibility.
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All single cysteine mutants have some type of biotinylation, and their immobilization
efficiencies can be tested hereafter.
The mutant biotinylation and future immobilization efficacies are quantified using
T4L WT* standard curves (A) on the five gels consisting of Figures 7-2 and 7-4. On each of
the five gels, a standard curve is located in the upper half of the gel. Known quantities of
T4L WT* are loaded into the gel wells 30 minutes after the initial load sample has
migrated through the gel. The electrophoretic migration continues for another 10
minutes. Therefore, the sample migration pattern is independent of the T4L WT*
standards at the top of the gel. In other words, the standard is not consistent with sample
molecular weight distribution. Nevertheless, the five standard curves are compiled to
create the standard curve in Figure 7-3.
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Figure 7-3. Band quantitation standard curve. Across five separate gels, the compilation of known mass and
signal per band creates a standard curve for future mass quantitation. Gels were imaged using LICOR Imager
at 700 nm. The resulting band signals processed and measured using Image Studio Lite for quantitation.

At their current ratio of biotinylated to unbiotinylated, the T4L equal volume
samples from Figure 7-2 are immobilized onto Streptavidin-coated Dynabeads. The excess
enzyme is washed away, and the immobilized T4L enzyme (with the bead) is directly
loaded on the SDS-PAGE gel. Like in Figure 6-1 schematic, the beads remain in the well
during the electrophoresis while the nonspecific enzyme leaves the surface and enters
the gel. In addition to the nonspecifically bound enzyme, enzymes conjugated through
their biotin crosslinker to streptavidin-coated bead surface detach and migrate through
the gel. The nearly covalent biotin-streptavidin complex disassociates when mixed with
SDS-PAGE sample buffer, containing 1 % SDS, and exposed to 95 °C for 10 minutes during
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the protein denaturing step (Cheah & Yamada, 2017). The resulting protein bands in
Figure 7-4 are representative of the mutant and avidin composition on the bead's surface.
Multiple bands per lane need explanation. Each gel has a T4L standard curve (A)
across all lanes except the molecular weight standard lane. Located at the top of the gel,
these bands contribute to the quantitation standard curve in Figure 7-3. In the bottom
half of each gel, there are six negative controls located in every gel's first and last lanes.
These negative controls are the unreacted streptavidin beads. In these lanes, containing
just the unreacted streptavidin-coated beads, there are two bands, one upper (E), faint
band of the avidin dimer at approximately 26 kDa, and one lower (F), strong band of the
avidin monomers at approximately 13 kDa. The avidin monomer band can also be seen
across all immobilized mutant bands as well but slightly fainter. Because each lane had
equivalent bead concentration loaded into the well, the streptavidin-biotin complex from
enzyme immobilization could influence the ability of streptavidin to disassociate into its
monomers. Nevertheless, the lack of avidin monomer represented in each mutant’s lane
does not affect the ability of biotin to separate from streptavidin. In Figure 7-7, many
mutants have immobilization efficiencies of 50-90 %. Thus, at most, less than 10 % of the
biotinylated enzyme-streptavidin complex remains on the beads during SDS-PAGE gel
electrophoresis.
Like in the Figure 7-2, each T4L mutant immobilized contains doublet, sometimes
triplet, bands around 18-20 kDa in Figure 7-4. These bands are the different conjugated
enzymes removed from the enzyme immobilized beads. The upper band of the doublet

146

(B) is the mono-biotinylated enzymes specifically bound to the beads’ streptavidin. The
lower band of the doublet (C) is the unbiotinylated enzymes nonspecifically bound to the
bead surface. In some instances, in the immobilized samples that were not biotinylated
in the presence of TCEP, a third band (D) appears. This band is assumed to be polybiotinylated enzyme immobilized via multi-site attachment to the beads’ streptavidin.
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Figure 7-4. The distribution of modified T4L mutants (varying degrees of biotinylation) that are immobilized
to streptavidin-coated Dynabeads. The beads containing the immobilized T4L are loaded into each well. The
nonspecifically and specifically bound enzyme and the noncovalently attached streptavidin are stripped off
the beads to migrate through the gel. Immobilized T4L underwent conjugation reaction with TCEP present
are labeled in blue. Immobilized T4L mutants that underwent conjugation reaction without TCEP present
are labeled in purple. Wells that just contain the streptavidin beads are labeled in green (no enzyme).
Soluble T4L standards (A) are labeled in black with their corresponding band quantities in picomoles. Bands
(B) are mono biotinylated, bands (C) are not biotinylated, and bands (D) are assumed to be poly-biotinylated
T4L enzyme that has been immobilized. Bands (E) and (F) are the avidin dimer and monomer, respectively.

For each mutant, the ratio of unbiotinylated to biotinylated enzyme in Figure 7-2
is the composition of enzyme mixed with the streptavidin-coated beads during
immobilization. Figure 7-4 shows the composition of enzyme that was immobilized.
Comparing the enzyme load composition to the immobilized enzyme composition visually
on the gels, there is a preference for biotinylated (mono- and poly-) to immobilize onto
the streptavidin-coated Dynabeads. Quantification of the composition shift using the
standard curve in Figure 7-3 is seen in Figure 7-5a and 7-5b.
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Figure 7-5a. Composition of biotinylated T4L enzyme mutants before (load) and after immobilization
(immobilized). These mutants loaded on the beads are previously biotinylated in the presence of 5 mM
TCEP, reducing agent. Error bars represent sample standard deviation. The average composition or mass
fraction of unbiotinylated enzyme for all T4L mutants (except WT*) is 0.11 ± 0.02.
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Figure 7-5b. Composition of biotinylated T4L enzyme mutants before (load) and after immobilization
(immobilized). These mutants loaded on the beads are previously biotinylated without TCEP, reducing
agent. Error bars represent sample standard deviation. The average composition or mass fraction of
unbiotinylated enzyme for all T4L mutants (except WT*) is 0.08 ± 0.03
.

The biotinylated enzyme dominates the immobilization composition profile when
immobilizing unbiotinylated and biotinylated T4L mutants on streptavidin-coated
Dynabeads. The composition across all mutants that are exposed to the beads for
immobilization (load) varies from 5-90 %, as seen by the black bars in the above figure. If
the immobilized composition remains the same as its load composition, it indicates that
streptavidin has no preference for biotinylated enzyme over unbiotinylated enzyme.
However, the resulting unbiotinylated immobilization composition of 5 mM TCEP samples
(Figure 7-5a) is 11 ± 2 % and 8 ± 3 % for 0 mM samples (Figure 7-5b) a clear overall shift
from the wide range of 5-90% unbiotinylated in the load. The shift in unbiotinylated to
biotinylated ratio between the load and immobilized enzyme demonstrates the specificity
the streptavidin has for biotin. Although gel analysis in Figure 7-4, alone, cannot
distinguish between nonspecific binding and specific binding to streptavidin coated
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beads, the shift in load and immobilized composition in figure II confirms streptavidin
preference for biotin.

Immobilized Amount, pmol

Immobilization Efficiencies

no biotinylation
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mono-biotinylation
poly-biotinylation

300
200
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0
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200
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800
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Figure 7-6. Immobilization yield. The load and immobilized amount are specific to biotinylation degree (no
biotinylation, mono-biotinylation, or poly-biotinylation) of T4L mutants.

Expanding on the notion that streptavidin-coated beads are more likely to
specifically immobilize biotinylated protein over nonspecifically adsorb unbiotinylated
protein, the dose-dependent response to T4L load amount to immobilized amount is
explored in Figure 7-6. A linear correlation (magenta) exemplifies that a proportional
amount immobilizes when more biotinylated protein mixes with the streptavidin-coated
surface. The opposite is true for unbiotinylated protein. The more unbiotinylated loaded
onto the beads, the less is immobilized. Figure 7-7 (left) shows unbiotinylated T4L
mutants’ immobilization efficiency decreases with more significant load amounts. The
decrease in efficiency indicates a limited number of “hotspot” locations where the
unbiotinylated can adsorb to the surface. Interestingly, these adsorption sites are still
available since streptavidin coated on the surface acts as a nonspecific binding blocking
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agent. It is possible that the unbiotinylated T4L binds directly to streptavidin, not the
polymer surface. It is possible that using a positively charged protein that shares the same
structural elements as T4L or an inactive T4L itself may do a better job of nonspecific
binding than the negatively charged streptavidin. For biotinylated T4L mutants in Figure
7-7 (left), the immobilization efficiency (the ratio of amount immobilized to amount
added) remains relatively constant for all load amounts inferring that there is streptavidin
space is not limited for biotin-streptavidin complex formation.
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Figure 7-7. Immobilization efficiency dependence on individual load amount (left) and total immobilized
amount (right).

Another interesting phenomenon is the nonspecific binding efficiency of
unbiotinylated T4L as seen in Figure 7-7 (right). The unbiotinylated immobilization
efficiency increases when there is more total T4L on the surface of the bead. Original
thinking explores the possibility that nonspecific binding is limited to the available space
on the bead surface. If this is the case, the immobilization efficiency will plateau once the
surface is completely covered with nonspecific binding. However, Figure 7-7 shows that
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nonspecific binding increases with total immobilized protein. The T4L itself may recruit
more nonspecific binding of T4L or the streptavidin-long linker-enzyme complex creates
new channels for more protein to settle in-between. Nevertheless, nonspecific binding is
inevitable but only makes up 10 % of the total protein immobilized.
Separating the immobilized enzyme by its perspective degree of biotinylation and
comparing their respective immobilization efficiencies supports the notion that
unbiotinylated T4L leads to surface adsorption, mono-biotinylated T4L is site-specifically
immobilized, and poly-biotinylated T4L is non-specifically immobilized via multi-point
attachment. Figure 7-8 shows the significant difference in the immobilization efficiency
between unbiotinylated, mono-biotinylated, and poly-biotinylated. Unbiotinylated
passively adsorbs to the streptavidin surface and results in ~10 % immobilization
efficiency. Mono-biotinylated T4L actively binds to the surface-immobilized streptavidin
at a much higher immobilization efficiency (~63 %) than unbiotinylated T4L. Since the
immobilization ratios of unbiotinylated and mono-biotinylated are six-fold difference, the
biotin promotes specific conjugation due to its high affinity to streptavidin. To further
support this claim, poly-biotinylated T4L has an even higher immobilization efficiency at
~ 83 %. The more biotin per T4L increases its chances of specific and multi-point
attachment to streptavidin. The efficiency differences between non-biotinylated, monobiotinylated, and poly-biotinylated are consistent with how each enzyme is immobilized.
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Figure 7-8. Immobilization efficiency based on immobilization type. Comparing the immobilization
efficiency based on the method of adherence to streptavidin-coated beads. Adsorption (black) refers to the
enzymes with no biotinylation that adheres to streptavidin-coated beads (n=30). Site-specific (magenta)
and non-specific (green) refers to mono- (n=25) and poly- (n=6) biotinylated enzymes forming biotinstreptavidin complex via single or multiple -point-attachment, respectively. P-values from a two-way
ANOVA analysis note a significant difference between samples with **** (< 0.0001) and * (0.0126).

Soluble Enzyme Concentration Effects on Activity

The detection limitations of T4L WT* are explored to understand the necessary
enzyme concentrations that result in accurate kinetic data. For different substrate
concentrations, the velocity (or initial rate) is normalized to its maximum velocity at the
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specified substrate concertation. The resulting activity profile across enzyme
concentration exhibits a bell-shaped curve, as seen in Figure 7-9. Previous literature
claims that it is common to see a nonlinear correlation between enzyme activity and
enzyme concentration, and it is necessary to establish the linear range in which enzyme
concentration directly influences enzyme kinetics (Chen, Hibbert, Dalby, & Woodley,
2008). The activity is barely detectable with a low signal-to-noise ratio for low enzyme
concentrations of 10-12 to 10-10 M of T4L WT*. As the enzyme concentration increases
from 10-10 to 10-8 M, the activity increases proportionally until reaching a maximum value
at 10-8 M. At high enzyme concentrations of 10-8 to 10--5 M, the activity declines
proportionally to the increase in activity. The decrease in activity at high enzyme
concentrations can be a function of experimental limitations or a product of enzyme
inhibition. The product formation or initial rate at high enzyme concentrations may be so
fast that the method does not capture the kinetic assay’s true initial rate. However, if the
experimental methods capture the true initial rate at high enzyme concentrations, the
enzyme itself may inhibit product formation. There are multiple locations for T4L to bind
to the substrate complex. Two enzymes may compete one another off the same
substrate-binding site, or two enzymes, bound to the same substrate, inhibit one another
during the substrate conversion to product. Avoiding high enzyme concentrations is
preferable. There are two orders of magnitude enzyme concentration span from 10-10 to
10-8 M where the activity directly responds to enzyme concentration. The extensive range
of enzyme concentrations should capture any variations of T4L mutant activity.
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Figure 7-9. The influence T4L WT* enzyme concentration has on normalized reaction velocity. For each
substrate concentration, [S], the velocity was normalized to the maximum velocity at that substrate
concentration. The range of substrate concentrations used is 752 – 28927 RFU (or 3.7 – 145 ng/μL). The
maximum velocity occurs at an enzyme concentration of about 10 -8 M. Error bars represent sample
standard deviation.

Deriving a specific enzyme’s activity based on initial rate may not fully capture the
enzyme-substrate conversion characteristics like Michaelis-Menten kinetics. As shown
previously, enzyme concentration does not necessarily correlate with activity. To
incorporate more data points into each T4L mutant activity, six different substrate
concentrations in triplicate are considered when calculating the Michaelis-Menten kinetic
derived parameter of catalytic efficiency, kcat/Km.
Applying the Michaelis-Menten equation to the current enzyme-substrateproduct system requires converting substrate concentration to the corresponding
fluorescent product. In other words, the substrate concentration needs to be in relative
fluorescent units (RFU) to provide the widely accepted value for kcat/Km. The two
equations below provide context to the units involved for the current system.
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𝑣=

𝑑[𝑃]
𝑉𝑚 [𝑆]
𝑘𝑐𝑎𝑡 [𝐸][𝑆]
=
=
𝑑𝑡
𝐾𝑚 + [𝑆]
𝐾𝑚 + [𝑆]

… 𝑒𝑞𝑛. 1

𝑅𝐹𝑈
𝑣
𝑘𝑐𝑎𝑡 [𝑆]
𝑀
∙ 𝑠 ∙ 𝑅𝐹𝑈 = 𝑅𝐹𝑈 𝑤ℎ𝑒𝑟𝑒 𝑘𝑐𝑎𝑡 ≞ 1
=
≞
[𝐸] 𝐾𝑚 + [𝑆] 𝑅𝐹𝑈 + 𝑅𝐹𝑈 𝑀 ∙ 𝑠
𝐾𝑚
𝑀∙𝑠

… 𝑒𝑞𝑛. 2

Conversion of substrate concentration from mass per volume to relative
fluorescent units requires a standard curve (2017), as seen in Figure 7-10. Known
concentrations of the substrate are reacted with excess T4L. The conversion of substrate
to product generates a maximum fluorescent signal. The maximum fluorescent signal
signifies the potential product created from a known substrate concentration. A linear
correlation on a log-log plot is used to convert substrate concentration to fluorescence
for Michaelis-Menten kinetics implementation.
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Figure 7-10. Determining the conversion between substrate concentration and product in relative
fluorescent units. Robust linear regression shown as y = 199.3x + 13.27. Error bars represent sample
standard deviation.

Combining the enzyme concentration linear range (10-10-10-8 M) and the substrate
unit conversion, the basis for Michaelis-Menten kinetics analysis of T4L activity is nearly
established. For the set substrate and enzyme concentrations, the velocity increases
linearly as enzyme concentration increases. Examining the catalytic efficiency of T4L WT*
across the linear range of enzyme concentrations in Figure 7-11, exploited unknown
catalytic efficiency drift. Theoretically, kcat and KM values are independent of enzyme
concentration, and the catalytic efficiency should remain constant. However, as T4L WT*
enzyme concentration increases, kcat,app decreases and KM,app increases (data not shown).
From the changes in kcat,app and KM,app over a range of enzyme concentrations, the catalytic
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efficiency, kcat,app/KM,app, decreases exponentially or “drifts” with increasing enzyme
concentration. One possible explanation for the decreases in catalytic efficiency is that
the substrate is not in high molar excess of the enzyme. The molarity of the manufacturerprovided substrate is unknown. Assuming that the substrate is a distribution of different
size Micrococcus lysodeikticus cell wall fragments with multiple lysozyme binding sites per
fragment, enzyme-substrate binding to one fragment could block more binding. As a
result, KM,app increases. Furthermore, if two enzymes bind to the same substrate
fragment, the multiple bound enzymes may inhibit substrate conversion, thus lowering
kcat,app. Since the reaction velocity correlates logarithmically with enzyme concentration
(10-10-10-8 M) at various substrate concentrations in Figure 7-9, the premise that substrate
is limited seems likely. To correct for the catalytic efficiency drift, the catalytic efficiency
of T4L mutants is normalized to that of T4L WT*.
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Figure 7-11. Catalytic efficiency (kcat/KM) dependence on T4L WT* enzyme concentration. A standard curve
for T4L WT*’s catalytic efficiency is generated above across enzyme concentrations, 2.1 x 10 -11 to 3.0 x 10-7
M. The second order polynomial fit has an R2 = 0.997. B0 = -27.19, B1 = -3.064, B2 = -0.05408.

Comparison of Enzyme Activity at Different States

The normalized catalytic efficiency of all 28 T4L mutants at three different states
is presented in Table 7-1. The monomer state refers to an enzyme that was pretreated
with a reducing agent (5 mM TCEP) before assayed. The natural state is the T4L mutant
as it exists in solution, represented by the monomer and dimer distribution in the
unreduced SDS-PAGE gels in Figure 6-6. Finally, the catalytic efficiency was measured
when the enzyme is immobilized (insoluble) onto streptavidin-coated Dynabeads through
a maleimide-PEG11-maleimide crosslinker with an immobilized enzyme population, as
shown in Figure 7-4. S44C, A98C, and Q123C had the highest soluble activity in their
natural state. F4C, L15C, A98C, and T152C have the highest soluble monomer activity.
N40C, A93C, and T109C have the highest immobilized activity. Most mutants either
maintain or decrease activity when converted to monomers from their natural state, with
a few exceptions. All mutants that have buried cysteine mutations exhibited no change
between activity in its natural and monomer states. R14C had the lowest activity as dimer
but essentially lost all activity when forced to monomer form. Mutants F4C, A134C,
T151C, and L164C increase their activity in monomer form compared to their natural
state. Mutants F4C, A134C, and T151C predominantly stay in monomer form, whereas
L164C exists as a majority dimer. The correlation between monomer fraction and activity
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is insignificant, but future molecular dynamic simulations may explain why individual T4L
mutants structurally differ from monomers to dimers.
Table 7-1. T4L mutant catalytic efficiency normalized to soluble WT*. The catalytic efficiency uncertainty is
the sample standard deviation.

T4L Mutant Catalytic Efficiency Normalized to Soluble WT*
Soluble
Soluble
MUTANT
(Monomer
Immobilized
(Monomer)
and Dimer)
WT*
M1_N2insC
I3C
F4C
R14C
L15C
T21C
N40C
S44C
V57C
K60C
A73C
R76C
R80C
K83C
L91C
A93C
R96C
A98C
T109C
Q123C
A134C
K135C
R137C
V149C
T151C
T152C
K162C
L164C

1.00
0.88
0.71
0.89
0.37
0.92
0.55
0.83
1.30
0.78
0.77
0.90
0.83
0.68
0.53
0.91
0.90
0.64
1.10
0.45
1.02
0.62
0.59
0.36
0.69
0.58
0.95
0.65
0.46

±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±

0.09
0.16
0.17
0.14
0.06
0.24
0.07
0.16
0.32
0.17
0.10
0.21
0.19
0.20
0.15
0.20
0.14
0.13
0.29
0.07
0.20
0.10
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Summarizing the difference between monomer and dimer catalytic efficiency
demonstrates that the majority of natural dimer T4L enzymes are more active as dimers
and natural monomer T4L enzymes are more active as monomers. Figure 7-12 shows the
relationship between dimer and monomer catalytic efficiency. T4L catalytic efficiency
does not deviate between monomer (TCEP treated) and dimer states, except for S44C and
F4C. T4L mutant S44C has greater activity as a dimer than its monomer counterpart. On
the other hand, F4C, which exhibits roughly 15 % dimer in its natural state, improved its
activity 1.5-fold when monomer. Overall, more mutant data points, regardless of
monomer or dimer state, fall below the catalytic efficiency of WT* (kcat/KM = 1). Therefore,
a single cysteine point mutation is more likely to disrupt activity than improve it.

[kcat/KM]monomer+dimer

1.5

0 to 15 % dimer

S44C

25 to 80 % dimer
1.0

F4C

0.5

0.0
0.0

0.5

1.0

1.5

[kcat/KM]monomer
Figure 7-12. The relationship between monomer and dimer catalytic efficiency. The solid black line
represents a 1:1 ratio of catalytic efficiency for reference.

Predicting the catalytic efficiency of immobilized enzymes based on their
corresponding soluble activity is not possible for the given system. There is no correlation
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between soluble activity and immobilized (insoluble) activity. Considering that an enzyme
has evolved to be active in solution (soluble) does not mean when taken out of its native
soluble environment, immobilized onto a surface that its insoluble activity will be
equivalent to before. However, when examining 23 different structural and experimental
characteristics unique to each T4L mutants, six unique identifiers minimally correlate to
immobilized activity. Figure 7-13, shows the relationship between cysteine accessibility
and enzyme amount immobilized effects on immobilized enzyme catalytic efficiency.
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Figure 7-13. Correlation between immobilized T4L mutant catalytic efficiency and experimental
characteristics. Each data point represents a single immobilized T4L mutant as represented by standardized
characteristics.

In above plots A-C, the cysteine accessibility, as described by the cysteine solvent
exposure, dimer fraction, and monomer cysteine labeling, positively correlates with
immobilized catalytic efficiency. The influence cysteine accessibility has on immobilized
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activity is no coincidence when examining plots D and E. As cysteine accessibility
increases, the chances T4L biotinylation increase resulting in more enzyme immobilized.
At higher amounts of total enzyme immobilized, the greater likelihood the enzyme
activity is retained. The percentage of unbiotinylated enzyme on the surface is about 10
% of the total immobilized amount of enzyme as seen in Figure 7-5. The nonspecifically
bound enzyme contributes very little to the overall immobilized activity. Thus, it is fair to
assume that the effect of adsorbed enzyme only changes the local environment of the
specifically bound enzyme to retain the site-specifically immobilized enzyme activity.
Previous literature has shown that the enhanced immobilized enzyme activity from high
surface coverage is dependent on the immobilized surface chemistry for adsorbed hen
egg-white lysozyme (HEWL): increasing immobilized enzyme on glass surface increases
activity while high density polyethylene (HDPE) surface decreases activity (Thyparambil
et al., 2015). With an alternative enzyme, adsorbed bilirubin oxidase immobilized activity
was not affected by surface chemistry and charge and exhibited the highest specific
activity at the lowest surface coverage (Hitaishi et al., 2018). For T4L site-specifically
immobilized onto streptavidin coated beads, the more enzyme on the surface changes
the immobilized enzyme’s micro-environment interactions from enzyme-surface to
enzyme-enzyme and, in turn, improves the activity of the site-specifically immobilized
enzyme. Finally, in plot F above, the variation of amino acids across different species T4L
homologs also correlates with immobilized activity. Residues that have variation may tend
to be less important to the overall structure of T4L and are primarily more solvent
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exposed. Thus, amino acid variation correlates with cysteine accessibility and enzyme
immobilization efficiency. The relationship between enzyme structure as confirmed by
enzyme modeling and experimental characteristics show that the immobilized enzyme
function is more likely to be retained when more enzyme is on the surface.
Conclusion
The switch from covalent amine-to-sulfhydryl to nearly covalent streptavidin-tosulfhydryl improves qualitative and quantitative analysis of the immobilized enzymecrosslinker-surface complex. Streptavidin-to-sulfhydryl immobilization reduces the
nonspecific binding and improves conjugation efficiency as compared to previous
attempts using NHS-ester conjugation. Unlike NHS ester-initiated immobilization
involving covalent attachment to the bead and enzyme simultaneously, streptavidinbiotinylated enzyme complexes can be separated under harsh buffer conditions and high
heat. Removal of the streptavidin-bound enzyme allows for SDS-PAGE analysis. Since the
biotin is covalently tethered through a thioether bond, ratios of unbiotinylated, monobiotinylated, and poly-biotinylated T4L of the immobilized system can determine
immobilization specificity. The composition of a biotinylated enzyme demonstrates the
preference streptavidin has for immobilizing biotinylated enzyme compared to an
unbiotinylated

enzyme.

In

turn,

streptavidin-to-sulfhydryl

improves

specific

immobilization efficiency and more in-depth knowledge of what type of enzyme adheres
to the beads.
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Some cysteine mutants are more easily immobilized than others. The difference
between T4L mutant conjugation efficiency results in a span of immobilized enzyme
concentrations.

Enzymatic activity measurements that are reliable across a few

magnitudes of enzyme concentration are required for comparison. Michaelis-Menten
kinetic analysis demonstrates a negative catalytic efficiency drift when enzyme
concentration increases. Although the reason why catalytic efficiency varies remains
unknown, future incorporation of substrate and/or enzyme inhibition may better
represent T4L reaction kinetics. Nevertheless, accounting for the catalytic efficiency
dependence on enzyme concentration allowed for the activity comparison across 28
different T4L mutants.
When comparing the activity of every single cysteine T4L mutant, buried cysteine
substitutions generally outperform solvent-exposed cysteine substitutions. This would
infer that those mutations in the hydrophobic protein core are more tolerated. Single
cysteine mutations can impact activity, but their soluble monomer and dimer activity is
not indicative of immobilized (insoluble) activity.
Predicting which T4L mutant retains activity when immobilized reduces simply
how much enzyme is loaded onto the surface. The more enzyme on the surface, positively
improves the likelihood that immobilized activity retains. Although this project aimed to
reduce non-specific to study site-specific immobilization, nonspecific binding may benefit
overall immobilized activity. Hypothetically, nonspecific binding may replace enzymesurface with enzyme-enzyme interactions. Lastly, if more enzymes can fit onto the surface
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when both nonspecific and specific binding are present makes it an improved strategy for
efficiently immobilization techniques.
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CHAPTER EIGHT
CONCLUSION AND FUTURE WORK
Attachment Point Accessibility

The accessibility of the attachment site amid the enzyme proved to be essential
for efficient enzyme immobilization. Single cysteine residues that were not accessible
prevented the potential for crosslinker attachment and subsequent site-specific
immobilization. Using cysteine provided an exciting advantage for determining cysteine
accessibility: solvent-accessible cysteine formed dimers. Those mutants that formed
dimers could be quickly identified through electrophoresis as solvent-accessible. The
structural models of T4L can highlight accessible cysteine mutants. In the absence of
dimer formation and available structural data of point mutations, other peptide mapping
methods such as a combination of protein modification and mass spectrometry would be
necessary to determine residue accessibility. The generality of using cysteine mutations
for all enzyme immobilization is very unlikely. Not all enzymes, like T4L, will retain activity
when removing native cysteines. Introducing a non-natural amino acid for site-specific
linker attachment can replace cysteine substitutions. An added benefit is that instead of
working with a limited number of reactive side chains of the common 20 amino acids for
linker attachment, non-natural amino acids can incorporate a variety of reactive side
chains. Non-natural amino acids can have fluorine, alkene, azide, or selenium presenting
side chains (Connor & Tirrell, 2007). The orthogonality of nonnatural amino acids provides
flexibility to the order of conjugation that is preferred. Regardless of the attachment site
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chemistry, determining its accessibility for conjugation is imperative for successful
immobilization.

Order of Conjugation

The order of the conjugation scheme, crosslinker to protein followed by proteincrosslinker to the surface, may have significantly improved overall conjugation efficiency.
Orthogonal chemistry, biotin, which is unreactive towards the common 20 amino acids,
allows maleimide-cysteine conjugation to occur without having the biotin end of the
crosslinker interfere. Soluble and free in solution, the crosslinker can more readily access
the single cysteine than the cysteine-containing enzyme trying to find the proper
orientation to conjugate to the maleimide activated surface before it irreversibly and
nonspecifically binds to the surface. The fact that the biotin-PEG11-maleimide crosslinker
was as long as the folded enzyme itself may have also played a role in immobilization
specificity. When using a crosslinker for site-specific immobilization, crosslinker
conjugation to the enzyme first, not the surface, should take priority.

Biotin-Streptavidin Specificity

The heterogeneous mixture of unbiotinylated, mono-biotinylated, and polybiotinylated provides insight into the conjugation specificity during the immobilization
process. If only biotinylated enzymes were introduced to the streptavidin surface,
understanding the nonspecific binding would not have presented itself. Varying the load
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amount of different biotinylated enzymes mixed per equal quantities of streptavidin
beads demonstrates that more biotinylated enzymes are immobilized than
unbiotinylated enzymes. The apparent specificity of streptavidin has for biotin during
immobilization is quite the improvement to previous amine-to-sulfhydryl conjugation
schemes. The appropriate controls of unbiotinylated enzymes can help prove the
specificity of immobilization. Otherwise, a deeper understanding of removing
nonspecifically bound enzymes with harsh wash conditions is warranted.

Larger Amounts of Immobilized Enzyme Led to More Activity

The results of the immobilized enzyme activity indicate that the more enzyme on
the surface results in higher activity. Previously, the complete surface coverage of sitespecifically immobilized phenylalanine ammonia-lysases (PALs) via maleimide-thiol
conjugation resulted in highest substrate conversion (Boros et al., 2021). Again, the
xylanase mutants with the highest immobilization yields, had the highest specific activity
on silica nanoparticles. It is possible higher immobilized activity could be a function sitespecifically immobilized enzymes interaction with the surface being replaced with
enzyme-enzyme interaction. To add to this point, more nonspecifically adsorbed enzyme
is present when more total enzyme is on the surface. Although the premise of this
dissertation is to reduce the nonspecific bound enzyme to see the sole effects of sitespecific bound enzyme, nonspecific binding should not necessarily be avoided if the
overall intention is to maximize overall immobilized activity.
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Future experiments comparing the immobilized activity of T4L mutants would
require equivalent immobilized enzyme concentrations. If all the T4L mutants fully
saturated the immobilization surface, any effects the point of attachment has on enzyme
orientation may present themselves. However, a long spacer, like PEG11, for
immobilization may prevent controlled orientation based on the attachment point. The
immobilized enzyme may fold onto itself and interact with the surface. As a result, the
enzyme-surface interaction would dictate the enzyme‘s orientation (Hitaishi et al., 2018),
instead of site-specific conjugation. Complementary molecular dynamic simulations to
predict immobilized enzyme orientation (Zhao, Peng, & Zhou, 2015) (Talasaz et al., 2006)
may be necessary to confirm this hypothesis.

Alternative Enzymes for Immobilization

Compared to T4L, studying other enzymes with varying structure and function can
improve the generality of better immobilization techniques while creating new
industrially relevant immobilized enzyme complexes. Two enzymes of interest for
immobilization are paraoxonases and cytochrome P450 (CYP201A2). Paraoxonases,
which have implications in national defense and agriculture for neurotoxin and pesticide
detection (Berne, Pignol, Lavergne, & Garcia, 2007; Manco, Porzio, & Suzumoto, 2018),
could be an interesting enzyme to study because of broad range of net charge.
Paraoxonases from Ps. diminuta, Ag. radiobacter, S. solfataricus, and D. radiodurans.
exhibit different isoelectric points at 6.74, 7.27, 6.12, and 5.44, respectively. They retain
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high structural alignment (PDB: 1PSC (Benning, Kuo, Raushel, & Holden, 1995), 2D2J
(Jackson, Kim, Carr, Liu, & Ollis, 2005), 2VC7 (Elias et al., 2008), and 2ZC1) with similar
substrate reactivity. This unique set of enzymes could help isolate the effects of surface
functionalization, linker chemistries, and enzyme isoelectric point on effective
immobilization while avoiding influences from enzyme size and structure. The enzyme
CYP201A2 is a cytochrome P450 from the Rhodopseudomonas palustris. CYP201A2 is
involved with the initial biodegradation of tributyl phosphate (TBP). TBP is an
organophosphorus compound that acts as a neurotoxin and is commonly used in nuclear
fuel reprocessing (Berne et al., 2007). TBP is a neurotoxin and used as a nuclear
reprocessing solvent and pesticide, which makes the study of potential enzyme
degradation capabilities attractive for bio-sensing applications through immobilization. A
CYP201A2 fusion protein, extensively outlined in Appendix E, is developed to improve
soluble enzyme expression and quick fluorometric quantitation of the immobilized
enzyme.

Enzyme Immobilization Directed Evolution

Enzymes have evolved their function and stability in their respective environment.
Removing enzymes from their native environment during immobilization generally results
in diminishing activity and stability. To counteract inefficient immobilized structurefunction integrity retention, previous research has proposed a combination of protein
engineering and enzyme immobilization to effectively adapt the enzyme for its new
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insoluble environment (Bernal, Rodríguez, & Martínez, 2018). More specifically, the
recent advance in directed evolution seems like this protein engineering strategy could
be applicable to creating an effective immobilized enzyme. The integration of protein
engineering and enzyme immobilization does not suggest that the soluble enzyme to be
engineered for high activity, stability, and substrate stability with the expectation that the
enzyme will retain some of these characteristics when immobilized. Rather, the activity
and stability of the immobilized enzyme to be the selection marker for directed evolution.
For example, starting with a set of enzymes that have similar substrate specificity, but
vary in amino acid consensus and charge, like paraoxanase, could be the foundation for a
library creation. Equipped with a specific tag for immobilization at the N- or C-terminus,
like AviTagTM which can the enzyme BirA can biotinylate in vivo (Beckett, Kovaleva, &
Schatz, 1999), this enzyme vector can undergo error-prone mutagenesis for library
development. After in vivo biotinylation, cell lyses, purification by immobilization, the
immobilized enzyme activity of each library variant can be used as a selection marker.
Alternative immobilization methods can also be applied with the use of noncanonical
amino acids. Although the crude method is logistically tedious and needs refinement, the
idea of combining directed evolution with immobilization seems feasible. Based on the
findings in this dissertation, it is possible that the initial generations of directed evolution
select for increases in enzyme expression because more immobilized enzyme results in
higher immobilized activity. After expression and immobilization efficiency maximizes,
induced mutations in following generations could improve structural integrity of the
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enzyme when immobilized. Following the direct evolution history may elucidate how a
soluble enzyme needs to change to be effective in a new insoluble environment.
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APPENDICES
APPENDIX A: Number of acetyl groups modifications on T4L WT*
Acetylation of T4L WT*
There are two ways to detect the degree of acetylation: fluorescently and with
MALDI-TOF. The addition of fluorescamine to a protein solution can generate fluorescent
signal when bound to amine-containing molecules. MALDI-TOF, like the above figure, can
determine the degree of acetylation when examining whole protein content and
molecular weight shift associated with the addition of acetyl acid. Acetylation of lysine
amino acid results in a molecular weight increase of 42 kDa. If acetic anhydride (acetic
anhydride-D6) contains deuterium (an isotope of hydrogen) instead of hydrogens, the
molecular weight increases by 45 kDa upon acetylation.
Here is an example of how to determine the number of acetyl groups modifying a
single protein. The sinapinic acid matrix, as opposed to CHCA matrix (CHCA data not
shown), did improve the signal of the acetylated protein peaks however the below
experiment was not be repeated.
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Figure A-1. Above is the overlap spectrum of whole protein, T4L WT* (green) and the whole protein,
acetylated T4L WT* (blue). The individual peaks are evidence in the acetylated protein when using sinapinic
acid as the matrix. The peaks 1-9 are approximately 42 kDa apart representing the amount of lysine with
an acetyl group. The solvent exposure (SESA) of each lysine residue inlayed on the right-hand side for
reference.
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APPENDIX B: T4L Mutation Creation, Expression, and Activity
T4L Creation
T4L WT* Plasmid Map (addgene #18111)

Figure B-1. Plasmid map of T4L WT* (pseudo-wild type, cysteine free from AddGene # 18111). The protein
of interest is highlighted in red and expression is controlled with the lac operator.
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Primers for Cysteine Mutations in T4L WT*

Table B-1. Primers for site-directed mutagenesis of T4L WT*. Each pairing of primers are the forward and
reverse primers for their respective mutant creation.
Mutant
A134C

Primer Sequence (5'-->3')
GCAGCAGTTAACTTATGTAAAAGTAGATGGTATAATCAAACA
TGTTTGATTATACCATCTACTTTTACATAAGTTAACTGCTGC

A73C

CTGAAAAACTCTTTAATCAGGATGTTGATTGTGCTGTTCGCGGAAT
ATTCCGCGAACAGCACAATCAACATCCTGATTAAAGAGTTTTTCAG

A93C

AAAACCGGTTTATGATTCTCTTGATTGCGTTCGTCGCGCTGCATTGA
TCAATGCAGCGCGACGAACGCAATCAAGAGAATCATAAACCGGTTTT

D159C

CAACGTTTAGAACTGGCACTTGGTGCGCGTATAAAAATCTATAAAGCTG
CAGCTTTATAGATTTTTATACGCGCACCAAGTGCCAGTTCTAAACGTTG

E5C

GGAGGTATTATGAATATATTTTGCATGTTACGTATAGATGAAGG
CCTTCATCTATACGTAACATGCAAAATATATTCATAATACCTCC

F4C

CTTAGGAGGTATTATGAATATATGTGAAATGTTACGTATAG
CTATACGTAACATTTCACATATATTCATAATACCTCCTAAG

I3C

GCTTAGGAGGTATTATGAATTGTTTTGAAATGTTACGTATAG
CTATACGTAACATTTCAAAACAATTCATAATACCTCCTAAGC

K135C

GGGATGAAGCAGCAGTTAACTTAGCTTGTAGTAGATGGTATAATCAAACACC
GGTGTTTGATTATACCATCTACTACAAGCTAAGTTAACTGCTGCTTCATCCC

K162C

CTTGGGACGCGTATTGTAATCTATAAAGCTGTTTACTTTC
GAAAGTAAACAGCTTTATAGATTACAATACGCGTCCCAAG

K60C

GTAATACTAATGGTGTAATTACATGTGATGAGGCTGAAAAAC
GTTTTTCAGCCTCATCACATGTAATTACACCATTAGTATTAC

K65C

GGTGTAATTACAAAAGATGAGGCTGAATGTCTCTTTAATCAGGATGTTGATGC
GCATCAACATCCTGATTAAAGAGACATTCAGCCTCATCTTTTGTAATTACACC

K83C

CTGTTCGCGGAATTCTGAGAAATGCTTGCTTAAAACCGGTTTATGATTCTCTTGA
TCAAGAGAATCATAAACCGGTTTTAAGCAAGCATTTCTCAGAATTCCGCGAACAG

L15C

GTTACGTATAGATGAAGGTCTTAGATGTAAAATCTATAAAGACACAGAAGGC
GCCTTCTGTGTCTTTATAGATTTTACATCTAAGACCTTCATCTATACGTAAC

L164C

GGCACTTGGGACGCGTATAAAAATTGCTAAAGCTGTTTACTTTCTCTTG
CAAGAGAAAGTAAACAGCTTTAGCAATTTTTATACGCGTCCCAAGTGCC

L91C

GCTAAATTAAAACCGGTTTATGATTCTTGTGATGCGGTTCGTCGCGC
GCGCGACGAACCGCATCACAAGAATCATAAACCGGTTTTAATTTAGC

M1_N2INSC

CCATCGATGCTTAGGAGGTATTATGTGCAATATATTTGAAATGTTACGTATAG
CTATACGTAACATTTCAAATATATTGCACATAATACCTCCTAAGCATCGATGG

N40C

CGGTCATTTGCTTACAAAAAGTCCATCACTTTGTGCTGCTAAATCTGAATTAGATAAAG
CTTTATCTAATTCAGATTTAGCAGCACAAAGTGATGGACTTTTTGTAAGCAAATGACCG

N68C

GATGAGGCTGAAAAACTCTTTTGTCAGGATGTTGATGCTGC
GCAGCATCAACATCCTGACAAAAGAGTTTTTCAGCCTCATC
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P86C

CTGAGAAATGCTAAATTAAAATGTGTTTATGATTCTCTTG
CAAGAGAATCATAAACACATTTTAATTTAGCATTTCTCAG

Q123C

CTAACTCTTTACGTATGCTTCAATGTAAACGCTGGGATGAAGCAGCAGT
ACTGCTGCTTCATCCCAGCGTTTACATTGAAGCATACGTAAAGAGTTAG

R137C

GCAGTTAACTTAGCTAAAAGTTGTTGGTATAATCAAACACCTAATCGC
GCGATTAGGTGTTTGATTATACCAACAACTTTTAGCTAAGTTAACTGC

R14C

AAATGTTACGTATAGATGAAGGTCTTTGTCTTAAAATCTATAAAGACACAGAAGG
CCTTCTGTGTCTTTATAGATTTTAAGACAAAGACCTTCATCTATACGTAACATTT

R76C

AGGATGTTGATGCTGCTGTTTGCGGAATTCTGAGAAATG
CATTTCTCAGAATTCCGCAAACAGCAGCATCAACATCCT

R80C

GTTCGCGGAATTCTGTGTAATGCTAAATTAAAACCGGTTTATG
CATAAACCGGTTTTAATTTAGCATTACACAGAATTCCGCGAAC

S44C

CACTTAATGCTGCTAAATGTGAATTAGATAAAGCTATTG
CAATAGCTTTATCTAATTCACATTTAGCAGCATTAAGTG

T109C

GGTTTTCCAAATGGGAGAATGCGGTGTGGCAGGATTTAC
GTAAATCCTGCCACACCGCATTCTCCCATTTGGAAAACC

T151C

CTAATCGCGCAAAACGAGTCATTTGTACGTTTAGAACTGGC
GCCAGTTCTAAACGTACAAATGACTCGTTTTGCGCGATTAG

T21C

GACTTAAAATCTATAAAGACTGTGAAGGCTATTACACTATTG
CAATAGTGTAATAGCCTTCACAGTCTTTATAGATTTTAAGTC

V57C

AAAGCTATTGGGCGTAATACTAATGGTTGTATTACAAAAGATGAGGCTGAAAAACTC
GAGTTTTTCAGCCTCATCTTTTGTAATACAACCATTAGTATTACGCCCAATAGCTTT

Sequencing Primers and Amino Acid Composition of T4L WT*

Figure B-2. DNA and corresponding translation of amino acid sequence of T4L WT* (highlighted in red).
External sequencing primers for mutants creation are outlined in purple.

Expression Analysis of T4L Mutants
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Figure B-3 Dot blots comparing expression levels of T4L mutants. Each of the four blots are biological
replicates as noted by N in the bottom right. Reference concentrations of purified T4L WT* are on the upper
left-hand side of each blot. Primary antibody detection of T4L using Mouse Anti-T4L Antibody. Secondary
antibody detection using Goat anti-mouse IgG (H+L) SuperclonalTM, Alexa Fluor 647. Imaging at 700 nm
wavelength for detection of secondary antibody.
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Figure B-4. Signal detected from dot blot at a 700 nm wavelength representing amount of T4L. Absorbance
at 600 nm to capture cell culture turbidity at time of harvest. The ratio of signal per absorbances
corresponds to T4L expression per cell. Each mutant averaged from 4 dot blots (n=4).

Purification of T4L Mutants
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Figure B-5. Abbreviated chromatograms of gradient elution step for all mutants. Note that the UV (280 nm)
detector has an upper limit of 3000.

16 17 18 19 20 21 22

32 33 34 35 36 37 38 39 40

Figure B-6. Loaded 1000 ng of total protein into each well from each fraction. Examples of K83C (right) and
Q123C (left) elution fraction purity shown above.
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APPENDIX C: Theoretical Model of Cysteine Substitutions and corresponding Structural
Elements
Solvent Exposure, Root-Mean-Square-Fluctuations (RMSF), and Amino Acid Consensus of

A 1.0

B 0.25

Mutant SESA

WT* RMSF (closed)

PDB: 1LW9
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Figure C-1. Comparing correlation of T4L structural characteristics. The relationships between the solvent
exposure (SESA) of T4L WT* and T4L mutants and the root-mean-squared-fluctuation of each residue’s
alpha carbon (Cα) in the open and closed states are shown in (A) and (B), respectively. The relationship
between the residue solvent exposure (SESA) of the WT* and mutant structures in the open and close states
are shown in (C) and (D), respectively.

183

1.0

open
L164C

T21C

T21C

close

Mutant
WT*

SESA

WT* RMSF

0.2

0.5

0.1

0.0

0.0
0.5

0.6

0.7

0.8

0.9

1.0

0.5

Consensus

0.6

0.7

0.8

0.9

1.0

Consensus

Figure C-2. (Left) The effects of amino acid conservation have on the root-mean-squared-fluctuations
(RMSF), left, and residue solvent exposure (SESA), right. Consensus refers to the fraction of T4L specified
mutant residues across 54 T4L homologs.

Creating Mutations and Determining SESA in Chimera

Molecular graphics and analyses performed with UCSF Chimera, developed by the
Resource for Biocomputing, Visualization, and Informatics at the University of California,
San Francisco, with support from NIH P41-GM103311. This includes creating cysteine
substitutions of T4L WT* (PDB: 1LW9). Cysteine substituted residues are developed using
the rotamer library (Dunbrack 2010) tool in Chimera. Each cysteine substitution was
checked for structural clashes or contacts in the mutated amino acids vicinity. For
instance, I3C clashed with A97, A98C had two contacts with T152, and A134C had one
contact with I150. If clashes existed, then the residue and surrounding protein underwent
structure minimization provided by Chimera. The relative exposure of amino acids in
native T4L WT* and the cysteine mutated analogs were also performed using UCSF
Chimera. First the solvent-excluded molecular surface is created for the given protein
model (Sanner et al., 1996). Each amino acid area is normalized to its size to prevent
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solvent exposure bias based on amino acid size. The software and corresponding text file
for Chimera calculations, “areaSESgxg.txt”, can be found in Chimera’s online user’s guide.
Conservation of Residues

T4L WT in UniProtKP (P00720) was blasted against all species. Homologs of P00702
with at least 50 % identity congruency across all species are compared. Out of the 54
homologs, 27 of those had at least one residue variations. Using “Muscle” alignment in
MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets (Kumar,
Stecher, and Tamura 2015) software, sequences are sorted and aligned to observe
conserved residue sights. At each amino acid position in the sequence, the consensus or
fraction of conserved residues out of the 54 homologs are calculated.
Determining RMSD and RMSF

Figure C-3. Molecular Dynamic simulations showing the transition of T4L (PDB: 1LW9) from closed to open
state (Dr. Siva Dasetty, PhD, May 2019-- Dr. Sapna Sarupria Lab). The particles analyzed are the Cα atoms
at each position in T4L WT* over the above time scale. There are two different reference positions: (1) timeaveraged position of each Cα atom (RMSF) when the protein is in the open state and (2) time-averaged
position of each Cα atom (RMSF) when the protein is in the closed state.
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MATLAB Code to determine the angle of separation between mutation and active site
when centroid is the vertex
% Code Setup Conditions
% ========================================================================
% file name : pdbAtomStructAnalysis.m
% function main % only use if multiple functions are created and used
% within a file
close all % close figure plots prior to running the rest of the code
% delete(findall(0)) % closes all windows (biological sequence alignment)
clear variables % clears stored variables present before running the script
clc % clears command window for readabilty purposes
% warning('off') % turns off unwanted warnings
tic % starts timer to see how long it takes for the code to run
% ========================================================================
% Background Information
% -----------------------------------------------------------------------% The goal is to extract and present the atomistic charcteristics of atoms
% of a protein from a PDB file.
% ========================================================================
% Load pdb file for T4L WT from current folder
% -----------------------------------------------------------------------pdbstruct = pdbread('1lw9.pdb'); % reads .pdb file from folder, instead of online
% pdbstruct = getpdb('2lzm'); % reads .pdb file from internet -% had to call 2LZM instead of the pseudo-WT T4L 1lw9 because there is
% for some reason more than 164 alpha carbons in 1lw9 (maybe ligands).
% This in turn should not effect calculations since alpha carbons are
% used primarily.
% ========================================================================
% Formatting Title with PDB code
% -----------------------------------------------------------------------Title = pdbstruct.Title; % pulling out title of structure
% combining title array from pdb file
dummy = strings(size(Title,1),1); % preallocation for loop speed
for i = 1:size(Title,1) % for every line of title
dummy(i) = convertCharsToStrings(Title(i,:)); % using a dummy variable
end % end i
pdbcode = convertCharsToStrings(pdbstruct.Header.idCode); % pulling out pdb code and
converting to string
Title = strjoin(dummy); dummy = [pdbcode Title];
% "Title = pdb code: name of the protein"
Title = strjoin(dummy,': '); % combining strings of pdb code and title
fprintf('%s\n\n',Title) % prints title in command window
% -----------------------------------------------------------------------% Number of Amino Acids in Sequence
% -----------------------------------------------------------------------pdbResNum = pdbstruct.Sequence.NumOfResidues; % extracts the number of amino acids in pdb
file
fprintf('Number of amino acids: %4.0f\n\n',pdbResNum) % prints in command window
% -----------------------------------------------------------------------% PDB Sequence
% -----------------------------------------------------------------------pdbSequence = pdbstruct.Sequence.Sequence; % extracts amino acid sequence from pdb file
pdbSequence = convertCharsToStrings(pdbSequence); % converts sequence from char to str
pdbSequence = char(pdbSequence); % converts string to char array
fprintf('PDB sequence (%s): %s\n',pdbcode,pdbSequence) % prints in command window
fprintf('
Molecular Weight = %6.0f\n',molweight(pdbSequence))
% ------------------------------------------------------------------------
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% PDB model atom characteristics
% -----------------------------------------------------------------------AtomName = {pdbstruct.Model.Atom.AtomName}'; % pulls out atom identifiers into cells (ex.
alpha carbon = CA)
% extracts model's coordinates of each atom
X = [pdbstruct.Model.Atom.X]'; % x-coordinate of every atom
Y = [pdbstruct.Model.Atom.Y]'; % y-coordinate of every atom
Z = [pdbstruct.Model.Atom.Z]'; % z-coordinate of every atom
AtomCoordinatesRaw = [X Y Z]; % compiles cartesian coordinates of each atom into matrix
% plot settings
figure(1) % opens new figure plot
set(gcf,'Color','w') % sets background color to white
% suptitle(Title) %,'FontName','Arial','FontSize',14) % puts title above all plots
% subplot(2,3,1) % creates sub plot space
hold on
% Plotting every atom in Euclidean space
%
hold on
%
plot3(X,Y,Z,'co-') % 3D plots raw atoms of structure
%
xlabel('x'); ylabel('y'); zlabel('z'); % labels x-axis
c = uicontrol('Style','text');
c.String = {'Figure 1. Depiction of T4L in Euclidean Space'};
tit = textwrap(c,c.String,100);
title(tit);
% -----------------------------------------------------------------------% Alpha carbon identification
% -----------------------------------------------------------------------index = find(cellfun('length',regexp(AtomName,'CA')) == 0); % finds all atoms that are
not alpha carbons
CoordinatesCA = AtomCoordinatesRaw; % preserves raw coordinates of every atom
CoordinatesCA(index,:)=[]; % removes all atoms that are not alpha carbons (CA)
% Xca = CoordinatesCA(:,1);
% Yca = CoordinatesCA(:,2);
% Zca = CoordinatesCA(:,3);
%
plot3(Xca,Yca,Zca,'yo-','MarkerSize',10) % 3D plots alpha carbon atoms
xlabel('X [Angstrom]')
ylabel('Y [Angstrom]')
zlabel('Z [Angstrom]')
% -----------------------------------------------------------------------% Finds the Centroid of the protein based on alpha carbon location
% -----------------------------------------------------------------------Centroid = mean(CoordinatesCA,1); % using all the CAs not just mutants
%
plot3(Centroid(1),Centroid(2),Centroid(3),'rx','MarkerSize',10,'LineWidth',2) % 3D
plots alpha carbon atoms
% -----------------------------------------------------------------------% Calculates average active site for T4L
% -----------------------------------------------------------------------ActiveSites = [11 20 26]; % active site residues (user input)
AvgActiveSite = mean(CoordinatesCA(ActiveSites,:),1); % average coordinate between two
active sites
%
plot3(AvgActiveSite(1),AvgActiveSite(2),AvgActiveSite(3),'r.','MarkerSize',20,'LineWidth'
,2) % 3D plots alpha carbon atoms
% -----------------------------------------------------------------------% Determining maximum width between alpha carbons
% -----------------------------------------------------------------------distance = zeros(length(CoordinatesCA)); % preallocation for speed
for i = 1:length(CoordinatesCA) % for all residues
for j = 1+i:length(CoordinatesCA) % for all residues + 1
distance(i,j) = pdist2(CoordinatesCA(i,:),CoordinatesCA(j,:),'euclidean'); %
calculates the distance between two points
end % end for j
end % end for i
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[M,I] = max(distance,[],'all','linear'); % maximum distance between two alpha carbons is
stored in M while the linear index is stored in I
[maxres1,maxres2] = ind2sub(size(distance),I); % converts linear index into row and
column form
fprintf('Maximum protein length = %4.2f Angstrom (between residues %3.0f and
%3.0f)\n',M,maxres1,maxres2)
% -----------------------------------------------------------------------% Input of mutants avaible
% -----------------------------------------------------------------------% Input of mutants avaible
mutants = [1 3 4 5 14 15 21 40 44 57 60 65 68 73 76 80 83 91 93 96 98 ...
109 123 134 135 137 149 151 152 159 162 164]'; % note that we do not have M1C
and N2C mutants but rather M1_N2insC
fprintf('\nAvailable mustants of T4L WT*:')
disp(mutants')
% -----------------------------------------------------------------------% Determining variance axis (future x-axis)
% -----------------------------------------------------------------------varvec = var(CoordinatesCA,0,1); % finds the axis with the most variance
nvarvec = varvec/norm(varvec); % normalizes
% finding the line perpendicular to variance axis and goes through acitive
% site point
f = @(t) (nvarvec)*(Centroid+(nvarvec*t)-AvgActiveSite)'; % dot product (function
handle)
t = fzero(f,0.1); % finds the value of t that makes ndvec perpendicular to a vector that
goes through the average active site coordinates
intersectpoint = nvarvec*t+Centroid; % point of intersection
%
plot3([AvgActiveSite(1) intersectpoint(1)],[AvgActiveSite(2)
intersectpoint(2)],[AvgActiveSite(3) intersectpoint(3)],'k--','LineWidth',2)
%
plot3([Centroid(1) intersectpoint(1)],[Centroid(2) intersectpoint(2)],[Centroid(3)
intersectpoint(3)],'k--','LineWidth',2)
% -----------------------------------------------------------------------% Model Translation
% -----------------------------------------------------------------------% caluclating new direction for normal vectors
Xlocal = Centroid - intersectpoint;
Xlocal = (Xlocal/norm(Xlocal))';
Ylocal = AvgActiveSite - intersectpoint;
Ylocal = (Ylocal/norm(Ylocal))';
Centroid = Centroid-intersectpoint;
AvgActiveSite = AvgActiveSite-intersectpoint;
CoordinatesCA = CoordinatesCA-intersectpoint;
Origin = intersectpoint-intersectpoint;
% -----------------------------------------------------------------------% Model Transformation
% -----------------------------------------------------------------------% Global coordinates of axis
Xglobal = [1 0 0]'; Yglobal = [0 1 0]';
% "Calculate Rotation Matrix [UU] to align Vector A to Vector B in 3d?"
GG = @(A,B) [dot(A,B) -norm(cross(A,B)) 0;norm(cross(A,B)) dot(A,B) 0;0 0 1];
FFi = @(A,B) [A (B-dot(A,B)*A)/norm(B-dot(A,B)*A) cross(B,A)];
UU = @(Fi,G) Fi*G/Fi; % where UU*A = B
% Citation: Reinstate Monica (https://math.stackexchange.com/users/76513/reinstatemonica), Calculate Rotation Matrix to align Vector A to Vector B in 3d?, URL (version:
2018-09-12): https://math.stackexchange.com/q/897677
% <https://math.stackexchange.com/questions/180418/calculate-rotation-matrix-to-alignvector-a-to-vector-b-in-3d/897677#897677>
%
%
U
%

Transforming Coordinates so that active site vector and spine of protein
fall onto axis
= UU(FFi(Xlocal,Xglobal), GG(Xlocal,Xglobal)); % function for rotational matrix
X-transformation

188

Xlocal = U*Xlocal;
Ylocal = U*Ylocal;
CoordinatesCA = (U*CoordinatesCA')';
Centroid = (U*Centroid')';
AvgActiveSite = (U*AvgActiveSite')';
V = UU(FFi(Ylocal,Yglobal), GG(Ylocal,Yglobal)); % function for rotational matrix
% Y-transformation
Ylocal = V*Ylocal;
Xlocal = V*Xlocal;
CoordinatesCA = (V*CoordinatesCA')';
Centroid = (V*Centroid')';
AvgActiveSite = (V*AvgActiveSite')';
% new alpha carbon coordinates
Xca = CoordinatesCA(:,1);
Yca = CoordinatesCA(:,2);
Zca = CoordinatesCA(:,3);
% plotting transformation
plot3(Xca,Yca,Zca,'ko-','MarkerSize',10) % 3D plots alpha carbon atoms
plot3(Centroid(1),Centroid(2),Centroid(3),'rx','MarkerSize',10,'LineWidth',2) % 3D
plots alpha carbon atoms
plot3(AvgActiveSite(1),AvgActiveSite(2),AvgActiveSite(3),'r.','MarkerSize',20,'LineWidth'
,2) % 3D plots alpha carbon atoms
plot3([AvgActiveSite(1) Origin(1)],[AvgActiveSite(2) Origin(2)],[AvgActiveSite(3)
Origin(3)],'k--','LineWidth',2)
plot3([Centroid(1) Origin(1)],[Centroid(2) Origin(2)],[Centroid(3) Origin(3)],'k-','LineWidth',2)
text(AvgActiveSite(1)+0.5,AvgActiveSite(2)+0.5,AvgActiveSite(3)+0.5,'Active
Site','FontName', 'Arial','FontSize',16,'color','b')
text(Centroid(1)+0.5,Centroid(2)+0.5,Centroid(3)+0.5,'Centroid','FontName',
'Arial','FontSize',16,'color','b')
text(Origin(1)+0.5,Origin(2)+0.5,Origin(3)+0.5,'Origin','FontName',
'Arial','FontSize',16,'color','b')
text(Xca(14,:),Yca(14,:),Zca(14,:),'14')
text(Xca(15,:),Yca(15,:),Zca(15,:),'15')
text(Xca(109,:),Yca(109,:),Zca(109,:),'109')
set(gca, 'FontName', 'Arial','FontSize',18)
view(3)
hold off
% -----------------------------------------------------------------------% Enzyme Orientation: Pitch and Roll
% -----------------------------------------------------------------------% counter-clockwise is positive direction (right-hnd rule)
Pitch = atand(Zca./Xca); % angle from x-axis in degrees
Roll = atand(Zca./Yca); % angle from y-axis in degrees
figure(4)
%subplot(2,3,4)
set(gcf,'Color','w')
hold on
plot(Pitch,Roll,'.','MarkerSize',10,'color',[0.6350 0.0780 0.1840])
plot(Pitch(mutants),Roll(mutants),'o','color',[0.6350 0.0780 0.1840])
for j = 1:length(mutants)
text(Pitch(mutants(j)),Roll(mutants(j))+5,num2str(mutants(j)),'FontName',
'Arial','FontSize',16)
end % for j
xlabel('Pitch (angle from x-axis)'); ylabel('Roll (angle from y-axis)');
c = uicontrol('Style','text');
c.String = {'Figure 4. Enzyme Orientation when Immobilized'};
tit = textwrap(c,c.String,50);
title(tit);
set(gca, 'FontName', 'Arial','FontSize',18)
hold off
% ------------------------------------------------------------------------
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% Temperature Factor
% -----------------------------------------------------------------------tempFactor = [pdbstruct.Model.Atom.tempFactor]';
tempFactorCA = tempFactor;
tempFactorCA(index,:)=[]; % removes all atoms that are not alpha carbons (CA)
figure(2)
set(gcf,'Color','w')
%subplot(2,3,2)
hold on
yyaxis left
plot((1:length(tempFactorCA))',tempFactorCA,'--','color',[0 0.4470 0.7410])
plot(mutants,tempFactorCA(mutants),'o','color',[0 0.4470 0.7410])
for j = 1:length(mutants)
text(mutants(j),tempFactorCA(mutants(j))+2,num2str(mutants(j)),'FontName',
'Arial','FontSize',10)
end % for j
xlabel('Residue #'); ylabel('Temperature Factor or B-factor of C_{\alpha}');
% -----------------------------------------------------------------------% Normalized Surface Exposure
% -----------------------------------------------------------------------%Transient protein-protein interface prediction: datasets, features, algorithms, and the
RAD-T predictor. Bendell CJ, Liu S, Aumentado-Armstrong T, Istrate B, Cernek PT, Khan S,
Picioreanu S, Zhao M, Murgita RA. BMC Bioinformatics. 2014 Mar 24;15:82.
SEres = [0.674394373 0.561261494
0.251033321 0.539719789 0.593164418 0
0
0.587713137 0.561655534 0.233542826 0.459770881 0.508949251 0.512072736 0.690905574
0.516825409 0.721917133 0.323390775 0.412948226 0.752289569 0.55089342 1.038724446
0.80124532 0.731003255 0.502237039 0.333930537 0.175784374 0
0.292083535 0.302927411
0.496233555 0.439464487 0.672804602 0.246681294 0.331416063 0.819475043 0.531058321
0.961263802 0.536012703 0.573408838 0.820846029 0.586423689 0
0.506401685 0.745486204
0.547202479 0
0.467890604 0.83858716 0.702641418 0.467728738 0.826991996 0.617785468
0.884807702 0.116664052 0.951697705 0.142795574 0.570408384 0.131249277 0.567109316
0.698016019 0.814736919 0.346709953 0.152111311 0.685566072 0.854370647 0.293136258
0.274035264 0.714554473 0.742252002 0.582356751 0.162112727 0.645951958 0.630540179
0.281859123 0.526512608 0.70787955 0.224794314 0.062234209 0.67405861 0.852449686
0.374816564 0.999629116 0.76159574 0
0.475334857 0.665707537 0.104667774 0.309883938
0.662460656 0.546997994 0.086785409 0.577212019 0.888826275 0.354305561 0.160547512
0.437336513 0.256320412 0
0.066491279 0.160558067 0.08476816 0.210421793 0.202002053
0.370798127 0.591050646 0.464999743 0.511560186 0.517693632 0.897587131 0.667545851
0.071284963 0.496201836 0.796501733 0.469729395 0.807772155 0.673655768 0.243246851
0.311265648 0.68110052 0.301766559 0.163646091 0.625775205 0.701289265 0.615986224
0.608439958 0.39477539 0.774962153 0.69651165 0.093359168 0.449755224 0.742832549
0.552609201 0.138818379 0.520005379 0.805616448 0.42155579 0.756622251 0.243560374
0.371755867 0.840917151 0.768064061 0.504770258 0.55733279 0.774399663 0.256067196 0
0.613844691 0.367062258 0.086452699 0.201684563 0.602300387 0.103035873 0.126783981
0.534212211 0.595744733 0.409051412 0.719437856 0.354222823 0.757788137 0.650491587
0.118085322 0.819410999 0.802317396 0.716765619]';
% https://www.cgl.ucsf.edu/chimera/docs/UsersGuide/surfnorm.html
yyaxis right
plot((1:length(SEres))',SEres,'--','color',[0.8500 0.3250 0.0980])
plot(mutants,SEres(mutants),'o','color',[0.8500 0.3250 0.0980])
for j = 1:length(mutants)
text(mutants(j),SEres(mutants(j))+0.05,num2str(mutants(j)),'FontName',
'Arial','FontSize',10)
end % for j
yyaxis right
xlabel('Residue #'); ylabel('Residue Normalized Surface Exposure');
c = uicontrol('Style','text');
c.String = {'Figure 2. Electron Density Distribution (left) and Residue Solvent
Exposure (right)'};
tit = textwrap(c,c.String,100);
title(tit);
set(gca, 'FontName', 'Arial','FontSize',14)
hold off
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% -----------------------------------------------------------------------% Determining the degree of separating between active site vector and
% mutants vector with the vertex being the Centroid and Origin
% -----------------------------------------------------------------------ThetaInDegreesCentroid = zeros(size(CoordinatesCA,1),1); % preallocation for speed
for i = 1:size(CoordinatesCA,1) % for (i) all mutants
% calculating the angle between two vectors
ThetaInDegreesCentroid(i) = atan2d(norm(cross(CoordinatesCA(i,:)Centroid,AvgActiveSite-Centroid)),dot(CoordinatesCA(i,:)-Centroid,AvgActiveSiteCentroid));
%
CosTheta =
dot(CoordinatesCA(i,:),AvgActiveSite)/(norm(CoordinatesCA(i,:))*norm(AvgActiveSite));
%
ThetaInDegrees(i) = real(acosd(CosTheta));
end % end for i
ThetaInDegreesOrigin = zeros(size(CoordinatesCA,1),1); % preallocation for speed
for i = 1:size(CoordinatesCA,1) % for (i) all mutants
% calculating the angle between two vectors
ThetaInDegreesOrigin(i) = atan2d(norm(cross(CoordinatesCA(i,:)-Origin,AvgActiveSiteOrigin)),dot(CoordinatesCA(i,:)-Origin,AvgActiveSite-Origin));
%
CosTheta =
dot(CoordinatesCA(i,:),AvgActiveSite)/(norm(CoordinatesCA(i,:))*norm(AvgActiveSite));
%
ThetaInDegrees(i) = real(acosd(CosTheta));
end % end for i
figure(3)
% subplot(2,3,3)
set(gcf,'Color','w')
hold on
plot((1:length(ThetaInDegreesCentroid))',ThetaInDegreesCentroid,'m--')
plot(mutants,ThetaInDegreesCentroid(mutants),'mo')
plot((1:length(ThetaInDegreesOrigin))',ThetaInDegreesOrigin,'--','color',[0.4940
0.1840 0.5560])
plot(mutants,ThetaInDegreesOrigin(mutants),'o','color',[0.4940 0.1840 0.5560])
for j = 1:length(mutants)
text(mutants(j),ThetaInDegreesCentroid(mutants(j))+5,num2str(mutants(j)),'FontName',
'Arial','FontSize',16)
text(mutants(j),ThetaInDegreesOrigin(mutants(j))+5,num2str(mutants(j)),'FontName',
'Arial','FontSize',16)
end % for j
legend('Centroid Vertex','Centroid Vertex (mutants)','Origin Vertex','Origin Vertex
(mutants)','Location','southeast','FontName', 'Arial','FontSize',16)
xlabel('Residue #'); ylabel('Angle in Degrees');
c = uicontrol('Style','text');
c.String = {'Figure 3. Separation Between Active and Attachment Site'};
tit = textwrap(c,c.String,50);
title(tit);
set(gca, 'FontName', 'Arial','FontSize',18)
hold off
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APPENDIX D: Programmable Coding for T4L activity (Opentrons Python Code)
Opentron python code for T4L activity plate preparation
# in cmd prompt (windows) enter...
# python -m opentrons.simulate
C:\Users\Maxwell\Desktop\Opentrons\Mutant_testing\Mutant_tests.py
# ... to simulate protocol below
# ==================================================================================
from opentrons import protocol_api
# ---------------------------------------------------------------------------------# Metadata and Version Selection (User):
metadata = {'protocolName': 'Mutant_tests.py', # file name
'author': 'Maxwell Hilbert <hilber2@g.clemson.edu>', # email address
'description': 'finding the optimal enzyme and substrate concentration for
michaelis-menten kinetics',
'apiLevel': '2.4'} # API Version 2.4, Introduced on OT-2 Software 3.16.0
# ==================================================================================
# User Input:
# ---------------------------------------------------------------------------------# LEFT MOUNT
Pipette_ModelName_left = 'p50_single' # user input, defines pipette type loaded on left
side, if no pipette is loaded enter 'none'
TipRack_Type_left = 'opentrons_96_tiprack_300ul' # user input, defines type of tip rack
for left pipette, if no tip rack is needed enter 'none'
TipRack_Position_left = 5 # user input (position of each tip rack), if no tip rack needed
enter 0
# RIGHT MOUNT
Pipette_ModelName_right = 'p50_multi' # user input, defines pipette type loaded on right
side, if no pipette is loaded enter 'none'
TipRack_Type_right = 'opentrons_96_tiprack_300ul' # user input, defines type of tip rack
for right pipette
TipRack_Position_right = 6 # user input (position of each tip rack), if no tip rack
needed enter 0
# ---------------------------------------------------------------------------------# Plate Input (User)
plate_type_1 = 'none' # type of plate, if no plate is needed enter, 'none'
plate_slot_1 = 0 # location of plates, if no plate needed enter 0
plate_type_2 = 'biorad_96_wellplate_200ul_pcr' # type of plate, if no plate is needed
enter, 'none'
plate_slot_2 = 2 # location of plates, if no plate needed enter 0
plate_type_3 = 'corning_96_wellplate_360ul_flat' # type of plate, if no plate is needed
enter, 'none'
plate_slot_3 = 3 # location of plates, if no plate needed enter 0
plate_type_4 = 'opentrons_24_aluminumblock_nest_1.5ml_snapcap' # type of plate, if no
plate is needed enter, 'none'
plate_slot_4 = 4 # location of plates, if no plate needed enter 0
# ---------------------------------------------------------------------------------# Enzyme Acitivity Assay Input (User)
E_vol_activity = 50 # volume of enzyme solution in each assay plate well [uL]
S_vol_activity = 50 # volume of enzyme solution in each assay plate well [uL]
# ==================================================================================
# Run function:
# ---------------------------------------------------------------------------------def run(protocol: protocol_api.ProtocolContext): # every run function must be nested
(indented below)
# ==================================================================================
# ---------------------------------------------------------------------------------# Loading Labware
protocol.comment("\n----------EQUIPMENT LOADED----------")
# ---------------------------------------------------------------------------------# Compiling Tip Rack Locations
# compiles single or multiple tip rack locations for future pipette tip loading
def tiploccompile(TipRack_Position, TipRack_Type):
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# compiles single or multiple tip rack locations for future pipette tip
loading
dummy = isinstance(TipRack_Position,int) # checks if defined tip rack slot
is one number
# Labware: Define labware using "protocol.load_labware('name', slot)"
if dummy == False: # if more than one slot for tip rack defined
tiprackloc = [protocol.load_labware(TipRack_Type, i) for i in
TipRack_Position] # loads each tip rack in a loop
elif TipRack_Position > 0: # zero means there is no module loaded
tiprackloc = [protocol.load_labware(TipRack_Type,TipRack_Position)]
# if one tip rack is loaded
else:
tiprackloc = 'none' # no tip rack loaded, slot = 0
return tiprackloc
tiprack_left = tiploccompile(TipRack_Position_left, TipRack_Type_left) # calls
above function for tip racks associated with left pipette mounted
tiprack_right = tiploccompile(TipRack_Position_right, TipRack_Type_right) # calls
above function for tip racks associated with right pipette mounted
# ---------------------------------------------------------------------------------# Pipettes Load with corresponding Tip Rack Loactions/Type
# When you load a pipette, you can optionally specify a list of tip racks you will
use to supply the pipette.
# This is done with the optional parameter tip_racks to
ProtocolContext.load_instrument().
# This parameter accepts a list of tipracklabware objects, allowing youto specify
as many tipracks as you want
# Associating tipracks with your pipette allows for automatic tip tracking
throughout your protocol.
# This removes the need to specify tip locations in
InstrumentContext.pick_up_tip().
def pipetteload(Pipette_ModelName, pos, tiprack): # function to load tip rack
along with the pipette simultaneously
if Pipette_ModelName != 'none' and tiprack != 'none': # if pipette
type/model and tip rack is defined by user
pos_pipette = protocol.load_instrument(Pipette_ModelName, pos,
tip_racks = tiprack) # loads pipette (pos) and associates with corresponding tip rack
protocol.comment("PIPETTE LOADED: " + str(pos_pipette) + "with " +
str(tiprack)) # displays pipettes loaded and associated tip racks
return pos_pipette # function output
left_pipette = pipetteload(Pipette_ModelName_left, 'left', tiprack_left) # loads
left
right_pipette = pipetteload(Pipette_ModelName_right, 'right', tiprack_right) #
loads right
# ---------------------------------------------------------------------------------# Plate Loading
def plateload(plate_type, plate_slot, i):
if plate_type != 'none' and plate_slot != 0: # if plate is defined by user
plate = protocol.load_labware(plate_type, plate_slot) # loads plate
in defined slot
protocol.comment("PLATE LOADED: plate_" + str(i) + " = " +
str(plate)) # print
return plate # output
# user can define name of each plate (left-hand side)
plate_deltaS = plateload(plate_type_2, plate_slot_2, 2)
plate_Activity = plateload(plate_type_3, plate_slot_3, 3)
plate_Stock = plateload(plate_type_4, plate_slot_4, 4)
# ==================================================================================
# Block Commands
protocol.comment("\n----------BLOCK COMMANDS----------")
# ---------------------------------------------------------------------------------# Serial dilution of ENZYME STOCK (~1280 ng/uL)
# add 100 uL of stock to 900 uL of buffer
# transfer 100 uL of above to 900 uL of buffer
# transfer 100 uL of above to 900 uL of buffer
# transfer 100 uL of above to 900 uL of buffer
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# transfer 100 uL of above to 900 uL of buffer (this tube is now the
working enzyme solution)
# DQ substrate (D1) @ 300 ng/uL
# make sure to calibrate biorad plates with 1 mm clearance
#
#
#
#
#
#

A1
A2
A3
A4
A5
A6

=
=
=
=
=
=

mutant 1 (1000)
mutant 2 (1000)
mutant 3 (1000)
mutant 4 (1000)
WT* (700)
buffer (700)

# B1 = water (1600)
# B2 = Water (1600)
# D1 = DQ stock # 290 ng/uL (965)
# D2 = DQ stock # 290 ng/uL (965)
protocol.comment("DISTRIBUTE Mutant Enzyme IN asssay wells:")
for z in range(0,96,24):
left_pipette.pick_up_tip()
for y in range(z,z+17,8):
for x in range(y,y+6):
left_pipette.mix(2,50,plate_Stock.well(int(z/6)),rate=10.0)
left_pipette.transfer(50,
plate_Stock.wells()[int(z/6)],plate_Activity.wells()[x],new_tip='never')
left_pipette.drop_tip()
# Time: 00:15:30
protocol.comment("DISTRIBUTE WT* Enzyme IN asssay wells:")
for z in [16]:
left_pipette.pick_up_tip()
for y in range(6,47,8):
for x in range(y,y+2):
left_pipette.mix(2,50,plate_Stock.well(z),rate=10.0)
left_pipette.transfer(50,
plate_Stock.wells()[z],plate_Activity.wells()[x],new_tip='never')
left_pipette.drop_tip()
# Time: 00:18:00
protocol.comment("DISTRIBUTE protein buffer IN asssay wells:")
for z in [20]:
left_pipette.pick_up_tip()
for y in range(54,95,8):
for x in range(y,y+2):
left_pipette.mix(2,50,plate_Stock.well(z),rate=10.0)
left_pipette.transfer(50,
plate_Stock.wells()[z],plate_Activity.wells()[x],new_tip='never')
left_pipette.drop_tip()
# Time: 00:20:30
protocol.comment("DISTRIBUTE Water IN Sgrad wells:")
left_pipette.pick_up_tip()
left_pipette.transfer(32.25,
plate_Stock.wells_by_name()['B1'],plate_deltaS.rows_by_name()['B'],new_tip='never') #
WATER 390 UL

194

left_pipette.transfer(47.25,
plate_Stock.wells_by_name()['B2'],plate_deltaS.rows_by_name()['C'],new_tip='never')
WATER 567 UL
left_pipette.transfer(42.00,
plate_Stock.wells_by_name()['B1'],plate_deltaS.rows_by_name()['D'],new_tip='never')
WATER 504 UL
left_pipette.transfer(47.25,
plate_Stock.wells_by_name()['B2'],plate_deltaS.rows_by_name()['E'],new_tip='never')
WATER 567 UL
left_pipette.transfer(26.25,
plate_Stock.wells_by_name()['B1'],plate_deltaS.rows_by_name()['F'],new_tip='never')
WATER 315 UL
left_pipette.transfer(32.25,
plate_Stock.wells_by_name()['B2'],[plate_deltaS.wells_by_name()[well_name]
in ['G2','H2','G8','H8']],new_tip='never') # WATER 129 UL
left_pipette.transfer(47.25,
plate_Stock.wells_by_name()['B1'],[plate_deltaS.wells_by_name()[well_name]
in ['G3','H3','G9','H9']],new_tip='never') # WATER 189 UL
left_pipette.transfer(42.00,
plate_Stock.wells_by_name()['B1'],[plate_deltaS.wells_by_name()[well_name]
in ['G4','H4','G10','H10']],new_tip='never') # WATER 168 UL
left_pipette.transfer(47.25,
plate_Stock.wells_by_name()['B2'],[plate_deltaS.wells_by_name()[well_name]
in ['G5','H5','G11','H11']],new_tip='never') # WATER 189 UL
left_pipette.transfer(26.25,
plate_Stock.wells_by_name()['B2'],[plate_deltaS.wells_by_name()[well_name]
in ['G6','H6','G12','H12']],new_tip='never') # WATER 105 UL

for well_name
for well_name

# Time: 00:44:55
protocol.comment("SERIALLY DILUTE Substrate IN Sgrad wells:")
count = 0
for y in 66.50,47.25,42.00,31.50,26.25:
for x in range(0,89,8):
left_pipette.mix(10,50,plate_deltaS.well(x+count),rate=10.0)
left_pipette.transfer(y,
plate_deltaS.wells()[x+count],plate_deltaS.wells()[x+count+1],new_tip='never')
count = count+1
count = 0
for y in 66.50,47.25,42.00,31.50,26.25:
for x in 6,7,54,55:
left_pipette.mix(10,50,plate_deltaS.well(x+count),rate=10.0)
left_pipette.transfer(y,
plate_deltaS.wells()[x+count],plate_deltaS.wells()[x+count+8],new_tip='never')
count = count+8
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#

for well_name

for x in 0,24,6,8,32,72,48,54:
left_pipette.mix(20,50,plate_Stock.wells_by_name()['D1'],rate=10.0)
left_pipette.transfer(119,
plate_Stock.wells_by_name()['D1'],plate_deltaS.well(x),new_tip='never')
for x in 55,56,80,64,88,7,40,16:
left_pipette.mix(20,50,plate_Stock.wells_by_name()['D2'],rate=10.0)
left_pipette.transfer(119,
plate_Stock.wells_by_name()['D2'],plate_deltaS.well(x),new_tip='never')

protocol.comment("ADD SUBSTRATE TO ENZYME IN ACTIVITY PLATE:")

#

for well_name

protocol.comment("DISTRIBUTE Inital Conc. Substrate IN Sgrad wells:")

# Time: 01:11:50

#

for well_name

# Time: 00:30:55

left_pipette.drop_tip()

#

right_pipette.pick_up_tip()
for well_name in ['A12','A6','A11','A5','A10','A4','A9','A3','A8','A2','A7','A1']:
right_pipette.mix(2,50,plate_deltaS.wells_by_name()[well_name],rate=10.0)
right_pipette.aspirate(50,plate_deltaS.wells_by_name()[well_name],rate=0.5)
right_pipette.well_bottom_clearance.dispense = 3
right_pipette.dispense(50,plate_Activity.wells_by_name()[well_name])
right_pipette.drop_tip()
# Time: 01:14:45
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APPENDIX E: The Enzyme Cytochrome P450 (CYP201A2)
Introduction

The enzyme, CYP201A2, however, is under studied and, with little knowledge and
no crystallographic structure, it makes it difficult for one to rationally immobilize the
enzyme onto a surface without compromising its function. To begin designing effective
means for immobilization, a homology model of CYP201A2 is created and shown in Figure
E-1.

N-terminus

Figure E-1. Homology model of CYP201A2, made up of ten PDB structures with substantial coverage and
sequence similarity in Chimera: 2VE3 (cyanobacterial phytochrome Cph1), 5IRQ (Human steroidogenic
cytochrome P450 17A1 (CYP17A1)), 4R21 (Zebra fish cytochrome P450 17A2) 5TL8_A Naegleria fowleri
CYP51), 1WOF (SARS-CoV Mpro), 3DBG (Cytochrome P450 170A1 (CYP170A1)), 3K9V (KIAA1718 Jumonji
domain), 3MDM (Cytochrome P450 46A1 (CYP46A1)), 4H24 (Cytochrome P450BM3-CIS cyclopropanation
catalyst), and 5VEU (Human Cytochrome P450 3A5 (CYP3A5))

Very little is known about the structure of CYP201A2, but the homology model
shows which region of the protein is necessary and possibly superfluous to its activity.
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The region of importance for enzymatic activity is the iron containing heme group and its
associated region. Cytochrome P450 enzymes generally share conserved heme group
with a cysteinyl sulfur for heme iron coordination (Berne et al., 2007). The heme group in
the homology model is near the only cysteine in CYP201A2 which may indicate the
sulfhydryl’s importance in reducing the iron core of the heme group during catalytic
operations. Site-directed mutagenesis to incorporate cysteines as means for linker
attachment may induce disulfide bridge formation and detrimentally affect the enzyme’s
catalytic efficiency; however, it is possible to carefully choose cysteine mutation sites to
try to avoid such problems. Alternative methods for immobilization, such as biotinylation
to the termini to create a point of attachment should be considered instead of using
cysteine, at the cost of flexibility in specific attachment point. The homology model shows
a long unstructured region of the N-terminus. If the unstructured peptide does not have
function, the N-terminus of CYP201A2 is a site for immobilization without compromising
enzymatic activity. The leader sequence or signal peptide on the N-terminus
(MSIAAIDDRPASRAPLIPPTPPRAPENLSALGR) could also be essential for cell membraneassociation.
Three gene constructs containing a fusion CYP201A2 are developed for the
improved expression, purification, immobilization, and quantitation in Figure E-2.
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Figure E-2. Gene constructs of CYP201A2 variants. (Top to bottom) CYP201A2+mCherry2, CYP201A2
without leader sequence + mCherry2, and mCherry2.

The three constructs will help us determine the effects, if any, of the leader sequence
on soluble expression and functionality. The top construct contains the entire CYP201A2
including its linker sequence fused to a fluorescent protein, mCherry2. The middle
construct is the same as the top construct except the leader sequence is removed.
Comparing the top two constructs expression and functionality can determine the
importance of the leader sequence. Finally, the bottom construct has the entire
CYP201A2 gene removed. This construct acts as the control and will help track the
efficiency of expression and immobilization. Each component plays an integral role in
improving some of the problems faced with T4L immobilization. These components are
described in depth below.
AviTag (15 aa) is the recognition sequence for the biotin-protein ligase, BirA (Beckett
et al., 1999) located at the N-terminus. Short ags on the N- or C- terminus have been
shown to have no overall effect on the proteins structure (Carson, Johnson, McDonald,
Brouillette, & Delucas, 2007). The fusion protein’s AviTag is biotinylated when reacted,
under mild conditions, with BirA. This allows for the fusion protein to be immobilized
using streptavidin coated surface with relative ease. The biotin-streptavidin complex
formation will be used as means for immobilization because its high binding affinity
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(nearly covalent), streptavidin-coated particles will hopefully act as a blocking agent,
covering potential denaturation sites and reduce nonspecific binding, and streptavidincoated particles are readily available. Two different streptavidin-coated polymer surfaces
will be tested for the effects of polymer surface chemistry on the immobilized specific
activity, Dynabeads M-270 (carboxylic Acid, hydrophilic) and M-280 (hydrophobic,
tosylactivated) streptavidin, diameter of 2.8 µm. Since CYP201A2 may is naturally
membrane associated, the hydrophobic surface may help to stabilize the enzyme
structure. Single cysteine inserts for site-directed immobilization are avoided to prevent
potential disulfide formation with the native cysteine that interacts with the heme group
binding site. Using only one attachment point (N-terminus) will prevent studying the
effects of orientation on specific activity, however, the unstructured region on the Nterminus is most likely not integral to the enzyme’s activity and gives the best chance of
retaining activity when immobilized.
IgA hinge region (15 aa) forms a kink in the structure (recommended linker from
Avidity), allowing the AviTag to protrude from the rest of the fusion protein. In turn, it will
increase BirA accessibility for biotinylation and eventual immobilization efficiency. When
dealing with site-directed cysteine mutations, some cysteines were inaccessible or buried,
potentially leading to a decrease in conjugation efficiency. To improve conjugation
efficiency by using a IgA hinge region that protrudes from the enzyme surface as the
attachment site.
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The entire CYP201A2 gene was codon optimized for Escherichia coli expression.
CYP201A2 is in total 460 amino acids (aa) long, with the first 32 aa being the unstructured
n-terminus region (Figure E-1, grey) or leader sequence. It is suspected that the leader
sequence to not be important to the enzyme’s function due to its lack of structure. To
know for certain if the leader sequence acts as a signal peptide or means of attachment
to the cell membrane, the leader is removed in one construct to see if soluble expression
is improved.
Just downstream of CYP201A2 gene a short linker (GGGS) followed by a Tobacco Etch
Virus (TEV) site (amino acid sequence: ENLYFQ|S). TEV protease recognizes this sequence
and cuts the peptide between glutamine and serine. Having a cut site in between our
enzyme of interest, CYP201A2, and the fluorescent protein (mCherry2) allows for the
removal of fluorescent protein after immobilized enzyme concentration quantitation to
prevent any negative effects mCherry2 may have on CYP201A2’s immobilized activity.
A fluorescent protein, mCherry2 (235 aa), is fused to CYP201A2. mCherry2 is located
downstream of CYP201A2 to ensure that when a fluorescent signal is expressed,
CYP201A2 has also been completely translated. Having a fluorescent protein can track the
levels of expression, purification, and immobilization spectroscopically. For this current
application, mCherry2 is preferred over other fluorescent proteins, such as Green
Fluorescent Protein (GFP), because mCherry2 has an excitation and emission (589/610)
spectra that does not interfere amine quantitation assay (fluorescamine, 380/470) and it
produces a more intense fluorescent signal and less toxic than its parent, mCherry (Y.
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Shen, Chen, Wu, Shaner, & Campbell, 2017). Furthermore, expressing an insoluble
enzyme fused with a soluble protein sometimes helps solubilize the fusion protein. An
added benefit of mCherry2 is that it contains a single cysteine at position 138. That
cysteine residue is at the exposed opening of mCherry2’s beta-barrel on the opposite side
of the N- and C-terminus. If chosen, immobilization via a maleimide functional group is
possible.
FLAG Tag (8 aa) is located at the C-terminus of the fusion process. This tag will be used
to purify the fusion protein prior to immobilization. A FLAG tag at the C-terminus
guarantees that all eluted, purified protein, contains the AviTag, CYP201A2, and mCherry2
components of the fusion protein, essential to immobilization and detection. Other tags
like strep tag and his-tag are avoided because the purification process could possibly
affect immobilization orientation and the bound heme group of CYP201A2, respectively.
One benefit of studying CYP201A2 is that there is very little known about its
capabilities. With roughly five journal articles, currently, that mention this enzyme, there
is still a lack of understanding expression, localization, activity, and immobilized activity.
Previously, the peripheral membrane protein CYP201A2 expressed in E. coli BL21-AI
yielded of the target protein at 1-4 mg/L (Bernaudat et al., 2011). Altering CYP201A2 for
soluble expression in the cytoplasm may supersede the current insoluble expression
limitations. Initial work to improving soluble expression is described in this Appendix. In
turn, future development of CYP201A2 activity and immobilized activity is yet to be
determined.
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Expression CYP201A2 and Variants

Method

A 10 mL culture of E. coli BL21(DE3) cells containing CYP201A2 (or corresponding
variants) expression plasmid is grown to an OD of 0.47. The cultures are diluted to 0.01
OD in a fresh 25 mL of TB media. Cell cultures are further grown until they reach an OD of
1.1-1.6 and induced with IPTG at a final concentration of 0.5 mM. One milliliter of cell
culture is loaded into a culture plate where the absorbance at 600 nm and the relative
fluorescence units (RFU, Ex/Em 589/610 nm) is monitored for 1-12 hours thereafter. The
protein expression per cell culture turbidity (RFU/A600) of cultures that were not induced
with IPTG were subtracted from that of the IPTG induced cultures.
Frozen cell pellets at equal wet mass were collected were resuspended in chilled
5 mM MES, 0.5 mM EDTA, 1 mM KCl, 0.6 M sorbitol and 1 mM PMSF. Cells were lysed
with heavy mixing for 1 minute followed by centrifugation to separate the insoluble from
soluble fraction. The cell debris was resuspended in the same volume as that of the
supernatant. The relative fluorescence units of each fraction were measured at Ex/Em
589/610 nm.
Results

Adapting the enzyme for soluble expression could encourage the pursuit of this
enzyme in their functional studies. Comparing the expression levels of each construct in

203

Figure E-3 shows that CYP201A2 fusion expresses significantly less than the positive on
control, mCherry2. Removing the signal peptide or leader sequence from the CYP201A2
N-terminus result is slightly higher expression than its parent sequence. However,
localization of CYP201A2 demonstrate expression in the insoluble fraction while

Protein Expression / Cell Culture Turbidity,
[RFU/A600]

mCherry2 expresses in the soluble fraction as seen in Figure E-4.

CYP201A2+mCherry2
10000

(CYP201A2-Signal Peptide)+mCherry2
mCherry2

5000

0
0

5

10

Time after Induction,
[hr]

Figure E-3. Protein expression of cell lines containing different CYP201A2 variants. The protein expression
is modeled using the Gompertz growth formula in Graphpad. The resulting lag time for all cell lines is 0.280.30 1/hr. The maximum protein expression per cell culture densities are 1975±37, 2377±35, and
15000±230 RFU/A.U. for CYP201A2+mCherry2, (CYP201A2-signal peptide)+mCherry2, and mCherry2,
respectively.
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Figure E-4. (Left) Comparison of insoluble and soluble fractions of CYP201A2+mCherry in BL21(DE3) E. coli
cells after sonication. Samples C1 and C2 are uninduced while samples R1, R2, and R3 are induced with
IPTG. SDS-PAGE gel stained with Coomassie Blue with CYP201A2 bands indicated by red dots. (Right)
Comparison of soluble expression level of CYP201A2 variants with error bars representing sample standard
error.
.
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APPENDIX F: Materials
Plasmid Purification and Concentration
•
•

Zyppy™ Plasmid Purification Kits, Zymo Research (D4037)
DNA Clean & Concentrator™ Kits, Zymo Research (D4004)

Reducing agents
•
•

•

Dithiothreitol (DTT, Cleland's reagent) for biotechnology from VWR (cat# 97061340)
Tris (2-carboxyethyl)phosphine Hydrochloride (TCEP), Quanta BioDesign, Ltd.
o Stock TCEP solutions were created by first dissolving the TCEP in 50 mM
sodium buffer and 50 mM NaCl (7.5). Then pH of the buffered TCEP was
adjusted to 7.5 using NaOH. Stock solutions were stored in -20 °C, void of
light.
Β-Mercaptoethanol (βME) or 2-mercaptoehtanol

Protein Modifiers and Crosslinkers
•
•
•
•
•
•

•
•
•
•

Acetic anhydride from Sigma-Aldrich (242845)
Acetic anhydride-D6 (D, 98%) from Cambridge Isotope Laboratories, Inc. (Cat #
DLM-1162-5)
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC),
commercial grade, poweder from Sigma-Aldrich (E7750)
GMBS (N-γ-maleimidobutyryl-oxysuccinimide ester), cat# 22309 from Thermo
Fisher Scientific (stock concentration = 234 mM)
MBS (m-maleimidobenzoyl-N-hydroxysuccinimide ester), cat# 22311 from
Thermo Fisher Scientific (stock concentration = 232 mM)
LC-SMCC (succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxy-(6amidocaproate)), cat# 22362 from Thermo Fisher Scientific (stock concentration
= 225 mM)
SM(PEG)2 (PEGylated SMCC crosslinker), cat# 22102 from Thermo Fisher
Scientific (stock concentration = 250 mM)
N-Ethylmaleimide (NEM) from Thermo Fisher Scientific (cat# 23030)
EZ-LinkTM Maleimide-PEG11-Biotin crosslinker from Thermo ScientificTM (cat#
21911)
Alexa Fluor™ 488 C5 Maleimide from Thermo Fisher Scientific (cat# A10254)

206

Polymer Beads
•

•

•
•

Polybead® Amino Microspheres were purchased from Polysciences, Inc. (catalog
# 17010-5, lot # 704297). These polystyrene micron spheres have a mean diameter
of 0.94 ± 0.0282 µm can some stored in 2.7 % solids (w/v) in an aqueous
suspension. Per the manufacturer’s description polystyrene beads are made
through a process of emulsion polymerization. It is estimated that only 2% crosslinking occurs during the process. After functionalizing polystyrene with carboxyl
groups, a DEPC-carbodiimide (EDAC) zero-length linker is used to create amine
functional groups on the polybead surface.
DynabeadsTM M-270 Amine were purchased from Thermo Fisher Scientific
(catalog # 14307D). These aminated magnetic beads are comprised of an iron core
surrounded by a highly crosslinked polystyrene coat. A hydrophilic layer of glycidyl
ether then coats the polystyrene shell. The stock concentration is ~ 2 x 109
beads/mL or ~ 30 mg/mL in an aqueous suspension. The active amine functionality
is approximately 100-200 μmol/g bead.
DynabeadsTM M-280 Streptavidin from Thermo Fisher Scientific (11205D)
Ocean NanoTech Maleimide Hi-Sur Magetic Beads, diameter =1 µm (Product ID:
HM1001)

Filters
•
•
•
•
•

ZebaTM Spin Desalting Columns, 7k MWCO from Thermo Fisher Scientific (cat#
89883)
PierceTM Dye and Biotin Removal Spin from Thermo Fisher Scientific
Whatman 0.45 µm syringe filers from VWR (cat# 76211-012)
GD/X 25 mm sterile, 0.45 µm PES, (cat# 6896-2504)
Nalgene® Rapid-Flow™ Filter Units and Bottle Top Filters, PES Membrane, Sterile,
Thermo Scientific, Bottle-Top Filters Only, Receiver Capacity=500 mL, Fits Neck
Size=45, Membrane Diameter=75 mm, Pore Size=0.2 µm (cat# 595-4520 )

Assay Kits
•
•
•
•

AmpliteTM Fluorimetric Fluorescamine Protein Quantitation Kit *Blue
Fluorescence* (AAT Bioquest®, cat # 11100)
Amplite Fluorimetric Maleimide Quantitation Kit, green fluorescence (cat# 5523,
AAT Bioquest).
EnzChek Lysozyme Assay Kit (E-22013)
HRP Activity Assay
o Peroxidase from horseradish (P28250-50KU) from Sigma-Aldrich
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•
•

o Azino-bis-[3-ethylbenzthiazoline-6-sulphonate] (ABTS) Diammonium salt
from Amresco (0400-1G) diluted to 0.2 g/L in water
o Hydrogen Peroxide (H2O2) solution at 35 % (w/w) from VWR BDH
Chemicals (BDH7814-3)
TM
Pierce BCA Protein Assay Kit from Thermo Fisher Scientific (cat# 23225)
Whatman® Panpeha™ pH indicator strips, pH range 0 to 14, pH indicators and
test papers from Cytiva (cat# 10360005)

Equipment
•
•
•
•
•
•
•
•

•
•
•
•
•
•
•

Zetasizer Nano MS from Malvern Instruments
Thermalcycler for PCR from Bio-Rad
Synergy MX BioTek microplate reader (for fluorescent readings primarily)
Absorbance microplate reader, Epoch 2, from BioTek (for absorbance readings
primarily)
LICOR Imager (for Coomassie stained fluorescent imaging)
NanoDrop 2000c from Thermo Fisher Scientific
NGC Chromatography System from Bio-Rad Laboratories
Sorvall Legend XFR Centrifuge from Thermo Fisher Scientific with swing bucket
(75003607) and holders (75003792 and 75003638). High centrifuge speeds of
15000 to 26200 x g a Fiber Lite (F15- 8x50 cy). Sorvall 75006449 Microplate
Buckets.
Sonic Dismembrator: Ultrasonic Processor, FB-120 model from Thermo Fisher
Scientific with a 1/4” probe (FB4435)
New Brunswick Scientific Excella E24 Incubator Shaker Series
VWR® Tube Rotator Unit with US Power Cord, 120V (cat# 10136-084)
Branson Ultrasonics™ Bransonic™ Ultrasonic Cleaning Bath Accessory,
Perforated Trays (Catalog number 22-066282)
Corning® LSE™ Digital Microplate Shaker (6780-4)
Welch™ Compact Aspiration/Filtration Vacuum Stations: Cell Culture Aspiration
Station Model 2515 Series
InvitrogenTM DynaMagTM-2 Magnet (12321D)

Reagents
•
•
•
•

Ethylenediaminetetraacetic acid, anhydrous, crystalline, BioReagent, suitable for
cell culture (EDTA) from Sigma-Aldrich (E6758)
1 % (w/v) nonfat dehydrated milk – Carnations
Acetic acid, Glacial 96% from EMD Millipore (AX0073-9)
Tween® 20, BioXtra, viscous liquid from Sigma-Aldrich (P7949)
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•
•

L-cysteine HCL (L-cys) from Fisher (24-301-100g)
Methyl sulfoxide (DMSO), extra dry, anhydrous, with AcroSeal (AC610421000)

Cell Lines
•
•
•

NEB® 10-beta Competent E. coli from NEB (for cloning)
BL21(DE3) Competent E. coli from NEB (C2527), for protein overexpression
Dh5α from addgene containing R96C (#18448), A98C (#18466), T152C (#18626),
and V149C (#18616)
o T4L WT* was a gift from Brian Matthews (Addgene plasmid # 18111 ;
http://n2t.net/addgene:18111 ; RRID:Addgene_18111)

Polymer Chain Reaction (all from New England BioLabs Inc.)
•
•
•
•
•
•

dNTPs
Q5 HF DNA polymerase
5x Q5 Reaction buffer
5x Q5 GC Enhancer
Phusion DNA polymerase
5x Phusion GC Buffer

Software
•
•
•
•
•
•
•
•
•
•
•

SnapGene for plasmid maps
Image Studio Lite v5.2 for SDS-PAGE gel imaging and signal quantitation
Image Lab for SDS-PAGE gel imaging
MATLAB R2019A for initial rate activity processing
GraphPad Prism 9 for figures containing graphs
UCSF Chimera 1.15rc for protein structural modeling
MEGA7 for amino acid consensus allignment
MarvinSketch for chemical reaction figures
ZetaSizer Software for zeta potential measurements
CytExpert for flow cytometry
ChromLab Software for FPLC analysis and control

Cell Media and Reagents
•
•
•
•

Bacto™ Yeast Extract, GibcoTM, (cat# 212750)
Bacto™ Tryptone, GibcoTM, (cat# 211705)
Sodium chloride for molecular biology, DNase, RNase, and protease, none
detected, ≥99% (titration), Sigma-Aldrich (cat# S3014-10kg)
Potassium dihydrogen phosphate (monobasic), anhydrous ACS, from VWR (cat#
97062-346)
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•
•
•
•
•

•

Glycerol, 99.5%, for molecular biology, DNAse, RNAse and Protease free, Thermo
Scientific™, (cat# AC327255000)
Lennox Broth (LB) media contains 10 g of tryptone, 5 g of yeast extract, and 5 g
of sodium chloride per liter.
2xYT media contains 16 g of tryptone, 10 g of yeast extract, and 5 g of sodium
chloride per liter.
Autoinduction media ZYM-5052 (Studier, 2005)
Terrific Broth (TB) contains 24 g of yeast extract, 20 g of tryptone, 4 mL of
glycerol, 0.017 M potassium phosphate monobasic, and 0.072 M potassium
phosphate dibasic
Isopropyl β-D-1-thiogalactopyranoside (IPTG) from Teknova (367-93-1)

Antibiotics
•

Ampicillin Sodium Salt (Amp) from Fisher Scientific (BP1760-25) at
concentrations of 0.1 g/L, unless otherwise stated.

Buffers
•

•
•

0.1 M MES Buffer made from dissolving 19.2 g of MES hydrate, BioPerformance
Certified, suitable for cell culture, ≥99.5%, from Sigma Aldrich (M2933) into 1 L of
water and adjusting to desired pH using NaOH0
Tris-buffered saline (20 mM Tris, 150 mM NaCl, pH 7.5) with 0.1 % Tween-20
(TBST)
Phosphate Buffered Saline solution made from Phosphate Buffered Saline
Tablets, Dulbecco’s Formula, 1X (cat# 1860049)

Antibodies
•
•
•

Mouse Anti-T4 Lysozyme (T4L) Antibody, clone 6A6 from Millipore Sigma
(MABS1289)
Goat anti-mouse IgG (H+L) SuperclonalTM, Secondary Antibody, Alexa Fluor 647
from Thermo Fisher Scientific (cat# A28181)
Rat anti-Mouse IgG1 Secondary Antibody FITC, eBioscienceTM (cat# 11-4015-82)
from Thermo Fisher Scientific

Well Plates and Other Disposables
•
•
•

Nuclon Delta MultiDish 48 Well Plate, Sterile, Thermo Scientific (cat # 150687)
for cell growth
96 well microplate, PS, F-bottom, non-binding, black (655900) for fluorescent
assays from Greiner Bio-One
Clear, flat-bottom, 96-well plates from Corning (3370) for colorimetric assays
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•
•

Fisherbrand Petri Dishes with Clear Lid (100mm x 15mm, 25/sleeve) from Fisher
Scientific (FB0875712)
Amersham Protran Nitrocellulose Western Blotting Membranes, GE Healthcare,
Dimensions=300 mm × 4 m, Packaging=Roll, Pore Size=0.45 µm (10600002)

MALDI-TOF
•
•
•
•
•
•
•
•

•
•
•

Acetonitrile, anhydrous (max. 0.003% H₂O) ≥99.9%, HiPerSolv CHROMANORM®,
super gradient grade for HPLC, VWR Chemicals BDH®
Sinapinic acid, SA (sigma, a7906-10g)
alpha-Cyano-4-hydroxycinnamic acid (CHCA) ≥99.0%, ProteoSpec™ matrix
substance for MALDI from Ricca Chemical RMB15101510C
SP 96 target Bruker Daltonik GmbH (8280799)
Bruker MicroFlex LRF (#601800), LP_protMIX.par manufacturer method, 2000
shots, laser level 40%
Trifluoroacetic acid (TFA), 99.5%, for biochemistry, ACROS Organics
Isopropyl Alcohol, HiPerSolv CHROMANORM® for HPLC (IPA) from VWR
BDH20880.100E
Matrix: solution
o 10 mg/mL of CHCA or SA in 50/50 acetonitrile/water with 0.15% TFA
o 10 mg/mL of CHCA in 50/50 acetonitrile/ethanol with 0.2% TFA
TA30 (30:70 [v/v] Acetonitrile:TFA 0.1% in water)
HyperSepTM Tip for Reversed Phase (C18, cat# 60109-201)
Kimwipes Delicate Task Wipers, White, 4.4" x 8.4" from Kimberly-Clark (34155)

SDS-PAGE Materials from Bio-Rad Laboratories
•
•
•
•
•
•
•
•
•
•

All Blue Protean standard (cat# 161-0393)
2x Laemmli sample buffer
Mini-PROTEAN® TGX™ Precast Gels 4-20 % (cat# 4561096)
Mini-PROTEAN Tetra Vertical Electrophoresis Cell from Bio
10x SDS-PAGE running buffer
PowerPac™ HC High-Current Power Supply
Bio-Rad Molecular Imager (ChemiDoc XRS+)
XcitaBlue™ Conversion Screen for fluorescent capture
White Conversion Screen
Bio-Safe™ Coomassie Stain

Chromatography Resin Column
•

HiTrap SP HP, 5 x 5 ml for cation exchange (Cytiva Life Sciences 17115201)
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